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Nature uses multivalency as one of the most important governing principles to control 
selective molecular recognition and assembly. By combining a large number of weak 
interactions, it is possible to obtain high affinity, selective and reversible non-covalent 
binding processes. Multivalency has also become an important tool in the design of synthetic 
molecular systems. The result of multiple binding events is not just a simple sum of individual 
contributions due to cooperative interactions between binding sites. 
The main part of this thesis deals with the study of chelate cooperativity in multivalent 
supramolecular systems. Firstly, a well-known H-bonded rosette system was revisited and the 
effective molarity was determined experimentally by 
1
H NMR titrations to be around 2 M, 
which is a high chelate cooperativity compared to other supramolecular systems. Moreover, 
the concept of peripheral crowding in solution was revisited, since rosettes based on less 
bulky pyrimidines showed higher stabilities and effective molarities than the rosettes based on 
bulky pyrimidines. 
The following two chapters deal with efforts towards a supramolecular system inside a 
porphyrin nanoring. The porphyrin nanoring shows the highest value of effective molarity 
reported in the literature and is, therefore, a great system to study the cooperative behaviour 
when a covalent ligand is replaced with a supramolecular system. The first studied system 
was based on small molecules containing simple hydrogen-bond acceptors and donors. 
Unfortunately, solubility issues led to the termination of the project. The second system used 
the hydrogen-bonded rosette motif. A number of different pyridine-pyrimidine and pyridine-
barbiturate ligands were synthesised and their assembly inside the porphyrin nanoring was 
studied in detail by UV-vis-NIR experiments. The effective molarities for the sequential 
binding of the rosette systems to 6-ring were determined to range from 0.23 to 3.7 M, which 
is significantly lower compared to the system that utilised a covalent hexadentate ligand 
(126 M). 
The final part of the thesis introduces a new class of hybrid hydrogen-bonded/metal-
coordinated cages based on the rosette motif. These complexes are a rare example of 
architectures where both hydrogen-bonding and metal-coordination form the crucial part of 
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This thesis deals with several topics and thus they will be introduced separately. The 
first part of the introduction describes multivalent systems and different types of cooperativity 
and its quantification. The second part deals with porphyrin nanorings, followed by a section 
that discusses a hydrogen-bonded rosette motif and the last part introduces different molecular 
containers. 
 
1.1.  Multivalency, cooperativity and effective molarity 
1.1.1. General 
Nature uses multivalency as one of the most important governing principles to control 
selective molecular recognition and assembly. By combining a large number of weak 
interactions, it is possible to obtain high affinity, selective and reversible non-covalent 
binding processes. Multivalency has also become an important tool in the design of synthetic 
molecular systems.
1-3
 The result of multiple binding events is not just a simple sum of 
individual contributions due to cooperative interactions between binding sites.
4,5
 Two types of 
cooperativity can be identified in multivalent systems: allosteric and chelate cooperativity. 
Allosteric cooperativity relates to a change in the intrinsic interaction properties of one 
binding site as a consequence of an intermolecular interaction at another nearby binding site. 
Chelate cooperativity relates to an increase in binding affinity due to the formation of multiple 
interactions between two molecules compared with simple monovalent interactions.
6
 The term 
“chelate” was first used by Morgan and Drew in 1920 to describe the binding of a divalent 
ligand in coordination complexes.
7
 The chelate effect describes the increased stability 
observed for complexes formed with multivalent ligands compared with complexes formed 
with monodentate ligands. Although the term chelate has its origins in the field of 
coordination chemistry, it is generally used to describe cooperative multivalent binding in 
different areas of chemistry. Chelate cooperativity is quantified by the effective molarity. The 
text below describes its origins as well as shows its application in supramolecular chemistry.  
 
It has been known empirically for a long time that intramolecular reactions are usually 
faster than intermolecular reactions. In 1934, Stoll proposed that the cyclisation constant (C) 
defined in Equation 1.1 could be used to quantify this phenomenon.
8
 In the same year, Kuhn 
suggested that a theoretical parameter Ceff could be used to predict the rate constant for an 












       (1.1) 
where kintra is the rate constant for the intramolecular reaction (cyclisation) and kinter is the rate 
constant for the bimolecular reaction (polymerisation).  
 
The constant C has units of concentration and denotes the concentration at which the 
intramolecular and intermolecular reactions have the same rate. In the 1970s, the term 
effective molarity (EM) was widely adopted to describe this parameter and to characterise the 
rate enhancements observed for intramolecular reactions.
10-12
 The effective molarity defined 
by Equation 1.1 is a kinetic EM, because it is based on the ratio of two reaction rates, but it is 
possible to define a thermodynamic EM in the same way, if equilibrium constants are 








        (1.2) 
where Kinter is the equilibrium constant for formation of an intermolecular bond, Kintra is the 
equilibrium constant for formation of an intermolecular bond, and Kref is the equilibrium 
constant for formation of an intermolecular bond in a closely related reference system. 
 
The application of the EM concept to supramolecular complexes is illustrated in 
Figure 1.a. The first A•B interaction is an intermolecular process associated with an 
equilibrium constant Kinter leading to the singly bound open complex o-AA•BB. This 
intermediate can either cyclise via an intramolecular process to form the doubly bound closed 
complex c-AA•BB with an equilibrium constant Kintra, or it can form higher order complexes 
via intermolecular binding processes. In most cases, Kinter cannot be measured directly, and 
the experimental parameter that is commonly reported is the global equilibrium constant Kf 
for assembly of the closed complex c-AA•BB from AA and BB (Figure 1.b). Thus a different 
approach is required to determine Kinter. Reference systems that form monovalent A•B 
interactions are commonly used to measure Kref (Figure 1.c), and this parameter is assumed to 
be equivalent to Kinter in Equation 1.2. However, it is clearly important that an appropriate 
reference system is used and that any contributions from allosteric cooperativity in the 
multivalent system can be quantified.
6
 The effective molarity for the system shown in 
Figure 1.1 is then given by Equation 1.3. 





Figure 1.1. (a) Stepwise assembly of a cooperative supramolecular complex with two binding 
interactions c-AA•BB. The first intermolecular equilibrium leads to the open o-AA•BB 
complex with one intermolecular interaction. This complex can cyclise via an intramolecular 
interaction (Kintra) or polymerise via a series of intermolecular interactions (Kinter). (b) The 
overall equilibrium observed for formation of the closed complex c-AA•BB. (c) Reference 
systems that can be used to measure Kref for a monovalent interaction, which serve as an 
estimates for Kinter in (a).  







2          (1.3) 
 
The value of EM obtained from Equation 1.3 includes a contribution from the 
statistical degeneracies of the complexes in Figure 1.1. It is possible to correct the value of 
EM for this contribution by using a statistical factor Kσ, which can be estimated based on the 
symmetry of the complex (Equation 1.4).
13-16 
Both statistically corrected and uncorrected 





2         (1.4) 
 
Equation 1.4 can be generalised to multivalent systems that make multiple non-covalent 









       (1.5) 
where n is the number of intermolecular binding interactions made in the multivalent 
complex, EMi are the effective molarities for each of the intramolecular interactions made in 
the multivalent complex, Kf is the equilibrium constant for formation of the multivalent 
complex and Ki are the equilibrium constants for formation of the corresponding monovalent 
interactions in the appropriate reference systems. 
 
The equilibrium constant for formation of the intramolecular interaction in Figure 1.1a 
is Kref × EM, so this parameter is the most important indicator of chelate cooperativity in 
supramolecular systems. When the product Kref × EM is much larger than one, cooperative 
assembly of the closed complex occurs, but when Kref × EM is less than one, the 
intramolecular interaction is not formed. 
  




1.1.2. Distribution of effective molarities and extreme values 
Figure 1.2 shows a distribution of thermodynamic effective molarities in 
supramolecular systems. The median value is 100 mM and EM > 10
2
 M are considered to be 
extremely high, since less than 5% of the reviewed supramolecular systems showed the values 
of this magnitude.
17
   
 
 
Figure 1.2. Distribution of thermodynamic effective molarities in supramolecular systems.
17
   
 
Examples of complexes with unusually large values of EM are discussed below. As 
expected, these systems are rigid and highly preorganised, so that losses in conformational 
entropy on formation of cooperative intramolecular interactions are minimised. However, the 
two examples discussed below also highlight the sensitivity of systems that have 
exceptionally high EM values to subtle changes in molecular structure. 
 
The Anderson group has measured EM values for a range of cyclic zinc porphyrin 
oligomers binding to oligopyridine ligands that were used as templates in the synthesis.
18-20
 
An exceptionally high value of EM (126 M) was found for the complex shown in Figure 1.3a. 
This value of EM is actually the average EM for five intramolecular interactions. Anderson 
used a series of ligands with two, three, four, and five pyridine binding sites to determine 
stepwise EMs for each binding interaction in the hexamer.
21
 The value of EM for the first 
intramolecular binding interaction is 100 mM, which is comparable to the value found for the 
majority of supramolecular complexes (see Figure 1.2). However, all four subsequent 
intramolecular binding interactions have exceptionally high values of EM of 10
3
 M. 
Presumably, the first intramolecular binding interaction organises the complex in a rigid 
geometry that is a precise match for subsequent binding interactions. 






Figure 1.3. (a) Anderson’s zinc porphyrin-pyridine complex which has a very high binding 




) and (b) the reference system (Ar are solubilising groups). 
 
  




The González-Rodríguez group have studied the self-assembly of cyclic hydrogen-
bonded tetramers based on nucleic acid base-pairs (Figure 1.4).
22
 The tetramer is extremely 
stable and persists in very competitive solvent environments (33% dimethylsulfoxide in 
chloroform). The value of EM for cyclisation interaction leading to the tetramer shown in 
Figure 1.4a is 860 M. It is interesting to note that the exceptionally high EM observed for this 
system depends critically on the base-pairing system. The corresponding cyclic hydrogen-
bonded tetramer prepared using 2-aminoadenine-uracil base-pairs (Figure 1.4c) in place of the 
guanine-cytosine base-pairs in Figure 1.4a has an EM of 100 mM, which is comparable to the 
value found for the majority of supramolecular complexes (see Figure 1.2).
23
 In the following 
work, they showed that also conformational equilibria and the length of the monomer have a 









Figure 1.4. (a) González-Rodríguez’s cyclic hydrogen-bonded tetramer based on guanine-




 are solubilizing groups). (c) An 
alternative base-pairing system based on 2-aminoadenine-uracil. 




1.2. Porphyrin nanorings 
Two important findings started the recent flourishing development in the field of 
porphyrin nanorings.
26
 Firstly, Anderson and Sanders showed in 1990 that the addition of 
feasible multivalent pyridine ligand can result in the template synthesis of specific cyclic 
porphyrin oligomers (Figure 1.5).
27
 By using a bidentate pyridine ligand, the yield of the 
dimer increased by approximately 50 percentage points to 70% compared to a reaction with 
no template present at all. Similarly, when a tridentate ligand was used, the trimer was 




Figure 1.5. Simplified scheme for template synthesis of cyclic porphyrin oligomers. Reaction 
conditions: CuCl, TMEDA, DCM, air. 
 
The second finding was the creation of meso-alkynyl porphyrins chemistry. Anderson 
synthesised the first of these in 1992 (Figure 1.6a).
28
 After that, the Anderson group prepared 
a large number of various linear oligomers and extensively studied their supramolecular 
behaviour (Figure 1.6b),
29










Figure 1.6. Meso-alkynyl porphyrins prepared by the Anderson group: (a) the first example 
prepared and (b) porphyrin ladder. 
 
In 2007, the Anderson group connected the two concepts. They used a linear 
porphyrin octamer based on a meso-alkynyl porphyrin and an octadentate pyridine ligand for 
the first reported synthesis of a porphyrin nanoring (Scheme 1.1). The cyclic oligomers 
prepared by Anderson and Sanders 17 years before this contribution (Figure 1.5) cannot be 
considered as genuine rings, since their diphenylethyne arms are perpendicular to the 
porphyrins and therefore these molecules lack the circular π-conjugation that is found in the 
porphyrin rings. 
 
Since this seminal paper, the Anderson group has used the template method for the 








 and many 
others up to a 40-ring
33
) as well as complex structures such as a “Russian dolls” complex that 





















1.3. Rosette motif 
1.3.1. General 
The rosette motif is derived from the lattice of melamine and cyanuric acid complex 
mixed in a 1:1 ratio as shown in red in Figure 1.7.
39
 There are other two motifs that can be 
derived from this lattice – a linear tape (blue) and crinkled tape (green). 
 
 
Figure 1.7. The melamine•cyaunuric acid lattice showing rosette (red), linear tape (blue) and 
crinkled tape (green) structures. 
 
The group of Whitesides pioneered the use of different compounds based on melamine 
together with derivates of cyanuric and barbituric acids, to prepare many complexes 
exhibiting all the structural motifs shown in Figure 1.7.
39
 A system based on  melamine M 
and barbiturate B that forms the rosette M3•B3 is shown as an example in Figure 1.8.
40
 This 
complex is probably the most studied and best characterised system of all.  
 





Figure 1.8. Rosette M3•B3 formation from a barbiturate B and a melamine M. 
 
The Whitesides group used non-polar solvents, such as chloroform, to study these 
complexes in solution. To characterise the complexes, several techniques have to be used.
39
 
The first hint of a successful formation of a rosette complex is a change in solubility. Both of 
the rosette building blocks (melamine and cyanuric/barbituric acids derivates) are usually 
poorly soluble in chloroform. They have to be dissolved in more polar solvent first, such as 
methanol and mixed together. After removal of methanol, the solubility of formed complex in 
chloroform is increased significantly compared to the respective building blocks, especially 





Once in solution, these complexes are investigated by 
1
H NMR spectroscopy. 
Fortunately, formation of a rosette results in the appearance of characteristic peaks – NH of a 
barbiturate/cyanurate in a region δ 13 – 16 ppm and the NH and NH2 from melamine in the 
region δ 8 – 11 ppm as depicted in Figure 1.9. The observation of these peaks is normally 
used for a judgment if the rosette is formed or not. 
1
H NMR titrations are used also to 









H NMR spectra showing characteristic rosette peaks and titrations used to 
determine the stoichiometry. Reprinted with permission from reference 39. ©1995 American 
Chemical Society 
 
Other methods used for characterisation of rosettes are GPC and VPO that determine 
the molecular size or weight of the complexes. Occasionally, it has been possible to obtain an 
X-ray structure that shows the rosette motif. One of the systems where this was successful is 
M3•B3 from Figure 1.8.
41
 Interestingly, the X-ray structure of melamine•cyanuric acid 
complex that contains the lattice, shown in Figure 1.7, was obtained only after the main part 
of the work on rosettes was conducted.
42
 The crystallisation required drastic hydrothermal 
conditions, which demonstrates the difficulty of obtaining  a suitable crystal for these systems. 
 
As these complexes are non-covalent, the utilisation of mass spectrometry for their 
characterisation has been limited. The group of Lehn used benzo[18]crown-6 functionalised 
melamines as a binding site for K
+
 that was then characterised by ESI-MS.
43
 The Whitesides 
group used Cl
–
 labelling that worked only for a special melamine derivative.
44
 The most 
elegant approach was from Timmerman et al.; they used Ag
+
 as a label for the rosette 









 binds to the aromatic parts on the periphery of the molecules, this method works 
only for molecules containing these aromatic parts. 
 
The groups of Whitesides, Reinhoudt and others extended the work to the preparation 
of complexes with more than one rosette.
39,46
 The Whitesides group prepared a complex with 
three rosettes that was assembled from 10 molecules (Figure 1.10).
47
 The Reinhoudt group 
used calix[4]arene dimelamines to prepare various double to tetra rosette complexes. They 
were able to obtain an X-ray structure of the double rosette complex with three guest 





Figure 1.10. Triple rosette complex prepared by the group of Whitesides. Reproduced with 






1.3.2.  Thermodynamic stability 
Firstly, a strong influence of concentration and temperature has been determined for 
the rosette complexes. The higher concentration, the more stable they are, as indicated by the 
improved resolution of peaks in the 
1
H NMR spectra, as shown in Figure 1.11. The 
Whitesides group used the concentration of 4 mM as a threshold between the formation of a 
rosette and other structural motifs for systems based on single rosettes.
23,40
 Others have found 
that this can be different if increased bulky molecules are used.
49
 The rosette complexes are 
usually more stable at lower temperatures as shown in Figure 1.12. 
 
 
Figure 1.11. Effect of concentration on the rosette assembly, as showed by partial 
1
H NMR 
(400 MHz, CDCl3) spectra of 1:1 complex of M (4) and B (3) at concentrations of 20 mM 




 are NH and NH2 of melamine, respectively. Adapted 
with permission from reference 40. ©1994 American Chemical Society 





Figure 1.12. Effect of temperature on the rosette assembly, as showed by partial variable 
temperature 
1





 are NH and NH2 of melamine, respectively. Adapted with permission from 






In order to predict the stability of rosette complexes, the Whitesides group came up 
with an empirical parameter HB/(N–1), where HB is the number of hydrogen bonds in the 
complex related to the enthalpy of formation of the complex, and N is the number of 
molecules needed for the assembly of the complex. N–1 is associated with the loss in 
entropy.
39
 The larger this parameter, the more stable a rosette complex should be. Therefore 
more hydrogen bonds (for example, in double rosettes) and using fewer molecules to 
assemble the system (by joining some of them into one molecule), should result in the 
increased stability of the rosette complexes. Whitesides stated that complexes with an 
empirical parameter  of  > 5 seem to be stable in chloroform and the ones with a value  > 9 are 
stable in 20% methanol in chloroform solutions. In later work,
50
 Whitesides renamed this 
parameter to ITm to indicate a melting point index and introduced additional two “rule of 
thumb” parameters. These were IG and IG/(N–1), where IG is a free energy index and is 
determined as 2.8HB–16(N–1) and IG/(N–1) index is then equal to 2.8HB/(N–1)–16, which 
corresponds conceptually to a free energy of association per particle. They showed that these 
parameters correlate well to the experimental observations with χ1/2
DMSO
 being the general 
experimental indicator of stability of an assembly. It describes the amount of DMSO that is 
needed for 50% of the assembly being present in solution. 
 
Interestingly, there are only few studies of the actual thermodynamic values for the 
rosette formation. In 2001, the group of Timmerman conducted a detailed study of 
thermodynamics of barbiturate/melamine system in CDCl3 by 
1
H NMR spectroscopy at 297 K 
and by VPO in 1,2-dichloroethane at 308 K.
51
 They used blocked barbiturates and melamines 
to measure reference intermolecular association constants K0 as depicted in Figure 1.13a. By 
using a model bis(melamine) system that should resemble a rosette based on the examination 
of molecular models (Figure 1.13b), they determined an effective molarity of rosette 
formation from measuring Kplug of the model assembly. Using Kplug = 4 × EM × K0, they 
calculated the effective molarity of the rosette formation to be 0.18 ± 0.05 M. We believe that 
this model does not provide a realistic view of the rosette cyclisation, because of the phenyl 
hydrogen highlighted in Figure 1.13b, which is not present in the rosette motif. Additional 
interactions with the barbiturate carbonyl group could, therefore, affect the stability of the 
model complex in comparison to the rosette. 
 





Figure 1.13. Equilibria used by the Timmerman group to study chelate cooperativity of the 
rosette motif. (a) Reference intermolecular interaction using blocked melamine and 
barbiturate. (b) Using bis(melamie) to simulate the rosette motif to obtain the effective 
molarity of rosette cyclisation. Highlighted hydrogen can affect the stability of the complex 
compared to the rosette motif.   
 
In 2004, Crego-Calama, Reinhoudt and co-workers studied the formation of different 
single and double rosette complexes by ITC in 1,2-dichloroethane at 298 K.
52
 They 
determined rosette equilibrium constants for the first time and provided thermodynamic 
values that explain some previous empirical observations, i.e. rosettes based on cyanurates are 
more stable than those based on barbiturates as shown in Figure 1.14. 
 
Rosette Kf  























1.3.3.  Concepts of preorganisation and peripheral crowding 
Originating from a study of a large diverse set of rosette complexes and their stability 
in solution, the Whitesides group postulated a concept of preorganisation.
39
 They connected 
several melamine units into one molecule. This decreased the entropy contribution and these 
rosette complexes were much more stable compared to a simple rosette. This is also the 
reason why Whitesides and co-workers were successful in assembling complexes with three 
rosettes that were shown above in Figure 1.10. 
 
Another concept that was postulated by Whitesides group is peripheral crowding.
21
 
This originated from using various substituent on the periphery of melamine that provide 
different structural motifs in the solid state (Figure 1.15), and their investigation of stability in 
solution by 
1
H NMR spectroscopy as judged by the observation of the characteristic rosette 
peaks of N-Hs or not.
40,41,53
 The concept postulates that molecules with bulky groups on the 
periphery destabilise other possible structures and therefore a formation of a rosette is 
preferred as shown in Figure 1.16. For less bulky melamines, the crinkled tape is preferred in 
the solid state, and the least bulky melamines crystalise in a form of linear tapes. 
 
However, the peripheral crowding concept was questioned by the work of the 
Timmerman group.
51
 They argued that obtaining different structures in the solid state can 
originate simply from a different solubility of competing species – the least soluble complex 
crystallises from the solution first, no matter what its stability in solution is. As a rosette motif 
has all polar groups bound, it should have higher solubility in non-polar solvents compared to 
structures based on a linear or crinkled tape. 
 
Interestingly, even the work from the Whitesides group can be used to point out some 
discrepancies of the concept of peripheral crowding. In one of their studies, they used the 
same bulky melamine (M) for two different partners – one based on barbiturate B and the 
second on cyanurate CYA (Figure 1.17).
40
 They stated that only the complex based on B 
forms the rosette as judged by 
1
H NMR spectroscopy, even though the rosettes based on a 
cyanurate are significantly more stable. Moreover, the original paper reporting the successful 
system M3•B3 did not report a well-defined characteristic rosette barbiturate N-H peak in the 
expected region, but only very broad one.
40
 This again shows how difficult the 
characterisation of these systems can be. 





Figure 1.15. Different structures of barbiturate/triaminotriazines complexes in solid state; a) 
rosette, b) linear tape and c) crinkled tape. 
 
Figure 1.16. Concept of peripheral crowding. The bulkiness of the periphery of melamines 







Figure 1.17. Cyanurate CYA that does not form a rosette with melamine M according to the 
Whitesides group. 
 
1.4. Molecular containers 
1.4.1.  General 
The topic of molecular containers includes a large number of different architectures of 
various sizes, shapes and functionalities.
54
 By and large, any discrete molecule or complex 
that has either an inner void volume that shows different properties compared to the outside of 
the species or a separation of the inside to the rest can be considered a molecular container. 
Traditionally, self-assembled molecular containers have been divided into two main 
categories: metal-coordinated cages and hydrogen-bonded capsules. Both types have been 










1.4.2.  Metal-coordinated cages 







 and others. An example from Fujita group is shown in 
Figure 1.18 in which they used bipyridine and palladium and platinum salts to prepare square 
complexes that were able to encapsulate various molecules in aqueous media.
67
 Over the 
years, initial simple 2D complexes have been extended to 3D architectures, since the 
geometry of both the ligand and metal centre allows one to rationally design and prepare 




Over the years, many other suitable ligands and metal systems have been explored. 
The illustration of the state of the art comes again from the Fujita group. In 2016, they 















Figure 1.19. Combination of angular and linear building blocks (metal centres and ligands) to 
assembly different 2D and 3D architectures. Reprinted with permission from reference 68. 






1.4.3.  Hydrogen-bonded capsules 
The chemistry of hydrogen-bonded capsules was pioneered in the group of Rebek in 
1993.
58,70
 They prepared a molecule shown in Figure 1.20a by condensing two molecules of 
diphenyl glycoluril with durene tetrabromide. This molecule self-assembles into the form of a 
tennis ball through eight hydrogen bonds (Figure 1.20b) in CDCl3 and benzene, and is able to 






Figure 1.20. (a) Molecule prepared in the group of Rebek, (b) that assembles in the tennis ball 
fashion. 
 
Since then, the Rebek group has used the same type of molecules to prepare larger 
semi-spherical structures that were used to study the encapsulation of different guest 
molecules.
72,73
 Their efforts resulted in the synthesis of non-spherical capsule shown in 
Figure 1.21 that was further utilised to study various topics, ranging from isomerism to 









Figure 1.21. Non-spherical capsule from the Rebek group. Reproduced with permission from 
reference 58.  
 
As mentioned above, the rosette motif has been used for the preparation of various 
hydrogen-bonded capsules that contain two to four rosettes. The best characterised example is 
the double rosette from Reinhoudt group shown in Figure 1.22a.
48
 This complex is able to 
encapsulate three guest molecules to form a well-defined hydrogen-bonded system inside its 
cavity as depicted in Figure 1.22b. They were able to characterise this host-guest system by 
X-ray studies and this is an exception in the rosette chemistry, as stated above. When a 
cyanurate is added to the complex, a more stable cyanurate-triazine rosette is formed that 
leads to the release of the guest molecules. The Reinhoudt group extended this work to 





Other types of hydrogen-bonded capsules utilise peptide-based systems, 








Figure 1.22. (a) Self-assembly of melamine calix[4]arene with barbiturate to form a double 
rosette complex and (b) encapsulation of three guest molecules. Reproduced with permission 




Figure 1.23. Tetra rosette complex that is capable to accommodate 6 guest molecules. 
Reproduced from Ref. 74 with permission from The Royal Society of Chemistry.  




1.4.4.  Hybrid molecular containers 
Ever since the initial development of metal-coordinated cages and hydrogen-bonded 
capsules, hybrid systems have been studied.
76
 Conversely, discrete well-defined 3D examples 
are rare. Moreover, there have been only a few reported systems where both types of the 
bonding form the crucial part of the structure, since many other system have one of them only 
on the periphery of the container backbone. In other words, we define a true hybrid system as 
a system where removal of one part (hydrogen-bonding or metal-coordination) leads to a 
change of the topology of the complex. Only the genuine discrete 3D hybrid examples will be 
discussed here. This strict definition excludes some examples of systems based on porphyrins 
and salen ligands,
77-79
 since the removal of just the metal would not lead to a change of the 
topology of the complex, and also complexes where the second type of binding only results in 
higher stability of the complex.
79,80
 Moreover, some of the complexes presented below are on 
the borderline of being considered a container, but we decided to include them since the 
number of examples is very limited. 
 
Appavoo and co-workers prepared an arene ruthenium rectangle using 2-ureido-4-
[1H]-pyrimidinone as the hydrogen-bonding motif, which is one of the most popular 





Figure 1.24. Structure of hybrid ruthenium/2-ureido-4-[1H]-pyrimidinone complex from 




The group of Houlton synthesised a cationic nucleobase duplex mimic using a 
tetrahedral bis(adeninyl)–Cu(I) complex that self-associated by hydrogen-bonding in polar 
solvents and solid phase as proven by the X-ray structure (Figure 1.25).
82
 Similarly, Kokan 
and co-workers showed a dimerisation of palladium complex (Figure 1.26) by hydrogen 





















In 2003, Alam and co-workers published a synthesis of hybrid container by a 
combination of hydrogen-bonding and copper(II) coordination using a ligand showed in 
Figure 1.27a. The capsule formed from eight copper atoms and eight molecules of ligand was 





 The group of Li prepared a strapped zinc porphyrin cyanuric acid and mixed it with a 
melamine and a pyridine-substituted barbiturate to prepare a hybrid container shown in 
Figure 1.28.
49 
The removal of metal-coordinated fragment from the double rosette complex 
would lead to the disassembly and produce a single rosette complex. Unfortunately, they 
characterised this cage only by simple 
1
H NMR spectroscopy and did not explore the host-
guest and stimuli-responsive behaviour. 





Figure 1.27. (a) Structure of the tetradentate ligand (the atoms that participate in hydrogen-
bonding are in red and atoms that participate in copper(II) coordination are in blue) used for 
the preparation of (b) hybrid molecular capsule showing the X-ray structure (CCDC 197602) 
with trapped pyridine molecules inside the cavity (the hydrogens were omitted for clarity). 
Colouring of the atoms: C (grey), N (blue), O (red), Cu (orange) and the turquoise dashed line 




Figure 1.28. Hybrid rosette container based on zinc porphyrin and rosette motif from the Li 









Multivalent supramolecular complexes show some degree of cooperativity in most of 
the cases. Two types of cooperativity exist: allosteric and chelate cooperativity. The chelate 
cooperativity has been studied extensively in a large number of systems. In spite of this, there 
is no predictor for it and even a small alternation of the studied system can lead to drastic 
changes in chelate cooperativity. Therefore each system has to be studied separately. The 
largest value of effective molarity that is used to quantify the chelate cooperativity is seen at 
highly rigid and preorganised systems, such as porphyrin nanorings from the Anderson group 
or cyclic hydrogen-bonded tetramers from the group of González-Rodríguez.  
 
The rosette motif has been investigated enormously in the last 30 year and became one 
of the textbook examples of hydrogen-bonded supramolecular systems. Several concepts 
originated from the research and they are used in other areas as well. The motif has been also 
used for the preparation of hydrogen bonded capsules that were able to encapsulate guest 
molecules. Literature provides an overwhelming number of other hydrogen-bonded capsules 
as well as metal-coordinated cages, but systems where these two would be connected to form 
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The general aim of this work is to study chelate cooperativity in multivalent 
supramolecular systems to increase the understanding of this fundamental phenomenon. 
 
As described in Chapter I, porphyrin nanorings show the highest values of effective 
molarity reported in the literature, particularly the 6-ring that was explored in great detail. The 
goal is to study if the extreme values of effective molarity found out for the 6-ring can 
stabilise a H-bonded system inside the 6-ring cavity. This would provide new insights about 
these extreme values of effective molarity and answer whether additional flexibility and 
different nature of the supramolecular ligand system compared to the one-molecule covalent 
ligand can be beneficial or not. The designed system would keep the pyridine units as the 
molecular recognition for the zinc porphyrins (Figure 2.1). 
 
 
Figure 2.1. H-bonded supramolecular system inside the porphyrin nanoring. 
 
Two different systems will be explored. The first one is based on a H-bonded system 
that utilises phenols as H-bond acceptors and phosphine oxides as H-bond donors 
(Figure 2.2a). This would presumably provide strong H-bonding according to the molecular 
recognition toolbox. The second system is based on a H-bonded rosette motif that employs 







Figure 2.2. (a) H-bonded supramolecular system based on phenols and phosphine oxides, (b) 
H-bonded supramolecular system based on the rosette motif. 
 
In order to fully quantify the binding of the rosette system inside the porphyrin 
nanoring, the chelate cooperativity of the rosette motif has to be studied initially, as this has 
not been reported so far, as was shown in Chapter I. 
 
In addition, we hypothesised that the aforementioned molecules could be used to 
explore the preparation of a new class of hybrid H-bonded/metal-coordinated cages 
(Figure 2.3) as they feature the H-bonded component (rosette) as well as the metal-
coordinated part (utilising the pyridines). Due to their hybrid character, these cages should 
potentially show an interesting stimuli-responsive behaviour. 
 
 












Rosette motif revisited 
  





The study of thermodynamic parameters of different multivalent supramolecular 
systems plays an important role in their understanding, and as a foundation stone for the 
design of new systems with desirable behaviour. Significant attention is paid to the 
competition of cyclisation and polymerisation of these systems through ring-chain equilibria.
1-
3
 When the cyclisation is preferred, a system shows chelate cooperativity, which is quantified 
by the effective molarity (EM). Many multivalent supramolecular systems have been studied 
in great detail and their EMs have been determined,
2
 such as porphyrin nanorings from the 
Anderson group,
4
 H-bonded systems based on G-C dinucleoside monomers from the group of 
González-Rodríguez,
5




Even though the rosette motif has been studied extensively by many groups over the 
last 30 years,
7-9
 the thermodynamics of its self-assembly has only been studied scarcely. The 
groups of Crego-Calama and Reinhoudt studied the formation of different single and double 
rosette complexes by ITC in 1,2-dichloroethane at 298 K.
10
 For the rosette shown in 







Figure 3.1. Rosette formation from a cyanurate and a triaminotriazine. 
 
The group of Timmerman conducted a detailed study of the thermodynamics of 
barbiturate/triaminotriazine system in CDCl3 by 
1
H NMR at 297 K and by VPO in 1,2-
dichloroethane at 308 K.
11
 They used blocked barbiturates and triaminotriazines to measure 
reference intermolecular association constants K0 as depicted in Figure 3.2a. By using a model 
bis(triaminotriazine) system that should resemble a rosette based on the examination of 




from measuring Kplug of the model assembly. Using  Kplug = 4 × EM × K0, they calculated the 
effective molarity of the rosette formation to be 0.18 ± 0.05 M. We believe that this model 
does not provide a realistic view of the rosette cyclisation, because of the phenyl hydrogen 
highlighted in Figure 3.2b, which is not present in the rosette motif. Additional interactions 
with the barbiturate carbonyl group could, therefore, affect the stability of the model complex 
in comparison to the rosette. We decided to revisit the thermodynamics of the rosette self-
assembly in detail and determine its effective molarity using a more suitable system. 
 
 
Figure 3.2. Equilibria used by the Timmerman group to study chelate cooperativity of the 
rosette motif. (a) Reference intermolecular interaction using blocked triaminotriazine and 
barbiturate. (b) Using bis(triaminotriazine) to simulate the rosette motif to obtain the effective 
molarity of rosette cyclisation. Highlighted hydrogen can affect the stability of the complex 
compared to the rosette motif.   
 
The extensive investigation of the rosette motif has led to two general concepts, 
preorganisation and peripheral crowding.
7
 The concept of peripheral crowding originated 
from the research of the Whitesides group. They obtained a series of X-ray structures with 
different substituents on the periphery of triaminotriazines that crystallise in different 
architectures: rosettes, linear tapes and crinkled tapes (Figure 3.3). From these results, they 
postulated that triaminotriazines with bulky substituents in a periphery form rosettes because 
of “peripheral crowding” that destabilise the other topologies (Figure 3.3a) both in solid phase 
and solution. However, this concept was questioned by the work of the Timmerman group,
11
 
who argued that the selectivity can originate simply from a different solubility of the 




competing species – the least soluble complex crystallises first, no matter what the relative 
stability of the species in solution is. Nobody continued in this work to fully proof their 
hypothesis experimentally and Whitesides concept is still being used for both solid an solution 
phases.
12




Figure 3.3. Different architectures of barbiturate/triaminotriazines complexes in the solid 
state; a) rosette, (b) linear tape and (c) crinkled tape. (a) Also shows the concept of peripheral 
crowding. The bulkiness of the periphery of triaminotriazine leads to a preferable formation 





Most of the work done by the groups of Whitesides, Reinhoudt and others used 1,3,5-
triaminotriazines for the construction of rosettes.
7-9
 These molecules provide some great 
advantages, such as modular synthesis.
13
 It is possible to selectively exchange the three 
chlorine atoms in cyanuric acid by a wide range of nucleophiles by simply changing the 
temperature (Figure 3.4a). On the other hand, triaminotriazines form rotamers that exchange 
slowly on the 
1
H NMR time-scale and complicate the NMR analysis of these molecules and 





Figure 3.4. (a) Modular synthesis of triaminotriazines (R are substituents). (b) Rotamers of 
triaminotriazines; only the highlighted rotamer can form a rosette.  
 
In this work, we decided to replace triazines with pyrimidines, which also allow for 
step-wise functionalisation while avoiding the formation of multiple rotamers on the NMR 
time-scale. In addition, the aromatic C-H of the pyrimidines should provide an additional 
NMR probe for studying supramolecular self-assembly. Moreover, the 
1
H NMR chemical 
shift of this aromatic C-H is around 6 ppm,
15
 which should not overlap with any other 
resonances and, therefore, greatly simplify the NMR analysis. Surprisingly, the use of 
pyrimidines to form rosettes has not been widely explored in the literature. There is only one 
example of using a pyrimidine successfully to form the rosette. However, this was mass 
spectrometry study.
15
 The group of Lehn has used pyrimidines to obtain supramolecular 
strands based on barbiturates.
16
 Lately, pyrimidines have been used in the origin of life 









To be able to determine the effective molarity of the rosette system, the intramolecular 
and intermolecular equilibrium constants Kintra and Kinter, respectively, outlined in Figure 3.5 
have to be measured. 
 
 
Figure 3.5. (a) Intramolecular cyclisation of a linear oligomer to form a rosette. (b) 
Intermolecular binding of triaminotriazine and barbiturate. (R is a substituent). 
 
The effective molarity for the intramolecular interaction involved in cyclisation of rosette is 





         (3.1) 
 
Unfortunately, neither equilibrium constant depicted in Figure 3.5 can be measured 
directly. This is usually overcome by measuring the overall equilibrium constant for the 
formation of the target complex, and using a suitable reference system that provides the 
equilibrium constants for the corresponding intermolecular interaction. The overall 
equilibrium constant for the formation of the rosette from its components can be measured 
easily (Figure 3.6a). We decided to employ blocked rosette building blocks to be able to 
measure the reference intermolecular association constant, which was also used by the group 
of Timmerman. The blocking is done by the substitution of N-H in the barbiturate or the 
pyrimidine for an alkyl group. Since the blocked species have only one site that is able to 
form a triply H-bond complex, which is significantly more stable than a doubly H-bond 
complex (Figure 3.7),
9




complex (Figure 3.6b). The effective molarity for the intermolecular interaction involved in 






        (3.2) 
 
where the statistical factor Kσ is based on the symmetry of the involved species.
18-21
 Figure 3.8 
shows that Kσ for the rosette formation is 
32
3
 as calculated by the symmetry number method 
from internal and external symmetry of each component. 
 
 
Figure 3.6. (a) Assembly of a pyrimidine and barbiturate to form a rosette. (b) Reference 
intermolecular equilibrium using blocked building blocks. (R is a substituent). 
 
 
Figure 3.7. Association constants (CHCl3, 298K) for a triply H-bonded complex (left) and 









Figure 3.8. Determination of the statistical factor Kσ for the rosette assembly (R is a 
substituent). 
 
To check if there is some allosteric cooperativity associated with multiple H-bond 
interactions with each component in the rosette, reference 1:2 complexes are also required 
(Figure 3.9). They can be described in two steps with two different macroscopic equilibrium 
constants K1,obs and K2,obs. In order to obtain the microscopic equilibrium constants K1 and K2 
that describe the intrinsic thermodynamic properties of the interactions, statistical factor have 
to be included (Figure 3.10), which translate to K1,obs = 2 × K1 and K2,obs = ½ K2. The 













Figure 3.9. Reference 1:2 equilibria using (a) pyrimidine and blocked-barbiturate and (b) 
barbiturate and blocked-pyrimidine (R is a substituent). 
  
We also decided to include cyanurates that are sometimes used instead of barbiturates 
in the preparation of rosettes. All the equations and statistical factors derived above for the 
barbiturates can also be applied to the cyanurates thanks to their analogous symmetry. In 
addition, the concept of peripheral crowding originated mostly from the solid state. Because 
of that, we decided to revisit this concept in the solution by employing both bulky (with p-
tert-butylphenyl being the best candidate based on the results from the Whitesides group) as 
well as a less bulky pyrimidine – one having only flexible alkyl groups. 
 
To study these equilibria, a non-polar solvent has to be used, as these H-bonded 
systems would be disrupted in polar solvents such as methanol. We decided to employ 
chloroform, because these compounds are quite polar and usually hard to dissolve. 
Chloroform provides a good balance between the H-bond strength and solubility. The less 
polar toluene would increase the H-bonding, but the solubility in toluene is significantly 
lower.
23
 We tried to increase the solubility in non-polar solvents as much as possible by 
introducing alkyl chains into these molecules. 
 





Figure 3.10. Determination of the statistical factors for the reference 1:2 systems. The 







Alkyl triaminopyrimidine PA and bulky tert-butylphenyl triaminopyrimide PB were 
synthesised in one step syntheses in good yields from commercially available 4,6-
dichloropyrimidin-2-amine at 130 – 150 °C under microwave irradiation (Scheme 3.1). 
Slightly harsher conditions had to be used to obtain PB as the aniline is less reactive. 
Different conditions using iso-propyl alcohol as a solvent and diisopropylethylamine as a base 
were therefore used. 
 
 
Scheme 3.1. Synthesis of triaminopyrimidines PA and PB. 
 
To prepare blocked-pyrimidines bPA and bPB, a modular synthesis was utilised 
(Scheme 3.2). Reacting 4,6-dichloropyrimidin-2-amine with N-methylpenthylamine and 
K2CO3 as a base in tert-butanol at 60 °C provided the singly substituted product bPA-Cl.  It 
was then converted to final product bPA by heating in neat n-penthylamine at 160 °C under 
microwave irradiation. For the synthesis of bPB, blocked tert-butylphenyl aniline bTBA had 
to be prepared first. This was achieved by a reaction of tert-butyl aniline with acetic 
anhydride followed by reduction using LiAlH4. The blocked aniline was then used for the 
synthesis of the singly substituted product bPB-Cl that was converted to target compound 
bPB simply by heating in neat tert-butyl aniline at 160 °C under microwave irradiation. 
 
Commercially available diethyl-barbiturate was not soluble enough in chloroform for 
NMR titrations, and therefore barbiturate B with longer alkyl chains was synthesised from 
urea (Scheme 3.3). The cyanurate C with n-pentyl was prepared from cyanuric acid by 
nucleophile substitution with iodopentane. The reaction also provided blocked-cyanurate bC 
(Scheme 3.3). Blocked barbiturate bB was synthesised in the same fashion as barbiturate B 
using N-methylurea instead of urea (Scheme 3.3). 
 









Scheme 3.3. Synthesis of barbiturate B, cyanurate C, blocked-cyanurate bC and blocked-
barbiturate bB. 
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3.4. Characterisation of rosettes 
To study rosette formation, all possible combinations (namely PA•B, PB•B, PA•C and 
PB•C) were prepared in CDCl3 at 3 mM concentration of each component and then 
investigated by NMR spectroscopy at 298 K and 233 K (Figure 3.11). At 233 K, all of the 
complexes showed the characteristic peak of rosettes in the region of δ 14 – 15 ppm 
corresponding to bound N-H from the barbiturate/cyanurate and two peaks in the region δ 8 – 
11 ppm from the N-H and NH2 in pyrimidines.
7
 At 298 K, only complexes containing 
cyanurate C showed the characteristic rosette peaks. They were broad as the rosette is less 
stable at 298 K. The reason why the rosettes based on barbiturate B are not visible at 298 K is 
probably because of an intermediate exchange of the free components and assemblies on the 
1
H NMR time-scale. 
 
Figure 3.11. Partial 
1
H NMR spectra (500 MHz, CDCl3) of rosette assemblies at (a) 298 K 
and (b) 233 K; from top to bottom: PA•B, PB•B, PA•C and PB•C with concentration of 
3 mM of each component. Barbiturate/cyanurate N-H in red, pyrimidine NH/NH2 in blue. 




3.5. Dilution experiments 
First of all, the self-association of rosette building blocks had to be checked, as this 
could highly influence the apparent stability of the rosette. For barbiturates and cyanurates, 
this was already done by the group of Timmerman (Table 3.1).
11
 Triaminopyrimidine PA and 
blocked-pyrimidine bPB were chosen to study pyrimidine self-association in chloroform 
(Figure 3.12). It was possible to follow the changes in the aromatic C-H and both N-H peaks. 
A dimerisation isotherm was fitted to the obtained experimental data. All of the rosette 
components self-associate with K < 10 M
–1
 (Table 3.1). Provided that the concentrations do 




H NMR (500 MHz, CDCl3, 298 K) dilution experiments for (a) 
triaminopyrimidine PA and (b) blocked-pyrimidine bPB. The 
1
H NMR spectra are shown on 
the left (pyrimidine C-H signal green, N-H signals blue and red). On the right are shown the 
experimental data (circles) and calculated values (lines) based on a dimerisation isotherm. 
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Table 3.1. Dimerisation constants in CDCl3 at 298 K, measured by 
1






1.7 ± 0.5 
     (a)
 
7.4 ± 0.09 
PA
b
 2 ± 1 
bPB
b 
1 ± 2 
a
Measured by Timmerman group at 297 K. 
b
Errors are quoted as two times the standard 
deviation based on two repetitions. 
R = p-[C6H4]CH(CH3)2 
 
3.6.  Reference intermolecular titrations 
To determine reference intermolecular association constants, we conducted 
1
H NMR 
titrations in CDCl3 at 298 K using blocked-pyrimidines bPA and bPB as hosts and blocked-
barbiturate bB and blocked-cyanurate bC as guests, respectively. Again, it was possible to 
follow both the aromatic C-H and both N-H peaks of pyrimidine. The titration of bB into bPA 
is depicted in Figure 3.13, and all the remaining titrations data can be found in the 
Experimental section. A 1:1 binding isotherm was used to fit the experimental data. The 





H NMR (400 MHz, CDCl3, 298 K) titration of bB into bPA (1.4 mM). 
1
H NMR spectrum is shown on the left (pyrimidine C-H signal green, N-H signals blue and 
red). On the right are shown the experimental data (circles) and calculated values (lines) based 
on a 1:1 binding isotherm. 












bPA•bB 240 ± 5 
bPB•bB 200 ± 10 
bPA•bC 3200 ± 40 
bPB•bC 1200 ± 200 
a
Errors are quoted as two times the standard 
deviation based on two repetitions. 
 
The results show two general trends. Firstly, the association constant measured with 
cyanurate C is approximately one order of magnitude higher than the corresponding value for 
barbiturate B no matter which pyrimidine is used as a partner.
11
 Secondly, the association 
constants for the alkyl pyrimidine PA is higher than the corresponding values for the bulky 
PB.  
 
3.7. Measurement of allosteric cooperativity 
To quantify allosteric cooperativity in the assembly of rosettes, 
1
H NMR titrations 
were carried out to measure the stability of the reference 1:2 complexes shown in Figure 3.9. 
The titration of bB into PA is depicted in Figure 3.14 and all the remaining titration data can 
be found in the Experimental section. We decided to employ several different ways of 
analysis. The first was using a non-cooperative binding isotherm that assumes that both 
binding sites are independent and identical. In this analysis, K1 = K2 = Knc and the change in 
chemical shift for formation of the 1:1 complex is identical to the subsequent change in 
chemical for formation of the 1:2 complex. This fitting provided values of association 
constants Knc as shown in Table 3.3, which were similar to the corresponding reference 
intermolecular association constants Kref determined for the 1:1 complexes in Table 3.2. The 
only outlier was complex B•bPB2, that also provided the worst description of the 
experimental data as judged by the global error E of the fit. These results suggested that there 
is no allosteric cooperativity, so we decided to check if a 1:2 binding isotherm with Knc fixed 
to the corresponding Kref, but allowing the changes in chemical shifts for both the first and 
second binding event to be variables, can be fitted well to the experimental data. When this 
method was used, all the experimental data were described well as shown in Table 3.3. The 
third method of fitting used K1 = Kref and K2 as a variable that was optimised along with the 
changes in chemical shifts for both the first and second binding events. Since this method uses 
Measurement of allosteric cooperativity 
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more variables, it provides better fits. However, the values of K2 are similar to the 
corresponding Kref. In conclusion, there is no allosteric cooperativity in this system and the 
values of intermolecular reference association constants Kref can be used for the following 
calculations of rosette chelate cooperativity. 
 


























 E [%] 
d
 
PA•bB2 bPA•bB 240 ± 5 200 ± 10 0.68
e
 0.65 – 0.69 334 ± 5 0.09 – 0.23  
PB•bB2 bPB•bB 200 ± 10 220 ± 20 0.82 – 1.2 0.73 – 1.1  320 ± 40 0.04 – 0.63 
PA•bC2 bPA•bC 3200 ± 40 3700 ± 200 2.1 – 2.2 1.4 – 1.6 1600 ± 10 0.40 – 0.57 
PB•bC2 bPB•bC 1200 ± 200 690 ± 100 0.52 – 0.55 0.08 – 0.20 1200 ± 30 0.08 – 0.19 
B•bPB2 bPB•bB 200 ± 10 1400 ± 250 3.7 – 4.0 1.3 – 1.5 200 ± 50 1.3 – 1.5 
a
Errors are quoted as two times the standard deviation based on two repetitions. 
b
Using a non-cooperative isotherm where Knc was optimised. 
c
Using a non-cooperative isotherm where Knc = Kref was fixed. 
d
Using a cooperative isotherm where K1 = Kref was fixed. 
e
No error for the significant numbers used. 
 
 







H NMR (400 MHz, CDCl3, 298 K) titration of bB into PA (0.99 mM). 
1
H NMR spectrum is shown on the left (pyrimidine C-H signal green, N-H signals blue and 
red). On the right are shown the experimental data (circles) and calculated values (lines) based 
on a 1:2 binding isotherms using (a) non-cooperative model using identical binding sites, (b) 
non-cooperative model where K1 and K2 were fixed to be the appropriate Kref and (c) 
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3.8. Measurement of chelate cooperativity 
Finally, we determined the macroscopic equilibrium constants for assembly of the 
rosette. The titration of B into PA is depicted in Figure 3.15. Using pyrimidines instead of 
triazines proved to be important as the pyrimidine N-H peaks became very broad after a few 
additions of guest as shown in Figure 3.15. In comparison, the aromatic C-H of pyrimidine 
stayed sharp for the whole titration. All the remaining titrations can be found in the 
Experimental section. A 3:3 binding isotherm was used to fit the experimental data. We tried 
to include also opening to 1:2 complexes in the presence of excess guest, but this did not 
change the association constant much as the 1:2 complexes were populated in only 10-20%. 





H NMR (400 MHz, CDCl3, 298 K) titration of B into PA (0.88 mM). The 
1
H NMR spectrum is shown on the left (pyrimidine C-H signal green, N-H signals blue). On 
the right are shown the experimental data (circles) and calculated values (line) based on a 3:3 
binding isotherm. 
 
Table 3.4. Macroscopic equilibrium constants for the formation of rosettes in CDCl3 at 








PA3•B3 (6.3 ± 0.1)×10
15
 
PB3•B3 (8.4 ± 0.4)×10
14
 
PA3•C3 (2.7 ± 0.2)×10
22
 




Errors are quoted as two times the standard 
deviation based on two repetitions. 




As expected from the literature, rosettes based on cyanurates are more stable than 
rosettes based on barbiturates. The results for cyanurate C show similar values to the value 




 determined by the groups of Crego-Calama and Reinhoudt in 1,2-
dichloroethane by ICT at 298 K.
10
 The rosettes formed by alkyl pyrimidine PA show higher 
stability than bulky PB (one order of magnitude for the barbiturate and two orders of 
magnitude for the cyanurate, respectively). 
 
These results allowed us to calculate the effective molarities for each rosette by using 
Equation 3.2 and association constants for appropriate reference intermolecular systems from 
Table 3.2. The values of rosette effective molarities are shown in Table 3.5. 
 






EM [M] Kref EM 
PA3•B3 bPA•bB 3.1 ± 0.4 740 ± 80 
PB3•B3 bPB•bB 1.2 ± 0.4 250 ± 60 
PA3•C3 bPA•bC 2.4 ± 0.2 7500 ± 700 
PB3•C3 bPB•bC 1.0 ± 0.9 1100 ± 900 
a




The determined effective molarities cluster around the value of 2 M, which is an order 
of magnitude higher compared to the value 0.18 ± 0.05 M determined by the Timmerman 
group. By comparing our determined value to the literature values of effective molarity for 
other supramolecular systems, rosette motif shows a high degree of chelate cooperativity.
2
 
The high value of rosette effective molarity can be used to explain why this system shows 
“…a surprisingly high degree of stability…”.
24
 Moreover, the results for PA and PB are 
similar for both the barbiturate and cyanurate, which provides additional proof that the 
reference systems used were well suited for their purpose. The results for less bulky alkyl 
pyrimidine PA are slightly higher (approximately twice) compared to the values for bulky 
pyrimidine PB. In addition, the chelate cooperativity connected to rosette formation is 
quantified by the product Kref EM, which is the equilibrium constant between open and closed 









 for rosettes based on cyanurates, less than 1% of 





In this chapter, we revisited the thermodynamics of the self-assembly of the rosette 
motif. For that, we used pyrimidines rather than commonly used triaminotriazines, which 
allowed us to easily study all the equilibria by 
1
H NMR following the aromatic C-H of 
pyrimidines. We studied rosettes based on both barbiturates and cyanurates as well as a bulky 
pyrimidine and a pyrimidine with little bulk to revisit the concept of peripheral crowding in 
solution. We determined the equilibrium constants for the formation of the rosettes of all 
possible combinations from the listed building blocks. We determined no allosteric 
cooperativity in the system. Our results show that the effective molarity of rosette is around 
2 M, which is a high chelate cooperativity compared to other supramolecular systems. We 
also found out that rosettes based on the less bulky alkyl pyrimidine show higher stability as 
well as effective molarity compared to rosettes based on the bulky pyrimidine. This was an 
unexpected result, since the literature predicts rosettes based on less bulky pyrimidines not to 
be formed. This study therefore brings new insights into the concept of peripheral crowding as 
our results show that this concept does not hold true in solution. The chelatecooperativity 
associated with the intramolecular interactions required to cyclise the rosette was quantified 
by the effective molarity, which is approximately 2 M for all four rosettes studied, and the 




 indicating that rosette self-assembly is highly cooperative with 
no other species populated to a significant extent in these systems.  




3.10. Experimental section 
3.10.1. General 
The chemicals were purchased from commercial suppliers and used without further 
purifications unless stated otherwise. Solvents were either distilled before use or used as 







Lumen (with UV light detection at 254 nm and 280 nm and evaporative light 
scattering detector for Lumen) with pre-packed puriFlash columns from Interchim (silica, 
25 μm) with a loading of mixtures on Celite were used. The microwave used was Biotage 
Initiator
+
. The reactions were monitored by LSMS Waters Acquity H-class UPLC coupled 
with a single quadrupole Waters SQD2 with the conditions as follows: UPLC Column (see 
below), solvent A: Water + 0.1% formic acid; solvent B: acetonitrile od THF (see below) + 
0.1% formic acid; gradient and flow rate (see below); column temperature of 40 °C, the signal 
was monitored at 254 nm and 280 nm. 
Column 
Col3: ACQUITY UPLC HSS T3 Column, 100Å, 1.8 μm, 2.1 mm X 50 mm 
Methods 
  MeCN-FAST: Gradient: 0 – 2 minutes 5% – 100%B + 1 minute 100%B 
    Flow rate: 0.6 ml/min 
  MeCN-SLOW: Gradient: 0 – 4 minutes 5% – 100%B + 1 minute 100%B 





C NMR spectra were recorded on Bruker 400 MHz Avance III HD 
SmartProbe Spectrometers at 400 MHz for 
1
H and 101 MHz for 
13
C or on a Bruker 500 MHz 
Avance TCI CryoProbe Spectrometer and Bruker 500 MHz AVIII HD SmartProbe 
Spectrometer at 500 MHz for 
1
H and 126 MHz for 
13
C. The variable temperature NMR 
spectra were measured on a Bruker 500 MHz Avance III HD SmartProbe Spectrometer at 
500 MHz for 
1
H. All chemicals shift are quoted in ppm and were referenced to the residual 
peaks of used solvents: CDCl3 (
1
H: 7.26 ppm; 
13
C: 77.00 ppm), CD3OD (
1
H: 3.31 ppm; 
13
C: 




H: 2.50 ppm; 
13
C: 39.52 ppm). Coupling constants J are stated in 
Hz. FT-IR spectra were measured on a Bruker Alpha spectrometer. HR-MS spectra were 
obtained on a Waters Xevo
 
G2-S, Waters Vion IMS Qtof or Waters LCT Premier by 
electrospray-ionisation of samples. Melting points were recorder on a Mettler-Toledo MP90 
system. Elemental analysis was performed by the Microanalysis facility at the Department of 





Synthesis of PA 
 
 
4,6-Dichloropyrimidin-2-amine (210 mg, 1.28 mmol) was flushed with nitrogen in a MW 
vial. Amylamine (2.5 mL, 21.4 mmol) was added and the mixture was heated at microwave at 
130 °C for 14 hours. The remaining amylamine was removed under reduced pressure and the 
residue was loaded on Celite. A combiflash of the residue on silica (EtOAc/MeOH: MeOH 




H NMR (CDCl3, 400 MHz, 298 K): δ 4.81 (s, 1H), 4.45 – 4.41 (m, 4H), 3.14 (dd, J = 13.0, 
7.0 Hz, 4H), 1.62 – 1.54 (m, 4H), 1.40 – 1.30 (m, 8H), 0.92 – 0.89 (m, 6H). 
13
C NMR (CDCl3, 101 MHz, 298 K): δ 164.3, 162.3, 71.9, 41.7, 29.1, 29.1, 22.4, 14.0. 
 
HR-MS (ESI): Calculated for C14H28N5 [M+H]
+
 266.2345, found: 266.2348 (Δ = 1.1 ppm) 
 




MP: 85 – 87 °C 
 
EA: Required for C14H27N5: C 63.36, H 10.25, N 26.39; found: C 63.28, H 10.34, N 26.04. 
 


























Synthesis of PB 
 
 
4,6-Dichloropyrimidin-2-amine (178 mg, 1.06 mmol) was flushed with nitrogen in a MW 
vial. N,N-diisopropylethylamine (0.5 mL, 2.48 mmol), isopropyl alcohol (1.0 mL) and                   
4-tertbutylaniline (0.6 mL, 562 mg, 3.77 mmol) were added and the mixture was heated in 
microwave at 150 °C for 1 hours. Then, additional 4-tert-butylaniline (0.5 μL, 467 mg, 
3.14 mmol) was added under nitrogen atmosphere and the mixture was heated in microwave 
at 170 °C for 10 hours. A saturated solution of NaHCO3 (20 mL) and water (20 mL) were 
added and the mixture was extracted with CH2Cl2/MeOH (10:1; 2 × 50 mL) and CH2Cl2 
(2 × 50 mL). The organic phase was dried over MgSO4, evaporated and loaded to Celite. A 
combiflash of the residue on silica (CH2Cl2/MeOH: MeOH 0%→10%) provided the title 





-DMSO, 400 MHz, 298 K): δ 8.52 (s, 2H), 7.44 (d, J = 8.5 Hz, 4H), 7.25 (d, 
J = 8.5 Hz, 4H), 5.80 (s, 2H), 5.50 (s, 1H), 1.26 (s, 18H). 
 
MP:  281 – 284 °C 
 
EA: Required for C24H31N5: C 74.00, H 8.02, N 17.98; found: C 73.75, H 8.14, N 17.66. 
 
LCMS Method: Col3-MeCN-SLOW 
 









Synthesis of bPA-Cl 
 
 
A mixture of 4,6-dichloropyrimidin-2-amine (344 mg, 2.06 mmol), N-methylpentylamine 
(0.4 mL, 290 mg, 2.9 mmol), K2CO3 (430 mg, 3.11 mmol) and tBuOH (15 mL) were heated 
at 60 °C for 3 days. The mixture was evaporated and water (20 mL) was added. The mixture 
was then sonicated for 20 minutes. Solid was collected by suction and dried overnight in 




H NMR (CD3OD, 400 MHz, 298 K): δ 5.94 (s, 1H), 3.47 (s, 2H), 3.00 (s, 3H), 1.61 – 1.54 
(m, 2H), 1.42 – 1.25 (m, 4H), 0.92 (t, J = 7.0 Hz, 3H). 
13
C NMR (CD3OD, 101 MHz, 298 K): δ 164.9, 163.9, 160.0, 92.3, 50.3, 35.9, 30.1, 28.0, 
23.6, 14.4. 
 
HR-MS (ESI): Required for C10H18N4Cl [M+H]
+
 229.1220, found: 229.1218 (Δ = 0.9 ppm). 
 
































Synthesis of bPA 
 
 
bPA-Cl (198 mg, 1.89 mmol) was flushed with nitrogen in a MW vial. n-Pentylamine (1 mL, 
0.75 g, 8.6 mmol) was added and the mixture was heated in microwave at 160 °C for 
10 hours. A saturated solution of NaHCO3 (20 mL) was added and the mixture was extracted 
with CH2Cl2 (4 × 50 mL). The organic phase was dried over MgSO4, evaporated and loaded 
to Celite. A combiflash of the residue on silica (CH2Cl2/MeOH: MeOH 0%→10%) provided 
the title compound (178 mg, 84% yield) as reddish oil. 
 
1
H NMR (CDCl3, 400 MHz, 298 K): δ 4.85 (s, 1H), 4.38 (s, 2H), 4.35 (s, 1H), 3.42 – 3.38 
(m, 2H), 3.14 (dd, J = 12.0, 7.0 Hz, 2H), 2.96 (s, 3H), 1.62 – 1.51 (m, 4H), 1.39 – 1.23 (m, 
8H), 0.90 (t, J = 7.0 Hz, 6H). 
13
C NMR (CDCl3, 101 MHz, 298 K): δ 164.1, 163.9, 162.2, 72.0, 49.2, 41.7, 35.4, 29.2, 
29.1, 29.1, 27.0, 22.5, 22.4, 14.1, 14.0. 
 
HR-MS (ESI): Required for C15H30N5 [M+H]
+
 280.2501, found: 280.2502 (Δ = 0.4 ppm). 
 































Synthesis of bTBA 
 
 
4-tert-Butylaniline (0.60 mL, 0.56 g, 3.77 mmol) and acetic anhydride (2.0 mL, 2.2 g, 
21.6 mmol) were left stirring for 3 hours at RT. A saturated solution of NH4Cl (20 mL) was 
then added with cooling to 0 °C. The mixture was extracted with (3 × 50 mL). The collected 
organic phase was dried over MgSO4 and the solvents were removed under reduced pressure 
to provide after drying in vacuum oven overnight the title product (724 mg, quantitative) as a 
white crystalline solid. 
 
1
H NMR (CDCl3, 400 MHz, 298 K): δ 7.40 (d, J = 8.5 Hz, 2H), 7.33 (d, J = 8.5 Hz, 2H), 
7.11 (bs, 1H), 2.17 (s, 3H), 1.30 (s, 9H). 
 
MP:  172 – 174 °C 
 




This compound (499 mg, 2.61 mmol) was flushed with N2 and THF (10 mL) was added and 
the mixture was cooled to 0 °C. A solution of LiAlH4 (1.0 M in THF, 6 mL, 6 mmol) was 
added dropwise at 0 °C. After 1 hour, the cooling bath was removed and the mixture was left 
stirring overnight at RT. Then, a saturated solution of NaHCO3 (10 mL) was added at 0 °C 
and the mixture was extracted with CH2Cl2 (4 × 50 mL). The organic phase was dried over 
MgSO4 and evaporated to produce the title product (407 mg, 88% yield) as reddish oil. 
 
1
H NMR (CDCl3, 400 MHz, 298 K): δ 7.23 – 7.19 (m, 2H), 6.60 – 6.56 (m, 2H), 3.42 (bs, 
1H), 3.15 (q, J = 7.0 Hz, 2H), 1.28 (s, 9H), 1.25 (t, J = 7.0 Hz, 3H). 
 








Synthesis of bPB-Cl 
 
 
4,6-Dichloropyrimidin-2-amine (229 mg, 1.40 mmol) was flushed with nitrogen in a MW 
vial. bTBA (585 g, 3.31 mmol), isopropyl alcohol (1.5 mL), DIPEA (1 mL) were added and 
the mixture was heated at microwave at 140 °C for 44 hours. A saturated solution of NaHCO3 
(30 mL) was added and the mixture was extracted with CH2Cl2 (3 × 50 mL). The organic 
phase was dried over MgSO4, evaporated and loaded to Celite. A combiflash of the residue on 
silica (CH2Cl2/MeOH: MeOH 0%→5%) provided the title compound (363 mg, 85% yield) as 
a pale-yellowish solid. 
 
1
H NMR (CDCl3/CD3OD, 400 MHz, 298 K): δ 7.48 (d, J = 8.5 Hz, 2H), 7.10 (d, J = 8.5 Hz, 
2H), 5.45 (s, 1H), 3.89 (q, J = 7.0 Hz, 2H), 1.35 (s, 9H), 1.15 (t, J = 7.0 Hz, 3H). (referenced 
to methanol) 
13
C NMR (CDCl3/CD3OD, 101 MHz, 298 K): δ 164.7, 163.4, 159.0, 151.7, 140.5, 128.5, 
127.7, 94.4, 45.6, 35.3, 31.7, 13.2. (referenced to methanol) 
 
HR-MS (ESI): Required for C16H21N4Cl [M+H]
+
 305.1533, found: 305.1533 (Δ = 0.0 ppm). 
 




MP: 198 – 202 °C 
 
























Synthesis of bPB 
 
 
bPB-Cl (83 mg, 0.272 mmol) was flushed with nitrogen in a MW vial. 4-tert-Butylaniline 
(0.6 mL, 0.56 g, 3.8 mmol) was added and the mixture was heated in microwave at 160 °C for 
2 hours. A saturated solution of NaHCO3 (5 mL) was added and the mixture was extracted 
with CH2Cl2/MeOH (20:1, 2 × 50 mL) and CH2Cl2 (2 × 50 mL). The organic phase was dried 
over MgSO4, evaporated and loaded to Celite. A combiflash of the residue on silica 




H NMR (CDCl3, 400 MHz, 298 K): δ 7.42 – 7.38 (m, 2H), 7.19 – 7.16 (m, 2H), 7.13 – 7.10 
(m, 2H), 7.00 – 6.98 (m, 2H), 6.15 (s, 1H), 5.06 (s, 1H), 4.57 (s, 2H), 3.92 (d, J = 7.0 Hz, 2H), 
1.33 (s, 9H), 1.24 (s, 9H), 1.17 (t, J = 7.0 Hz, 3H). 
13
C NMR (CDCl3, 101 MHz, 298 K): δ 164.4, 162.6, 160.9, 149.6, 145.6, 141.0, 137.0, 
127.9, 126.3, 125.6, 120.5, 77.2, 44.0, 34.5, 34.2, 31.4, 31.3, 13.6. 
 
HR-MS (ESI): Required for C26H36N5 [M+H]
+
 418.2971, found: 418.2962 (Δ = 2.2 ppm). 
 
FT-IR (thin film): 3456, 3343, 3229, 2953, 2918, 2850, 1629, 1573, 1540, 1429, 1359, 1256, 




MP:  180 – 182 °C 
 
EA: Required for C26H35N5: C 74.78, H 8.45, N 16.77; found: C 74.62, H 8.53, N 16.32. 
 





















Synthesis of B 
 
 
NaH (60% in mineral oil, 140 mg, 3.5 mmol) was flushed with nitrogen and DMF (6 mL) was 
added. The mixture was cooled to 0 °C and urea (418 mg, 7.0 mmol) was added. After 
2 hours of stirring, diethyl dibutylmalonate (0.5 mL, 473 mg, 1.73 mmol) was added dropwise 
at 0 °C. The mixture was stirred overnight at RT and a saturated solution of NH4Cl (10 mL) 
was added with cooling to 0 °C. Water (15 mL) was added and the mixture was extracted with 
CH2Cl2/MeOH (10:1, 40 mL) CH2Cl2 (2 × 50 mL). The collected organic phase was dried 
over MgSO4 and the solvents were removed under reduced pressure (60 °C, <20 mBar). A 
combliflash of the residue on silica (Celite loading, PE/DCM, DCM: 0%→100%) provided 




H NMR (CD3OD, 400 MHz, 298 K): δ 1.92 – 1.88 (m, 4H), 1.33 – 1.24 (m, 4H), 1.20 –
 1.12 (m, 4H), 0.88 (t, J = 7.5 Hz, 6H). 
 
MP:  154 – 155 °C 
 
EA: Required for C12H20N2O3: C 59.87, H 8.39, N 11.66; found: C 59.13, H 8.25, N 11.38. 
 








Synthesis of bC and C 
 
 
Cyanuric acid (4.2 g, 32.5 mmol) and 1,8-diazabicyclo[5.4.0]undec-7-ene (0.57 mL, 
0.58 g, 3.8 mmol) were flushed with N2. DMF (10 mL) and 1-iodopentane (0.5 mL, 0.79 g, 
3.96 mmol) were added and the mixture was heated at 60 °C for 5 days. The solvents was 
then removed under reduced pressure and a combiflash of the residue on silica (Celite 
loading, CH2Cl2/MeOH, MeOH: 0%→5%) provided the title products bC (164 mg, 




H NMR (CD3OD, 400 MHz, 298 K): δ 3.78 – 3.75 (m, 4H), 1.66 – 1.58 (m, 4H), 1.42 – 
1.27 (m, 8H), 0.92 (t, J = 7.0 Hz, 6H). 
13
C NMR (CD3OD, 101 MHz, 298 K): δ 151.7, 150.5, 49.6, 43.0, 29.9, 28.5, 23.4, 14.3. 
 
HR-MS (ESI): Required for C13H24N3O3 [M+H]
+
 270.1818, found: 270.1812 (Δ = 2.2 ppm). 
 




MP: 98 – 101 °C 
 




H NMR (CD3OD, 400 MHz, 298 K): δ 3.79 – 3.75 (m, 2H), 1.66 – 1.58 (m, 2H), 1.42 – 
1.27 (m, 4H), 0.92 (t, J = 7.0 Hz, 3H). 
 
MP:  229 – 232 °C 
 
EA: Required for C8H13N3O3: C 48.23, H 6.58, N 21.09; found: C 48.27, H 6.55, N 20.92. 
 





















Synthesis of bB 
 
 
NaH (60% in mineral oil, 266 mg, 6.65 mmol) was flushed with nitrogen and DMF (10 mL) 
was added. The mixture was cooled to 0 °C and N-methylurea (1.25 g, 16.9 mmol) was 
added. After 3 hours of stirring, diethyl butylmalonate (0.55 mL, 541 mg, 1.99 mmol) was 
added at 0 °C. The mixture was stirred overnight at 60 °C. Then a saturated solution of NH4Cl 
(15 mL) was added at 0 °C. Water (20 mL) was added and the mixture was extracted with 
dichloromethane (4 × 50 mL). The collected organic phase was dried over MgSO4 and the 
solvents were removed under reduced pressure. A combliflash of residue on silica (Celite 




H NMR (CDCl3, 400 MHz, 298 K): δ 8.04 (s, 1H), 3.31 (s, 3H), 2.03 – 1.92 (m, 4H), 1.31 – 
1.22 (m, 4H), 1.19 – 0.99 (m, 4H), 0.85 (t, J = 7.5 Hz, 6H). 
13
C NMR (CD3OD, 101 MHz, 298 K): δ 174.6, 174.0, 151.7, 57.6, 40.4, 28.2, 27.7, 23.7, 
14.0. 
 
HR-MS (ESI): Required for C13H21N2O3 [M–H]
–
 253.1552, found: 253.1549 (Δ = 3.3 ppm). 
 





MP:  97 – 98 °C 
 


























H NMR (500 MHz, CDCl3) spectra of PA•B at 298 K, 273 K, 253 K and 233 K 




H NMR (500 MHz, CDCl3) spectra of PB•B at 298 K, 273 K, 253 K and 233 K 








H NMR (500 MHz, CDCl3) spectra of PA•C at 298 K, 273 K, 253 K and 





H NMR (500 MHz, CDCl3) spectra of PB•C at 298 K (top) and 233 K (bottom) 
with c(PB) = c(C) = 3 mM. 




3.10.4. NMR dilutions and titrations  
General 
The NMR titrations were recorded on a Bruker 400 MHz Avance III HD Smart Probe 
at 400 MHz and on a Bruker 500 MHz AVIII HD SmartProbe Spectrometer at 500 MHz at 
298 K with CDCl3 as a solvent. A host solution with known concertation was prepared and a 
fraction of this solution (500/600 μL) was transferred into a NMR tube. Then, the guest 
solution was prepared by dissolving a known amount of guest in the host stock solution in a 
volumetric flask. A change of chemicals shifts of 
1
H upon addition of aliquots of guest 
solution were followed. For dilution experiments, a solution with known concentration of a 
compound was prepared and aliquots of this solution were added to a NMR tube containing 
only the solvent (500 μL/600 μL) and the change of chemicals shifts of 
1
H upon addition was 
followed. The observed changes of chemical shifts were analysed using a purpose-written 
fitting macro in Microsoft Excel (written by Professor Hunter). A dimerisation isotherm, 1:1 
binding isotherm, different 1:2 binding isotherms (see below) and 3:3 binding isotherm were 
used to fit the experimental data. The experiments were measured at least two times on two 
different days with freshly prepared solutions in order to eliminate possible systematic errors. 
The results are stated as average values and errors are quoted as two times the standard 
deviation. 
 
1:2 binding isotherms 
a) Non-cooperative model using identical binding sites: 
K1 = K2 = Knc and the change in chemical shift for formation of the 1:1 
complex is identical to the subsequent change in chemical for formation of the 
1:2 complex 
b) Non-cooperative model where K1 and K2 were fixed to be the appropriate Kref 
c) Cooperative isotherm where K1 was fixed to be the appropriate Kref 
 
Global error of the fit 
𝐸 =
∑ (𝛿i,calc − 𝛿i,obs)
2N−1
i=0




where δi,calc is the calculated chemical shift, δi,obs is the observed chemical shift and δ0,obs is 
the observed chemical shift for the first point in the titration, N is the total number of data 








H NMR (400 MHz, CDCl3, 298 K) titration of bB into bPB (0.53 mM). 
1
H NMR spectrum is shown on the left (pyrimidine C-H signal green, N-H signals blue and 
red). On the right are shown the experimental data (circles) and calculated values (lines) based 




H NMR (400 MHz, CDCl3, 298 K) titration of bC into bPA (0.86 mM). 
1
H NMR spectrum is shown on the left (pyrimidine C-H signal green, N-H signals blue and 
red). On the right are shown the experimental data (circles) and calculated values (lines) based 
on a 1:1 binding isotherm. 







H NMR (400 MHz, CDCl3, 298 K) titration of bC into bPB (0.83 mM). 
1
H NMR spectrum is shown on the left (pyrimidine C-H signal green, N-H signals blue and 
red). On the right are shown the experimental data (circles) and calculated values (lines) based 







H NMR (400 MHz, CDCl3, 298 K) titration of bB into PB (0.53 mM). 
1
H NMR spectrum is shown on the left (pyrimidine C-H signal green, N-H signals blue and 
red). On the right are shown the experimental data (circles) and calculated values (lines) based 
on a 1:2 binding isotherms using (a) non-cooperative model using identical binding sites, (b) 
non-cooperative model where K1 and K2 were fixed to be the appropriate Kref and (c) 
cooperative isotherm where K1 was fixed to be the appropriate Kref. 
 
 






H NMR (500 MHz, CDCl3, 298 K) titration of bC into PA (0.77 mM). 
1
H NMR spectrum is shown on the left (pyrimidine C-H signal green, N-H signals blue and 
red). On the right are shown the experimental data (circles) and calculated values (lines) based 
on a 1:2 binding isotherms using (a) non-cooperative model using identical binding sites, (b) 
non-cooperative model where K1 and K2 were fixed to be the appropriate Kref and (c) 








H NMR (500 MHz, CDCl3, 298 K) titration of bC into PB (0.65 mM). 
1
H NMR spectrum is shown on the left (pyrimidine C-H signal green, N-H signals blue and 
red). On the right are shown the experimental data (circles) and calculated values (lines) based 
on a 1:2 binding isotherms using (a) non-cooperative model using identical binding sites, (b) 
non-cooperative model where K1 and K2 were fixed to be the appropriate Kref and (c) 
cooperative isotherm where K1 was fixed to be the appropriate Kref. 
  







H NMR (500 MHz, CDCl3, 298 K) titration of bPB into B (0.90 mM). 
1
H NMR spectrum is shown on the left (CH3 signal red, (C=O)2C(CH2)2 signal blue). On the 
right are shown the experimental data (circles) and calculated values (lines) based on a 1:2 
binding isotherms using (a) non-cooperative model using identical binding sites, (b) non-
cooperative model where K1 and K2 were fixed to be the appropriate Kref and (c) cooperative 







H NMR (400 MHz, CDCl3, 298 K) titration of B into PB (1.1 mM). The 
1
H NMR spectrum is shown on the left (pyrimidine C-H signal green). On the right are shown 





H NMR (500 MHz, CDCl3, 298 K) titration of C into PA (0.30 mM). The 
1
H NMR spectrum is shown on the left (pyrimidine C-H signal green). On the right are shown 
the experimental data (circles) and calculated values (line) based on a 3:3 binding isotherm. 
The weight averaging was used to obtain the average chemical shift of pyrimidine C-H signal. 
  







H NMR (500 MHz, CDCl3, 298 K) titration of C into PB (0.26 mM). The 
1
H NMR spectrum is shown on the left (pyrimidine C-H signal green). On the right are shown 
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system inside            
porphyrin nanoring 
  





In nature, most of the biological systems are multivalent. Due to cooperativity, the 
product of multiple bindings is usually not just a simple sum of individual binding 
contributions.
1
 In multivalent supramolecular systems, two types of cooperativity exist: 
allosteric and chelate cooperativity. Allosteric cooperativity happens when a first binding 
influences the strength of the second binding. Chelate cooperativity originates from the 
binding of a multivalent host and guest which leads to the change of the “effective 
concentration” for the second binding. Nowadays, the term effective molarity is used for the 
quantification of chelate cooperativity. A model divalent system is described in Figure 4.1. 
The first binding is always intermolecular with an equilibrium constant Kinter. For second 
binding, two different pathways are possible: intramolecular cyclisation with an equilibrium 
constant Kintra (that usually differs from Kinter) or intermolecular interaction with an 
equilibrium constant Kinter resulting in oligomerisation.  
 
 
Figure 4.1. Schematic representation of chelate cooperativity in the c-AA•BB complex. The 
first binding is always intermolecular. The second binding is either intramolecular cyclisation 
or intermolecular interaction resulting in oligomerisation. 
 












The literature provides a distribution of effective molarities in supramolecular 
systems. The median value is 100 mM and EMs greater than 10
2
 M are considered to be 





Porphyrin nanorings from the Anderson group are examples of such system with 
exceptionally high values of EM. The highest value has been found for complex 6-ring•T 
(Figure 4.2). The Anderson group used a series of ligands with two, three, four and five 
pyridine binding sites to determine stepwise EMs for each binding interaction in the 
hexamer.
3
 The value of EM for the first intramolecular binding interaction is 100 mM, which 
is comparable to the value found for the majority of supramolecular complexes. However, all 






Figure 4.2. Complex of 6-ring (black) with hexadentate ligand T (blue). R is a substituent. 
 
The goal of this project was to test if the extreme values of effective molarity found 
for the 6-ring can stabilise a weakly-interacting H-bonded system inside the 6-ring cavity. 
This should provide new insights into the extreme values of effective molarities and answer if 
the additional flexibility and different nature of the hexadentate supramolecular ligand system 
can be beneficial or not compared to the hexadentate covalent ligand. The H-bonded system 













The initial idea for the supramolecular system was to utilise small molecules based on 
pyridine that would contain simple H-bond acceptors and donors units. The strength of the H-
bonding interactions can be predicted by using the molecular recognition toolbox.
4
 It is 
possible to quantify the free energy of a solution phase intermolecular interaction in defined 
solvent S by using Equation 4.2. 
   
𝛥𝐺°pred = −(𝛼 − 𝛼s)(𝛽 − 𝛽s) + 6 kJ · mol
−1    (4.2) 
where α and β describe the H-bond donor and acceptor properties, respectively, S is an 
annotation for solvent and the value 6 kJ · mol
–1
 is the free energy cost of the bimolecular 
association. 
 




𝑅𝑇         (4.3) 
 
Since phosphine oxides and phenols should produce the strongest H-bonding (β = 10 
and α = 4, respectively), these were the functional groups chosen to start with. Figure 4.4 
shows two supramolecular systems using different bisphosphine oxides and commercially 
available pyridine-3,5-diol (pyridinediol). In addition, we also wanted to test systems that 
utilise weaker H-bonding acceptors to investigate the influence of H-bonding strength on the 







initial candidates were selected: a sulfoxide and an amide, both of which should still be 
reasonably strong H-bond acceptors (with β = 9 and with β = 8, respectively). The amide 
seemed the best candidate because of its synthetic accessibility. A supramolecular system 
inside the porphyrin nanoring cavity based on the different H-bonding acceptor and 
pyridinediol is shown in Figure 4.4c. It can be noted that these molecules are technically 
imides rather than amides and they should provide the optimal geometry for the target 




Figure 4.4. Supramolecular H-bonded system based on (a) (b) bisphosphine oxides and (c) 
imides. R is a solubilising group. 
 
This approach would also allow us to construct a range of lower valency ligands by 
combining mono and bisphosphine oxides and phenols. An example based on pyridinediol 
and mono phosphine oxide is shown in Figure 4.5b. 
 
 
Figure 4.5. (a) Linear covalent template and (b) its supramolecular equivalent (R is a 
solubilising group). 
 
To study the supramolecular system, a non-polar solvent has to be used, as these       
H-bonded systems would be disrupted in polar solvents such as methanol. We decided to 









Computational chemistry was used to test the different designs described in Figure 4.4. 
DFT calculations cannot be used for conformational searches for these systems due to the 
large number of atoms. Molecular mechanics cannot be used for these systems, because they 
contain both H-bonding and zinc-pyridine interactions, which are not parameterised well. 
Herein, we describe a strategy to overcome these issues.  
 
We took ligand T from the X-ray structure of the 6-ring •T (Figure 4.6) and used it as 
a template.
5
 For molecular modelling calculations, we constrained the coordinates of the 
nitrogen atoms and the carbon atoms in the position 4 (Figure 4.7). With this, the 
conformational search could rotate the pyridines freely around their axes. In addition, this 
modelling does not employ 6-ring. This method lowers the calculations costs, but it does not 














Figure 4.7. Template  T as a template for molecular modelling calculations. The atoms in red 
were constrained for the calculations to allow rotation around the pyridine axis (one is 
highlighted in blue).  
 
With this simplified method in hand, we were able to model the systems proposed in 
Figure 4.4. The restricted conformational search provided structures with either 5 or 6           
H-bonds connecting the ligands of these systems as shown in Figure 4.8. The system based on 
bisphosphine oxide shown in Figure 4.8a provided a structure that is not fully connected by 
H-bonding. This does not mean that the proposed system cannot be formed inside the 
porphyrin nanoring, since the search was restricted as stated above. The other two systems 
from Figure 4.4, based on a different bisphosphine oxide and imide, provided lowest energy 
structures that are connected together by 6 H-bonds. This showed that it should be possible to 
obtain the target H-bonded supramolecular systems inside the cavity of porphyrin nanoring. 
 





Figure 4.8. Lowest energy structures from restricted molecular mechanics conformational 
search of H-bonded supramolecular systems based on (a) and (b) bisphosphine oxides and (c) 
imines using T as a template. The coordinates of nitrogen atoms and carbon atoms in the 
position 4 were constrained (See Figure 4.7). Hydrogen atoms that do not contribute to H-
bonding were omitted for clarity; colouring of atoms: C (black), N (blue), O (red), P (yellow), 





4.4. Synthesis  
4.4.1.  Synthesis of porphyrin nanoring 
First of all, a porphyrin nanoring had to be synthesised. To do that, a porphyrin 
monomer and a suitable template had to be prepared.
3,6
 The synthesis of porphyrin monomer 
M was accomplished in seven steps (Scheme 4.1). Dipyrromethane 1 was prepared from 
pyrrole on a multigram scale with a yield of 35%. Also on a multigram scale, the substituted 
benzaldehyde 2 was synthesised by radical bromination of substituted toluene and a 
subsequent Sommelet reaction. The reaction of 1 and 2 with trifluoroacetic acid followed by 
an in-situ reaction with DDQ provided a porphyrin that was immediately treated with zinc 
acetate to generate zinc porphyrin 3 in 28% yield. The bromination of this porphyrin with 
NBS produced the dibromo porphyrin 4 with a yield of 83%. Trihexylsilyl acetylene 5 was 
prepared in 95% yield from ethynylmagnesium bromide. The Sonogashira coupling of 4 with 
5 produced the THS-protected meso-alkynyl porphyrin 6 with a yield of 96%. In the last step, 
6 was deprotected by TBAF to obtain the target porphyrin monomer M in 80% yield. 
   









The template T was prepared in two steps (Scheme 4.2). The bromination of 
hexaphenylbenzene with neat bromine provided hexabromo-hexaphenylbenzene 7 in a 82% 
yield. The subsequent six fold Suzuki coupling provided template T with a yield of 42% 











Having both porphyrin monomer M and template T in hand, the next step was the 
synthesis of porphyrin nanoring complex 6-ring•T by oxidative coupling (Scheme 4.3). The 
crucial aspect of this preparation is the work-up since 6-ring, 12-ring and higher oligomers 
and polymers are all formed in this reaction and have to be separated. Particularly, the 6-ring 
and 12-ring are similar and therefore more difficult to separate from each other. The published 
procedure used size exclusion chromatography for this purification. However, nowadays the 
Anderson group uses preparative GPC. With the aid of GPC, the 6-ring•T was prepared in 
16% yield and only traces (<1 mg) of the 12-ring were detected. However, we found a new 
more straightforward method for the isolation of 6-ring. This method is based solely on the 
use of alumina plugs and column chromatography on silica. With the aid of this new 
purification method, 6-ring•T was prepared in 22% yield. The column chromatography is 
actually just a simple filtration, since the 6-ring•T is eluted in approximately 30% hexane in 
toluene, whereas the 12-ring and polymers stay at the top of the column with this solvent 
system and are eluted only upon using 100% toluene. This significant difference could permit 
the porphyrin nanoring synthesis on a large scale since the loading amounts of GPC are 
limited and it should be easy to scale this new method up. 
 
Template T binds extremely well to the 6-ring and therefore drastic conditions have to 
be used to obtain the template-free porphyrin nanoring 6-ring from 6-ring•T. One possible 
method is the treatment of 6-ring•T with trifluoroacetic acid which removes zinc from the 
porphyrins and thus removes the template T as well. The obtained free base porphyrin ring 
has to be treated with zinc acetate again to produce template-free zinc porphyrin nanoring     
6-ring. The yield of this two-step procedure was 35% (Scheme 4.3).  












4.4.2.  Synthesis of ligands 
After the successful preparation of 6-ring, the synthesis of the proposed ligands from 
Figure 4.4 and Figure 4.5 was undertaken. The simplest molecule 8 was synthesised first 
(Scheme 4.4). Lithiation of 4-methylpyridine with n-butyllithium, followed by a reaction with 
a chlorodialkylphosphine and finally in-situ oxidation of the obtained phosphine produced 
phosphine oxides 8a and 8b in good yields (53% and 73%, respectively). 
 
 
Scheme 4.4. Synthesis of ligands 8a-b. 
 
Next, the synthesis of the more complex ligands based on bisphosphine oxides 
(Figure 4.4a) was attempted. Firstly, the same methodology employed for the preparation of 
the mono phosphine oxides 8 was used (Scheme 4.5). Unlike in the previous examples, the 
reaction did not proceed, probably due to the bulkiness of alkyl groups on the phosphorus 
atom, which could have severely limited access of the base to the methylene group.  
 
 
Scheme 4.5. Attempted synthesis of bisphosphine oxides (R is a solubilising group). 
 
A different approach for the synthesis of the desired bisphosphine oxides was 
proposed. It entailed the preparation of bisphosphine oxide scaffold first by oxidation of 
commercially available bisphosphine to produce 9 (Scheme 4.6). Several different reaction 
conditions were tested to prepare the target compound from 9.
7,8
 Again, all attempts failed.  
 





Scheme 4.6. Different approach for the synthesis of target bisphosphine oxides. 
 
Since we did not succeed in the preparation of  the compound shown in Figure 4.4a, 
we resorted to preparation of the ligand from Figure 4.4b. The synthesis for a phosphonate 
diester based on this structure is known.
9
 Phosphonate diesters are just slightly worse 
hydrogen-bond acceptors (with β = 8.9) than phosphine oxides,
4
 therefore we employed this 
procedure to obtain 10 in a 57% yield (Scheme 4.7). 
 
 
Scheme 4.7. Synthesis of 10. 
 
Finally, to explore the system that uses a different H-bonding acceptor shown in 
Figure 4.4c, cyclic imide 11 was prepared by a reaction of 4-aminopyridine with succinic 
anhydride as shown in Scheme 4.8.  
 
 







Firstly, the H-bonding properties of the ligands were obtained by NMR titrations in  
d
8
-toluene. For all the H-bond acceptors, 4-methylphenol (P) was used as the H-bond donor, 
since all the proposed systems utilise pyridinediol as the second partner (Figure 4.4).  
 As an example of a phosphine oxide, 8a was used (Figure 4.9). Equations 4.1 and 4.2 
predict an association constant of 540 M
–1
 for the formation of complex between 8a (β = 9.9) 
and P (α = 3.8) in toluene (αS = 1.0; βS = 2.2). The 
31
P NMR signal of the phosphine atom 
shifts significantly upon formation of H-bond, therefore it was easy to follow the change 
(Figure 4.9b) and use a 1:1 binding isotherm to fit the experimental data (Figure 4.9c). The 







P NMR (162 MHz, d
8
-toluene, 298 K) titration of P into 8a (3mM). (a) 
Structure of the complex optimised by molecular modelling; hydrogen atoms that do not 
contribute to H-bonding were omitted for clarity; colouring of atoms: C (black), N (blue), O 
(red), P (yellow), H (grey); green dashed line is the H-bond; (b) change of 
31
P chemical shift 
upon addition of P in d
8
-toluene at 298 K; (c) experimental data (circles) and calculated 
values (lines) based on a 1:1 binding isotherm. 
 
Commercially available lactam L was used as a model for imide ligand 11, 
(Figure 4.10). Equations 4.1 and 4.2 predict an association constant for the complex L•P in 
toluene as 90 M
–1 
(using α(P) = 3.8 and β(L) = 8.3). The addition of L to a solution of P 




resulted in a significant change of the Ar-OH chemical shift (Figure 4.10b). A 1:1 binding 
isotherm was used to fit the titration data (Figure 4.10c) and the association constant was 
determined to be 16 ± 1 M
–1
. This value is an order of magnitude lower than that determined 






H NMR (400 MHz, d
8
-toluene, 298 K) titration of P into 8a (11 mM). (a) 
Structure of the complex optimised by molecular modelling; hydrogen atoms that do not 
contribute to H-bonding were omitted for clarity; colouring of atoms: C (black), N (blue), O 
(red), H (grey); green dashed line is the H-bond; (b) change of 
1
H chemical shift of –OH upon 
addition of L in d
8
-toluene at 298 K; (c) experimental data (circles) and calculated values 
(lines) based on a 1:1 binding isotherm. 
 
4.6. Mixing experiments 
Next, we investigated the formation of the target supramolecular systems inside         
6-ring. Unfortunately, a major problem appeared – it was realised that pyridinediol is 
insoluble in both toluene and chloroform. Therefore, it had to be added as a solution in 
methanol to an empty NMR tube. Afterwards, methanol was removed and all the remaining 
compounds were added. We assumed that the solubility issue would be overcome in the final 





pyridinediol. Since the 6-ring solutions are dark brown colour, it was hard to judge if 
pyridinediol dissolved after the addition of all remaining compounds. An example of these 
NMR mixing experiments is depicted in Figure 4.11. When the NMR tube was cleaned 
afterwards, it was noticed that there is probably still some undissolved solid at the bottom. 
These mixing NMR experiments thus did not provide any useful information as it was hard to 
judge if all the compounds dissolved as well as bound to 6-ring. The insolubility of 
pyridinediol also resulted in impossibility to conduct any direct formation titrations (both 
NMR and UV-vis-NIR). Therefore the only feasible additional experiment was a 
displacement UV-vis-NIR titration with either quinuclidine or pyridine. Unfortunately, it was 
not possible to obtain any titration curves, because even a small initial addition changed the 
spectra completely and there was no observable change after further additions as seen in 
Figure 4.12. Additionally, we realised that both quinuclidine and pyridine are also H-bond 
acceptors, and by that, they can disrupt the target H-bonded system. For the correct execution 
of the displacement titrations, it is desired that the displacement happens only at the zinc 





H NMR spectra of (a) 6-ring (400 MHz, d
8
-toluene), (b) 10 (400 MHz, CHCl3) 
and (c) mixture of 6-ring, pyridinediol and 10 in a 1:3:3 ratio (400 MHz, d
8
-toluene).  





Figure 4.12. UV-vis-NIR titration of quinuclidine to 6-ring, pyridinediol and 10 in a 1:3:3 
ratio taken from a NMR stock solution. The spectra are shown on the left with the spectrum of 
the complex in thick black line and the end spectrum in red thick line. 
 
4.7. Conclusion 
Different pyridine ligands based on phosphine oxides and an imide were prepared. 
Their H-bond properties were investigated by 
1
H NMR titrations. We attempted to use these 
molecules to prepare a supramolecular system inside a porphyrin nanoring, but all the 
attempts failed, mostly due to the insolubility of pyridinediol in solvents used (chloroform 
and toluene). Because of this, the work on this project was terminated. However, recently, we 
realized a possible solution to overcome the solubility issue. The synthesis of pyridinediol 
(Figure 4.13) with R = tert-butyldimethylsilyl is known. If a different solubilizing group, such 
as trihexylsilyl and citronellyl, is used, the solubility of the pyridinediol should increase 
significantly in non-polar solvents. This has not been explored so far, as a completely 
different system was proposed, which is described in the following Chapter. 
 
 






4.8. Experimental section 
4.8.1. General 
The majority of chemicals were bought from commercial suppliers and used without 
further purifications unless stated otherwise. 3,5-Di-tert-butyltoluene was synthesised in the 
lab of Prof H. Anderson. Solvents were either distilled before use or used as obtained; the 









Lumen™ (with UV light 
detection: 254 nm and 500 nm for porphyrin nanorings, and evaporative light scattering 
detector for Lumen) with pre-packed puriFlash
®
 columns from Interchim (silica, 25 μm; 
15 μm for porphyrin nanorings) with an absorption of mixtures on Celite
®
 were used. For 
plugs, silica gel 60 (Merck, 40–63 μm) and alumina (either Aluminium oxide 90 standardised 
from Merck or Aluminium oxide, activated, basic, Brockmann I, standard grade from Sigma-
Aldrich) were used. The reactions were monitored by glass TLC plates coated with silica gel 
60 F254 (Merck) and the plates were inspected by UV light (254 nm). For GPC, recycling 
Shimadzu Prominence GPC with UV light detection (500 nm) with a set of columns JAIGEL 







P NMR spectra were recorded on Bruker 400 MHz Avance III HD 
Spectrometers at 400 MHz for 
1
H, 101 MHz for 
13
C and 252 MHz for 
31
P. All chemicals shift 
are quoted in ppm and were referenced to residual peaks of CDCl3 (
1
H: 7.26 ppm; 
13
C: 
77.00 ppm). Coupling constants J are stated in Hz. FT-IR spectra were measured on a Bruker 
Alpha spectrometer. HR-MS spectra were obtained on a Waters Xevo
®
 G2-S by electrospray 
ionisation of samples. Melting points were recorder on a Mettler-Toledo MP90 system. 
  





Synthesis of 1  
 
 
Formaldehyde (37% in water, 9.7 mL, 130 mmol) was added to pyrrole (200 mL, 2.84 mol) 
and the solution was degassed by the vaccum/Ar cycle (5×). The flask was covered with 
aluminium foil and trifluroacetic acid (99%, 1.1 mL, 14 mmol) was added by syringe under 
vigorous stirring. After 6 minutes, CH2Cl2 (200 mL) was added, followed immediately by 
saturated solution of Na2CO3 (200 mL). The organic phase was separated and washed with the 
saturated solution of Na2CO3 (2 × 200 mL), water (200 mL) and dried over Na2SO4. The 
volatiles were removed under reduced pressure (up to 70 °C and 9mBar to remove unreacted 
pyrrole). The Kugelrohr distillation (130 °C, 1 mBar) of the residue produced the title 
compound as yellowish solid (6.1 g, 35% crude yield). The compound was used in the next 
step without any additional purification. 
 
1
H NMR (CDCl3, 400 MHz, 298 K): 7.63 (br, 2H), 6.62–6.61 (m, 2H), 6.20–6.18 (m, 2H), 
6.09–6.06 (m, 2H), 3.94 (s, 2H). 
 








Synthesis of 2  
 
 
3,5-Di-tert-butyltoluene (25.0 g, 123 mmol), N-bromosuccinimide (33.0 g, 185 mmol) and 
azobisisobutyronitrile (0.90 g, 5.5 mmol) in benzene (50 mL) were heated slowly to reflux. 
Then it was refluxed gently for 4 hours. After this time, the mixture was cooled to room 
temperature and the precipitate was filtered off over filtrate paper and the solvent was 
removed under reduced pressure. The residue was dissolved in a mixture of EtOH/H2O (1:1, 
70 mL) and urotropine (50.0 g, 357 mmol) was added. The mixture was then refluxed for 
4 hours. HCl (37%, 21 mL) was added and the mixture was refluxed for additional 
30 minutes. The mixture was cooled and ethanol was removed under reduced pressure (40 °C, 
125 mBar). The residue was then extracted with diethyl ether (1 × 300 mL, 2 × 200 mL). The 
collected organic phases were then dried over Na2SO4 and the solvent was removed under 
reduced pressure. Recrystallisation from EtOH afforded the title compound as white crystals 
(8.89 g, 33% yield). 
 
1
H NMR (CDCl3, 400 MHz, 298 K): δ 10.01 (s, 1H), 7.75–7.69 (m, 3H), 1.37 (s, 18H). 
 








Synthesis of 3 
 
 
1 (1.88 g, 12.9 mmol) and 2 (2.81 g, 12.9 mmol) were placed into a freshly open Winchester 
bottle of CH2Cl2 (2.5 L) and the solution was degassed by the vacuum/Ar cycle (3×). 
Trifluoroacetic acid (0.62 mL, 8.0 mmol) was added rapidly and the Winchester bottle was 
covered with aluminium foil. The reaction mixture was then stirred for 3.5 hours and 2,3-
dichloro-5,6-dicyano-1,4-benzoquinone (DDQ, 4.38 g, 19.3 mmol) was added and stirring 
was continued for 30 minutes. Triethylamine (12.5 mL) was then added and the mixture was 
concentrated to a volume of about 300 mL by reduced pressure. Then it was passed over a 
large silica plug with CH2Cl2 and washed thoroughly (4×, after each run the volume was 
concentrated to approximately 300 mL). The solvent was removed by reduced pressure and 
the residue was dissolved in fresh CH3Cl (300 mL). Zn(OAc)2•2H2O (3.17 g, 14.4 mmol) was 
dissolved in methanol (30 mL) and added to the CH3Cl solution. The reaction mixture was 
stirred for 1 hour. The mixture was then passed over medium-size silica plug with CH2Cl2. 
The solvents were removed by reduced pressure and the residue was recrystallised by layer 
addition (CH2Cl2/ CH3OH) at fridge and then dried under high vacuum overnight to obtain a 
purple powder (1.28 g, 28% yield). 
The procedure was repeated at the same scale and smaller scale (with 1.55 g of 
dipyrromethane) with the same yields (29% and 28%, respectively). 
 
1
H NMR (CDCl3 + 1% d
5
-pyridine, 400 MHz, 298 K): δ 10.19 (s, 2H), 9.36 (d, J = 4.5 Hz, 
4H), 9.11 (d, J = 4.5 Hz, 4H), 8.10 (d, J = 2.0 Hz, 4H), 7.79 (t, J = 2.0 Hz, 2H), 1.55 (s, 36H).  
 








Synthesis of 4 
 
 
To a solution of zinc porphyrin 3 (1.06 g, 1.41 mmol) in CH2Cl2 (175 mL) and pyridine 
(2.9 mL) was added N-bromosuccinimide (freshly recrystallised, 505 mg, 2.84 mmol) at         
–10 °C. After stirring for 10 minutes at –10 °C, the cooling bath was removed and the 
reaction flask was covered by aluminium foil and the reaction mixture was left heated slowly 
to room temperature. After 1.5 hours, hexane (180 mL) was added and the reaction mixture 
was passed over medium-size silica plug, which was previously treated with a mixture of 
CH2Cl2/hexane/pyridine (1:1:0.08, 0.5 L). Then the mixture of CH2Cl2/hexane was used for 
washing the plug. The solvents were removed under reduced pressure and then toluene 
(30 mL) was added and subsequently removed under reduced pressure three times to help to 
remove pyridine. The residue was dissolved in the mixture of CH2Cl2 (150 mL) and pyridine 
(4 drops). Then methanol (400 mL) was added as a second layer and the slow crystallisation 
at fridge provided purple solid that was washed with plenty of methanol and dried under high 
vacuum to obtain a purple powder (1.07 g, 83% yield). 
 
1
H NMR (CDCl3, 400 MHz, 298 K): δ 9.64 (d, J = 4.5 Hz, 4H), 8.89 (d, J = 4.5 Hz, 4H), 
7.97 (d, J = 2.0 Hz, 4H), 7.78 (t, J = 2.0 Hz, 2H), 1.53 (s, 36H). 
 
Rf (CH2Cl2/hexane 1:1; silica): 0.62. 
 












Chlorotrihexylsilane (97%, 10.0 g, 30.4 mmol) was added dropwise to a stirred solution of 
ethynylmagnesium bromide (0.5 in THF, 100 mL, 50 mmol) under N2. The mixture was 
refluxed for 2 hours. To a cooled down solution, HCl (aq., 10%, 80 mL) was added and the 
organic phase was washed with water (80 mL), dried over MgSO4 and evaporated to obtain 
the title product (8.88 g, 95% yield) as yellowish liquid. 
 
1
H NMR (CDCl3, 400 MHz, 298 K): δ 2.36 (s, 1H), 1.41 – 1.21 (m, 24H), 0.89 (t, 
J = 7.0 Hz, 9H), 0.67 – 0.55 (m, 6H). 
 








Synthesis of 6 
 
 
Triphenylphosphine (59 mg, 0.23 mmol), CuI (46 mg, 0.24 mmol), tris(dibenzylideneacetone) 
-dipalladium (105 mg, 0.10 mmol) and dibromoporphyrin 4 (1.05 g, 1.15 mmol) were placed 
in a flame-dried Schlenk tube under argon. Then toluene (74 mL), diisopropylamine (40 mL) 
and pyridine (2.1 mL) were added and the mixture was thoroughly deoxygenated by 4 
freeze/pump/thaw cycles. After this, trihexylsilylacetylene 5 (1.4 mL, 3.6 mmol) was added 
by syringe through the septum. The reaction mixture was then heated at 55 °C for 90 minutes. 
The solvents were removed under reduced pressure and the residue was dissolved in CH2Cl2 
and passed over silica plug and the solvent was reduced under reduced pressure again. 
Toluene (2 × 30 mL) was added and subsequently removed under reduced pressure to remove 
the remaining pyridine. The layer recrystallisation (CH2Cl2/CH3OH) of the residue produced a 
green solid that was washed with plenty of methanol to produce the title product as a green 
solid (1.51 g, 96% yield). 
 
1
H NMR (CDCl3, 400 MHz, 298 K): δ 9.72 (d, J = 4.5 Hz, 4H), 8.96 (d, J = 4.5 Hz, 4H), 
8.05 (d, J = 1.5 Hz, 4H), 7.82 (s, 2H), 1.82 – 1.69 (m, 12H), 1.54 (m, 48H), 1.46 – 1.23 (m, 
24H), 1.06 – 0.97 (m, 12H), 0.89 (t, J = 7.0 Hz, 18H). 
 
Rf (CH2Cl2/EtOAc/pyridine 10:1:1, silica): 0.92. 
 













Synthesis of M 
 
 
To a solution of THS-protected porphyrin 6 (600 mg, 0.44 mmol) in CH2Cl2 (60 mL), TBAF 
(4.2 mL, 1.0M solution in THF, 4.2 mmol) was added in one portion. After 15 minutes, the 
mixture was passed over silica plug (CHCl3/pyridine 100:1). The solvent was removed under 
reduced pressure and toluene (2 × 100 mL) was added and subsequently removed under 
reduced pressure to remove the remaining pyridine. A layer recrystallisation 
(CH2Cl2/CH3OH) produced a dark violet solid that was washed with CH3OH (3 × 40 mL) and 




H NMR (CDCl3 + 1% d
5
-Py, 400 MHz, 298 K): δ 9.67 (d, J = 4.5 Hz, 4H), 8.91 (d, 
J = 4.5 Hz, 4H), 8.00 (d, J = 2.0 Hz, 4H), 7.79 (t, J = 2.0 Hz, 2H), 4.14 (s, 2H), 1.54 (s, 36H). 
 








Synthesis of 8 
 
 
To a finely ground hexaphenylbenzene (1.07 g, 2.00 mmol), neat bromine (3 mL) was added. 
After 30 minutes of stirring, additional bromine (1 mL) was added. After additional 
30 minutes, additional bromine (1 mL; altogether 5 mL, 194 mmol) was added. The reaction 
mixture was stirred for 1 hour and then cooled to –78 °C by a dry-ice/acetone bath and 
ethanol (20 mL) was added in two parts. The precipitate was collected at room temperature by 
filtration and washed with EtOH (2 × 20 mL) and water (2 × 20 mL), then was stirred with 
CH2Cl2 (10 mL) for 10 minutes and the supernatant solution was pipetted off. This procedure 
was repeated several times with CH3OH (5–10 mL), CH2Cl2 (5–10 mL) to remove the 
yellowish colour from the solution phase. The remaining white solid was then dried under 
high vacuum overnight to yield title product as a white solid (1.65 g, 82% yield). 
 
1
H NMR (CDCl3, 400 MHz, 298 K): δ 7.05 (d, J = 8.5 Hz, 1H), 6.61 (d, J = 8.5 Hz, 1H). 
 
MP: > 400 °C 
 








Synthesis of T 
 
 
8 (600 mg, 0.60 mmol) was placed into a big Schlenk flask. Dimethoxyethane (18 mL), THF 
(42 mL) and PdCl2(PPh3)2 (80 mg, 0.11 mmol) were added. NaHCO3 (900 mg, 10.7 mmol) 
and hydrate of 4-pyridineboronic acid (2.17 g, 15 mmol) were partially dissolved in water 
(HPLC quality, 26 mL) and transferred into the Schlenk flask. Additional NaHCO3 (90 mg, 
1 mmol) was added. The mixture was thoroughly deoxygenated by 4 freeze/pump/thaw 
cycles. The mixture was then heated at 70 ° C with stirring for 5 days. Additional 
PdCl2(PPh3)2 (35 mg, 0.05 mmol; altogether 115 mg, 0.16 mmol), NaHCO3 (350 mg, 
4.2 mmol; altogether 1340 mg, 16 mmol) and hydrate of 4-pyridineboronic acid (450 mg, 
3.0 mmol; altogether 2.62 g, 18 mmol) were added and the heating was continued for 
additional 2 days. Solvents were then removed under reduced pressure. CombiFlash of the 
residue on silica (CH2Cl2/Et3N/CH3OH 100:0.25:0%→10%) provided white solid that was 
partially dissolved in small amount of freshly open CHCl3 and a large quantity of CH3OH was 
added. The precipitated solid was washed with excess of CH3OH and dried under high 
vacuum to obtain the title product as a white crystalline solid (251 mg; 42% yield). 
  
1
H NMR (CDCl3, 400 MHz, 298 K): δ 8.53 (dd, J = 5.0, 1.5 Hz, 12H), 7.32 (dd, J = 5.0 Hz, 
J = 1.5 Hz, 12H), 7.25 (borderline d/dd hidden under solvent, 12H), 7.02 (d, J = 8.0 Hz, 12H). 
 
MP: > 400 °C 
 









Synthesis of 6-ring•T 
 
 
With GPC work-up: 
Template T (64 mg, 64 μmol) and porphyrin monomer M (200 mg, 251 μmol) and freshly 
opened CHCl3 (280 mL) were sonicated for 2 hours. In the meantime, a solution of catalyst 
was prepared by mixing dichlorobis(triphenylphosphine)-palladium(II) (58 mg, 83 μmol), CuI 
(79 mg, 415 μmol), 1,4-benzoquinone (184 mg, 1.7 mmol) and freshly opened CHCl3 
(80 mL), sonicating for 2 minutes and addition of freshly distilled diisopropylamine (0.5 mL). 
Both solutions were cooled to room temperature and the solution of catalyst was added to the 
mixture of template and porphyrin under vigorous stirring. The flask was closed with septum 
and covered with aluminium foil. The mixture was stirred vigorously for 18 hours and 
afterwards it was filtered over basic alumina plug that was then washed with additional CHCl3 
and 1% pyridine in CHCl3. The solvents were removed under reduced pressure and the 
residue was dissolved in 1% pyridine in toluene (10 mL). SEC chromatography of this 




solution on Biobeads™ SX-1 (Bio-Rad
®
) using 1% pyridine in toluene as an eluent removed 
the rest of benzoquinone. Again, solvents were removed under reduced pressure and the 
residue was dissolved in 1% pyridine in toluene (4 mL) and filtered over a PTFE filter 
(0.20 μm) and injected into GPC system. The recycling GPC with toluene and a flow rate of 
8.5 mL/min provided a solution of the title compound where solvents were removed under 
reduced pressure and after drying under high vacuum overnight, the title compound was 
obtained as a brown solid (38 mg, 16% yield).  
 
With CombiFlash work-up: 
Template T (22 mg, 22 μmol) and porphyrin monomer M (67 mg, 85 μmol) and freshly 
opened CHCl3 (150 mL) were sonicated for 2 hours. In the meantime, a solution of catalyst 
was prepared by mixing dichlorobis(triphenylphosphine)-palladium(II) (21 mg, 30 μmol), CuI 
(32 mg, 168 μmol), 1,4-benzoquinone (70 mg, 0.65 mmol) and freshly opened CHCl3 
(30 mL), sonicating for 2 minutes and addition of diisopropylamine (0.2 mL). 
Both solutions were cooled to room temperature and the solution of catalyst was added to the 
mixture of template and porphyrin under vigorous stirring. The flask was covered with 
aluminium foil. The mixture was stirred vigorously for 18 hours and afterwards it was filtered 
over neutral alumina plug that was then washed with additional CHCl3. The solvents were 
removed under reduced pressure and the residue was dissolved in 1% pyridine in toluene and 
filtered over a new neutral alumina plug. The solvents were removed under reduced pressure. 
CombiFlash of the residue on silica gel (hexane/toluene, toluene: 0%→30%→100%) 
followed by removing of solvents under reduced pressure and drying under high vacuum 
overnight provided the title compound as a brown solid (18 mg, 22% yield). 
 
1
H NMR (CDCl3, 400 MHz, 298 K): δ 9.57 (d, J = 4.5 Hz, 24H), 8.79 (d, J = 4.5 Hz, 24H), 
8.03 (s, 12H), 7.85 (s, 12H), 7.79 (s, 12H), 5.51 (d, J = 9.0 Hz, 12H), 5.46 (d, J = 9.0 Hz, 
12H), 4.99 (d, J = 7.0 Hz, 12H), 2.31 (d, J = 7.0 Hz, 12H), 1.56 (s, 108H), 1.52 (s, 108H).    
 








Synthesis of 6-ring 
 
 
To a solution of 6-ring•T (8.7 mg, 1.5 μmol) in CH2Cl2 (9 mL), trifluoroacetic acid (90 μL, 
1.2 μmol) was added in one portion. After 5 minutes of vigorous stirring, pyridine (1.5 mL) 
was added. The mixture was filtered over a silica plug previously pre-treated with 1% 
pyridine in CH2Cl2. The filtrate was absorbed on Celite
 
and CombiFlashed on silica (petrol 
ether/CH2Cl2, CH2Cl2: 0%→100%). Afterwards, the solvents were removed under reduced 
pressure. The residue was dissolved in CH2Cl2 (20 mL) and Zn(OAc)2•2H2O (96 mg; 
437 μmol) in CH3OH (4 mL) was added. The mixture was stirred overnight and then filtered 
over a small silica plug and the filtrate was absorbed on Celite
®
. CombiFlash on silica 
(EtOAc) provided a solid that was recrystallised from CH2Cl2/CH3OH and dried under high 
vacuum to obtain the title compound as a brown solid (2.5 mg, 35% yield). 





H NMR (CDCl3, 400 MHz, 298 K): δ 9.70 (d, J = 4.5 Hz, 24H), 8.88 (d, J = 4.5 Hz, 24H), 
7.96 (d, J = 1.5 Hz, 24H), 7.78 (t, J = 1.5 Hz, 24H), 1.50 (s, 216H). 
 








Synthesis of 8 
 
 
To a solution of 4-methylpyridine (300 μL, 3.08 mmol, 1 eq.), diisopropylamine (450 μL, 
3.21 mmol, 1.05 eq.) in THF (10 mL) under N2 atmosphere was added nBuLi (1.6M in 
hexanes, 2.4 mL, 1.25 eq.) dropwise at –78 °C (colour changed to orange). The mixture was 
then stirred for 1.5 hours at –78 °C, di-tert-butylchlorophosphane (96%, 1.2 mL, 6.06 mmol, 
2 eq.) was added dropwise at –78 °C (colour changed to yellow). Then the mixture was stirred 
for 1.5 hours at –78 °C and left heated to room temperature. Then the reaction mixture was 
stirred at this temperature for 1 hour and solvents were removed under reduced pressure. To 
the residue CH3OH (10 mL) was added, and H2O2 (20%, 1.5 mL, 8.82 mmol, 3 eq.) was 
slowly added and the reaction mixture was stirred for 4 hours. Then brine solution (2 mL) and 
water (10 mL) were added and the mixture was extracted with CH2Cl2 (2×40 mL) and EtOAC 
(40 mL), dried with anhydrous MgSO4 and solvents were removed under reduced pressure. 
CombiFlash of the residue on silica gel (CH2Cl2/CH3OH, CH3OH: 0%→5%→10%) provided 
the title compound as a white solid (416 mg, 53% yield). The compound can be recrystallised 




H NMR (CDCl3, 400 MHz, 298 K): δ 8.49 (d, J = 5.5 Hz, 2H), 7.39 (d, J = 5.0 Hz, 2H), 
3.09 (d, J = 10.5 Hz, 2H), 1.23 (d, J = 13.5 Hz, 18H). 
13
C NMR (CDCl3, 101 MHz, 298 K):  δ 149.4 (d, J = 1.0 Hz), 144.1 (d, J = 6.5 Hz), 125.6 
(d, J = 4.5 Hz), 36.5 (d, J = 59.0 Hz), 28.6 (d, J = 48.5 Hz), 26.9. 
31
P NMR (CDCl3, 252 MHz, 298 K): δ 58.0. 
 
HR-MS (ESI): Calculated for C14H25NOP [M+H]
+
 254.1674, found: 254.1679 (Δ = 1.9 ppm). 
 




MP: 189–190 °C 
 
Rf (EtOAC/CH3OH 1:1; silica): 0.57. 
  



















C DEPT NMR 
 




Synthesis of 8b 
 
 
To a solution of 4-methylpyridine (300 μL, 3.08 mmol, 1 eq.), diisopropylamine (1.35 mL, 
9.63 mmol, 3 eq.) in THF (10 mL) under N2 atmosphere was added nBuLi (1.6M in hexanes, 
2.4 mL, 1.25 eq.) dropwise at –78 °C (colour changed to orange). The mixture was then 
stirred for 1.5 hours at –78 °C, diisopropylchlorophosphane (96%, 1.0 mL, 6.03 mmol, 2 eq.) 
was added dropwise at –78 °C (colour changed to yellow). Then the mixture was stirred for 
1.5 hours at –78 °C and left heated to room temperature. Then the reaction mixture was stirred 
at this temperature for 1 hour and solvents were removed under reduced pressure. To the 
residue, CH3OH (10 mL) was added, and H2O2 (20%, 1.5 mL, 8.82 mmol, 3 eq.) was slowly 
added and the reaction mixture was stirred for 1 hours. Then brine solution (2 mL) and water 
(10 mL) were added and the reaction mixture was extracted with the mixture of CH2Cl2 and 
EtOAc (1:1, 3×50 mL), dried with anhydrous MgSO4 and solvents were removed under 
reduced pressure. CombiFlash of the residue on silica gel (CH2Cl2/CH3OH, CH3OH: 
0%→5%→10%) provided the title compound as sticky oil (505 mg, 73% yield). 
 
1
H NMR (CDCl3, 400 MHz): δ 8.49 (d, J = 5.5 Hz, 2H), 7.29 (d, J = 4.5 Hz, 2H), 3.03 (d, 
J = 12.0 Hz, 2H), 2.08 – 1.88 (m, 2H), 1.17 – 1.10 (m, 12H). 
13
C NMR (CDCl3, 101 MHz):  δ 149.7 (d, J = 1.5 Hz), 142.4 (d, J = 7.0 Hz), 125.1 (d, J = 
4.5 Hz), 31.2 (d, J = 53.0 Hz), 25.9 (d, J = 64.5 Hz), 15.9 (dd, J = 14.5, J = 3.0 Hz). 
31
P NMR (CDCl3, 252 MHz): δ 53.7. 
 
HR-MS (ESI): Calculated for C12H21NOP [M+H]
+
 226.1361, found: 226.1361 (Δ = 0 ppm). 
 






























Synthesis of 9 
 
 
To a solution of bis(dimethylphosphanyl)methane (97%, 1.37 g, 3.46 mmol, 1 eq.) in CH2Cl2 
(15 mL) at RT was H2O2 added (20%, 16 mL, 94 mmol, 27 eq.). After 4 hours of stirring, 
organic phase was separated, washed with water (10 mL), dried with anhydrous MgSO4, and 
the solvent was removed under reduced pressure to produce the title compound as a white 
crystalline solid (1.22 g, 85%).  
 
1
H NMR (CDCl3, 400 MHz, 298 K): δ 7.76–7.70 (m, 8H), 7.44–7.31 (m, 12H), 3.52 (t, 
J = 14.5 Hz, 2H). 
31
P NMR (CDCl3, 252 MHz, 298 K): δ 24.7. 
 
MP: 186 – 187 °C  
 
Rf (CH2Cl2, silica): 0.05. 
 











Synthesis of 10 
 
 
Synthesis according to the published procedure.
9
 57% yield (transparent oil) 
 
1
H NMR (CDCl3, 400 MHz, 298 K): δ 9.11 – 9.08 (m, 2H), 8.46 (tt, J = 13.0, 2.0 Hz, 1H), 
4.26 – 4.10 (m, 8H), 1.35 (t, J = 7.0 Hz, 12H). 
31
P NMR (CDCl3, 252 MHz, 298 K): δ 14.2 (s) 
 








Synthesis of 11 
 
 
4-Aminopyridine (1.00 g, 10.6 mmol) and succinic anhydride (1.08 g, 10.8 mmol) in xylenes 
(50 mL) were refluxed in Dean-Stark apparatus for 29 hours. After cooling down, the solid 
was collected with the aid of petrol ether (2 × 100 mL) and petrol ether was then removed 
under reducer pressure. The solid was extracted with CH2Cl2 (2 × 200 mL) at reflux for 
30 minutes and directly filtered. The solvent was removed under reducer pressure and the 
residue was recrystallised from EtOH to produce the title product as a white crystalline solid 
(406 mg, 21% yield).  
 
1
H NMR (CDCl3, 400 MHz, 298 K): δ 8.73 (dd, J = 5.0 Hz, J = 1.5 Hz, 2H), 7.41 (dd, 
J = 5.0 Hz, J = 1.5 Hz, 2H), 2.92 (s, 4H). 
13
C NMR (CDCl3, 101 MHz, 298 K): δ 175.0, 150.8, 139.5, 119.9, 28.4. 
 
HR-MS (ESI): Calculated for C9H9N2O2 [M+H]
+
 177.0664, found: 177.0663 (Δ = 0.56 ppm). 
 
























The structures of H-bonded complexes were optimised by molecular mechanics in 
Schrödinger Suite 2016-4 using MacroModel suite. A global minimum structure was found 
by conformational search using OPLS3 as a force field without any solvent model and no  
cut-off for non-covalent interactions. 
4.8.4. NMR titrations 
The NMR titrations were recorded on a Bruker 400 MHz Avance III HD Smart Probe 
Spectrometer at 298 K. As a solvent, d
8
-toluene was used. A host solution with known 
concertation was prepared and fraction of this solution (0.6 mL) was transferred into a NMR 
tube. Then, the guest solution was prepared by dissolving a known amount of guest in the host 





addition of aliquots of guest solution were followed. The d
8
-toluene residual peak was used 
for reference (CH3: 2.11 ppm). The observed changes of chemical shifts were analysed using 
a purpose-written fitting macro in Microsoft Excel (written by Prof Hunter). A 1:1 binding 
isotherm was used to fit the experimental data. The experiments were measured at least two 
times on at least two different days in order to eliminate possible systematic errors. The 
results are stated as average values and errors are quoted as two times the standard deviation. 
  





(1) Hunter, C. A.; Anderson, H. L. Angew. Chem. Int. Ed. 2009, 48, 7488-7499. 
(2) Motloch, P.; Hunter, C. A. Adv. Phys. Org. Chem. 2016, 50, 77-118. 
(3) Hogben, H. J.; Sprafke, J. K.; Hoffmann, M.; Pawlicki, M.; Anderson, H. L. J. Am. 
Chem. Soc. 2011, 133, 20962-20969. 
(4) Hunter, C. A. Angew. Chem. Int. Ed. 2004, 43, 5310-5324. 
(5) Sprafke, J. K.; Kondratuk, D. V.; Wykes, M.; Thompson, A. L.; Hoffmann, M.; 
Drevinskas, R.; Chen, W.-H.; Yong, C. K.; Kärnbratt, J.; Bullock, J. E.; Malfois, M.; 
Wasielewski, M. R.; Albinsson, B.; Herz, L. M.; Zigmantas, D.; Beljonne, D.; 
Anderson, H. L. J. Am. Chem. Soc. 2011, 133, 17262-17273. 
(6) Hoffmann, M.; Kärnbratt, J.; Chang, M.-H.; Herz, L. M.; Albinsson, B.; Anderson, H. 
L. Angew. Chem. Int. Ed. 2008, 47, 4993-4996. 
(7) Montel, S.; Jia, T.; Walsh, P. J. Org. Lett. 2014, 16, 130-133. 
(8) Yip, S. F.; Cheung, H. Y.; Zhou, Z.; Kwong, F. Y. Org. Lett. 2007, 9, 3469-3472. 
(9) Zon, J.; Videnova-Adrabinska, V.; Janczak, J.; Wilk, M.; Samoc, A.; Gancarz, R.; 
Samoc, M. CrystEngComm 2011, 13, 3474-3484. 
(10) Littler, B. J.; Miller, M. A.; Hung, C.-H.; Wagner, R. W.; O'Shea, D. F.; Boyle, P. D.; 
Lindsey, J. S. J. Org. Chem. 1999, 64, 1391-1396. 
(11) Megiatto, J. D.; Schuster, D. I.; Abwandner, S.; de Miguel, G.; Guldi, D. M. J. Am. 
Chem. Soc. 2010, 132, 3847-3861. 
(12) Shediac, R.; Gray, M. H. B.; Uyeda, H. T.; Johnson, R. C.; Hupp, J. T.; Angiolillo, P. 
J.; Therien, M. J. J. Am. Chem. Soc. 2000, 122, 7017-7033. 
(13) Cheng, F.; Zhang, S.; Adronov, A.; Echegoyen, L.; Diederich, F. Chem. Eur. J. 2006, 
12, 6062-6070. 
(14) Lehnherr, D.; Gao, J.; Hegmann, F. A.; Tykwinski, R. R. Org. Lett. 2008, 10, 4779-
4782. 
(15) Taylor, P. N.; Anderson, H. L. J. Am. Chem. Soc. 1999, 121, 11538-11545. 
(16) Rathore, R.; Burns, C. L.; Deselnicu, M. I. Org. Lett. 2001, 3, 2887-2890. 











inside porphyrin nanoring 
  





Most biological systems are multivalent.
1
 The product of multiple bindings is usually 
not just a simple sum of individual binding contributions because of cooperativity.
2
 In 
multivalent supramolecular systems, two types of cooperativity exist – allosteric and chelate 
cooperativity. Allosteric cooperativity occurs when the first binding influences the strength of 
the second binding. Chelate cooperativity originates from the binding between a multivalent 
host and guest, where the local “effective concentration” is increased for the second binding. 
Such increase is quantified through effective molarity (EM). 
 
The literature provides a distribution of effective molarities in supramolecular 
systems. The median value is 100 mM and EM > 10
2
 M is considered to be extremely high, 
since less than 5% of the reviewed supramolecular systems showed the values of this 
magnitude.
3
 Porphyrin nanorings from the Anderson group show exceptionally high values of 
EM. The highest value has been found for complex 6-ring•T (Figure 5.1a).
4
 The Anderson 
group used a series of ligands with two, three, four and five pyridine binding sites to 
determine stepwise EMs for each binding interaction in the hexamer.
5
 The value of EM for 
the first intramolecular binding interaction is 100 mM, which is comparable to the value 
found for the majority of supramolecular complexes. However, all four subsequent 
intramolecular binding interactions have exceptionally high values of EM of 10
3
 M. Another 
system that shows high degree of chelate cooperativity is the H-bonded rosette motif 





Figure 5.1. Two supramolecular systems with high effective molarity. (a) Complex of 6-ring 
(black) with hexadentate ligand T (blue) and (b) rosette motif using pyrimidines (blue) and 





The goal of this work was to test if the extreme values of effective molarity found for 
6-ring and the rosette motif can be joined together to prepare a system that contains both of 
them to study whether there are any synergistic effect in the assembly. Anderson and co-
workers stated that the size of template T is actually smaller than what would be optimal for 
the binding to 6-ring based on results of the X-ray crystallography.
7
 This means that the 
target supramolecular H-bonded system might be a better fit thanks to its flexibility compared 
to the covalent hexadentate template T. On the other hand, there are much higher entropic 
costs associated with the assembly of supramolecular system inside the 6-ring cavity. The 
interplay between those two effects will decide if the target H-bonded system can be formed 
inside a porphyrin nanoring. 
 
5.2.  Approach 
To be able to prepare a supramolecular system based on the rosette motif inside a 
porphyrin nanoring, the rosette building blocks (barbiturate and pyrimidines) have to be 
coupled to pyridine units that would work as the molecular recognition for the zinc porphyrins 
of 6-ring. We decided to test barbiturate-pyridines and pyrimidine-pyridines with a different 
substitution positions on the pyridine and different linker lengths to increase the probability to 
find the optimal system. Two barbiturate-pyridine ligands 3B3 and 4B3, and four different 
pyrimidine-pyridine ligands 3P1, 3P2, 4P1 and 4P2 are depicted in Figure 5.2. The alkyl 
substituents should increase the solubility in non-polar solvents that will be used for the study, 
such as chloroform.  
 
 





Figure 5.2. Building blocks for rosettes equipped with pyridine ligands; (a) barbiturate-
pyridines 3B3 and 4B3 and (b) pyrimidine-pyridines 3P1, 3P2, 4P1 and 4P2. 
 
The association constant for the formation of the supramolecular system based on the rosette 
inside 6-ring (Figure 5.3 and Figure 5.4) is given by Equation 5.1.  
 
𝐾f = 𝐾rosette × 𝐾Py,1
3 × 𝐾Py,2
3 × EM̅̅ ̅̅
5
     (5.1) 
 
where Krosette is an association constant for the formation of the rosette (Figure 5.3),  KPy,1 and 
KPy,2 are association constant for the binding of the pyridine units of the ligands to 6-ring and 
EM̅̅ ̅̅  is the geometric average of effective molarities of sequential binding of the rosette to      
6-ring, thus EM̅̅ ̅̅ = √EM1 · EM2 · EM3 · EM4 · EM5
5
 as shown in Figure 5.4. If the statistical 
factor Kσ is included,
8-10
 the statistically corrected value of EM̅̅ ̅̅ s can be determined by 
Equation 5.2 
 
𝐾f = 𝐾σ × 𝐾rosette × 𝐾Py,1
3 × 𝐾Py,2
3 × EM̅̅ ̅̅ s
5
    (5.2) 
 







and KPy,2 will be measured with the aid of suitable model pyridine compounds. By measuring 
Kf, we will be able to determine EM̅̅ ̅̅ s and compare it to the values obtained with covalent 







Figure 5.3. Thermodynamic cycle for the formation of the rosette supramolecular system 
inside 6-ring from barbiturate-pyridines and pyrimidine-pyridines. R is a solubilising group, 
Ar = 3,5-bis(t-butyl)phenyl, n is 1 or 2, Py is a pyridine unit. 
 





Figure 5.4. Schematic representation of sequential binding of the rosette (red and blue 
hexagone) to 6-ring (black circle), green line denotes pyridine–zinc porphyrin interaction. 







All the possible combinations (namely 3B33•3P13, 3B33•3P23, 3B33•4P13, 3B33•4P23, 
4B33•3P13, 4B33•3P23, 4B33•4P13, 4B33•4P23) were investigated by a conformational search 
using molecular mechanics in the absence of 6-ring. The structure of T from the X-ray 
structure of 6-ring•T was used as a template,
7
 where the coordinates of the nitrogen atoms 
and carbon atoms in the position 4 were constrained. The rest of the molecules were then built 
from these fragments. With this, the conformational search could rotate the pyridine units 
freely around their axes. This modelling does not employ 6-ring, which has both benefits and 
drawbacks. The main benefits are lower calculation costs, and the main drawback is that this 
method does not find all the possible structures, since the real structure can have the pyridines 
tilted from the fixed axis taken from the X-ray structure and there can be also some movement 
of the porphyrin units of 6-ring. On the other hand, when it provides the desired 
conformation, the probability of obtaining this architecture should be high. It has to be noted 
that the conformational search was done without the solubilising alkyl groups on barbiturate 
as well as pyrimidine to decrease the computational costs. Only complex 3B33•3P23 provided 
a structure containing the rosette motif as shown in Figure 5.5. 
 
 
Figure 5.5. Lowest energy structure of 3B33•3P23 rosette system from a conformational 
search using molecular modelling (OPLS3/no solvent) and T as a template, where the 
coordinates of the nitrogen atoms and carbon atoms in the position 4 of pyridine units were 
constrained (the alkyl groups of both barbiturate-pyridines and pyrimidine-pyridines were 
replaced by hydrogen atoms in the calculations). Hydrogen atoms that do not contribute to    
H-bonding were omitted for clarity; colouring: 3B3 in red, 3P2 in blue, green dashed line is 
the H-bond. 




Then, the optimised structure of 3B33•3P23 was placed inside 6-ring and further 
optimised by semi-empirical method PM6 as depicted in Figure 5.6b (the 3,5-bis(t-
butyl)phenyl groups were replaced by hydrogen atoms in the calculations). As stated above, 
the restricted conformational search does not explore all the possibilities, therefore we 
modelled all the possible complexes by using different starting structures. In this way, it was 
possible to find structures containing the rosette motif for all the complexes based on 3B3 
(Figure 5.6). No structures containing the rosette motif were found for the complexes based 
on 4B3. This modelling showed that rosette systems 3B33•3P13 and 3B33•3P23 fit well into 6-
ring as depicted in Figures 5.6a and 5.6b. In comparison, some porphyrin units had to rotate 
significantly in the 3B33•4P13 and 3B33•4P23 systems to be able to accommodate them inside 







Figure 5.6. PM6-optimised structures of the H-bonded rosettes (a) 3B33•3P13, (b) 3B33•3P23, 
(c) 3B33•4P13, (d) 3B33•4P23 bound inside the 6-ring (alkyl groups on barbiturate-pyridines 
and pyrimidine-pyridines as well as 3,5-bis(t-butyl)phenyl on 6-ring were replaced by 
hydrogen atoms in the calculations). Hydrogen atoms that do not contribute to H-bonding 
were omitted for clarity. Colouring: 6-ring in black with highlighted Zn atoms in yellow, 
barbiturate-pyridines in red, pyrimidine-pyridines in blue, green dashed line is the H-bond. 





The synthesis of 6-ring was described in Chapter IV. Pyrimidine-pyridines 3P1, 3P2, 
4P1 and 4P2 were synthesised in two steps from the commercially available 4,6-
dichloropyrimidin-2-amine in good to excellent yields as shown in Scheme 5.1. The first 
reaction provided singly substituted products that were easily isolated by precipitation. These 
were then converted to the final products in neat n-pentylamine at 150 – 160 °C. 
 
 
Scheme 5.1. Synthesis of pyrimidine-pyridines 3P1, 3P2, 4P1 and 4P2. 
 
The barbiturate-pyridines 3B3 and 4B3 were synthesised starting from commercially 
available (3-pyridin-3-yl)propan-1-ol and (3-pyridin-4-yl)propan-1-ol, respectively, as shown 
in Scheme 5.2. Firstly, the hydroxyl group was transformed to a mesylate, followed by the 
protection of the nucleophilic pyridine nitrogen atoms with BH3•SMe2 in excellent yields in 
order to avoid mixtures of alkylation products.
11
 The protected mesylates were then reacted 
with n-butyl diethylmalonate to produce malonates c that were obtained both as protected 
(majority) and deprotected (⅓ to ½) forms. The target barbiturate-pyridines were obtained 
directly from the deprotected malonate c by a reaction with urea in DMF as shown on 4B3 or 
from the protected malonate c-BH3 by the same reaction that provided again protected and 

















5.5.  UV-vis-NIR titrations 
Firstly, a reference association constant of binding of a pyridine unit to a zinc 
porphyrin had to be measured. Since we used compounds based on 3-pyridinyl as well as 4-
pyridinyl, we decided to use 3-methylpyridine (3Py) and 4-methylpyridine (4Py) to obtain the 
association constants. The UV-vis-NIR titration of 3Py to 6-ring in chloroform at 298 K is 
depicted in Figure 5.7. To fit the experimental data with a 1:1 binding isotherm, we assumed 
that all six porphyrin units act independently and identically. This leads to the description of 
each pyridine–zinc porphyrin coordination event independently. The apparent 1:1 association 
constants measured for the pyridine–zinc porphyrin interaction are outlined in Table 5.1. The 
4Py binds slightly stronger to 6-ring than 3Py. 
 
 
Figure 5.7. UV-vis-NIR titration (CHCl3, 298 K) of 3Py to 6-ring. UV-vis-NIR spectra are 
shown on the left with the spectrum of unbound 6-ring in thick black line and the end 
spectrum in red thick line. On the right are shown the experimental data at 833 nm (circles) 
and calculated values (line) based on a 1:1 binding isotherm assuming that the six porphyrin 
units of 6-ring act identically and independently while the host concentration was also 
allowed to change upon fitting. 
 
Then we investigated the binding of the prepared barbiturate-pyridine and pyrimidine-
pyridine compounds to 6-ring again by UV-vis-NIR titrations in chloroform at 298 K using 
the same fitting method as stated above. The results are shown in Table 5.1. The determined 
apparent association constants are all higher by average an order of magnitude than the 
reference association constants for methylpyridines 3Py and 4Py. Although these systems 
cannot form rosettes, multiple H-bonding interactions are still possible as shown on the 





Table 5.1. Apparent 1:1 association constants measured by UV-vis-NIR titrations in CHCl3 at 
298 K for the pyridine–zinc porphyrin interaction using 6-ring as the host. Errors are quoted 
as two times the standard deviation based on two repetitions. 










log K / M
–1
 
3Py 4.2 ± 0.1     
4Py 4.4 ± 0.1     
3B3 4.7 ± 0.1 3B3 + P 4.6 ± 0.3   
4B3 5.2 ± 0.1 4B3 + P 5.3 ± 0.1   
3P1 5.2 ± 0.3 3P1 + B 5.6 ± 0.1 3P1 + C 5.6 ± 0.1 
3P2 5.4 ± 0.2 3P2 + B 5.5 ± 0.1 3P2 + C 5.5 ± 0.1 
4P1 5.2 ± 0.1 4P1 + B 5.4 ± 0.5 4P1 + C 5.5 ± 0.3 
4P2 5.2 ± 0.5 4P2 + B 5.5 ± 0.1 4P2 + C 5.9 ± 0.4 
 
 
Figure 5.8. PM6-optimised structure of 3B3 ligands bound to 6-ring showing H-bonding 
interactions between the ligands (alkyl groups on 3B3 and 3,5-bis(t-butyl)phenyl on 6-ring 
were replaced by hydrogen atoms in the calculations). Hydrogen atoms that do not contribute 
to H-bonding were omitted for clarity. Colouring: 6-ring in black with highlighted Zn atoms 
in yellow, 3B3 in red, green dashed line is the H-bond. 
 
Next, we investigated the complexes in which one of the rosette building blocks 
contained the pyridine unit and the second was the corresponding rosette partner without any 
pyridine (see Figure 5.9). We decided to include also a cyanurate partner that should form 
more stable rosettes.
12
 We conducted UV-vis-NIR titrations by an addition of the mentioned 
two rosette components in a 1:1 ratio as the guest solution into 6-ring in CHCl3 at 298 K. A 
1:1 binding isotherm was used to fit the experimental data assuming that all six porphyrin 




units of 6-ring coordinate a pyridine ligand and act identically and independently. By that, we 
determined apparent 1:1 association constants for the pyridine–zinc porphyrin interaction and 
they are depicted in Table 5.1. All the titrations can be found in the Experimental section. 
Within the experimental error, all of these complexes showed the same stability as the ligands 
on their own. In the absence of any increased stability due to the presence of the rosette 




Figure 5.9. Barbiturate B, cyanurate C and pyrimidine P. 
 
Next, we investigated the complexes in which both of the rosette components 
contained the pyridine unit. We determined apparent 1:1 association constants for the 
pyridine–zinc porphyrin interaction by UV-vis-NIR titrations in CHCl3 at 298 K by titrating a 
solution of barbiturate-pyridine and pyrimidine-pyridine in a 1:1 ratio to 6-ring. A significant 
difference could be observed when the mixture was used compared to the separate ligands as 
shown in Figure 5.10. A 1:1 binding isotherm was used to fit the experimental data assuming 
that all six porphyrin units of 6-ring coordinate a pyridine ligand and act identically and 
independently, and using the total concentration of pyridine units as the guest concentration. 
All the titrations can be found in the Experimental part. The results are shown in Table 5.2.  
To quantify the difference between a mixture and ligands, a cooperativity factor 
COOP defined by Equation 5.3 was used. Two systems (3B3 + 3P1 and 3B3 + 4P1) showed 













Figure 5.10. UV-vis-NIR titration (CHCl3, 298 K) of 3B3 (red), 3P1 (blue) and a 1:1 mixture 
of 3B3 and 3P1 (black) to 6-ring (0.8 μM) showing the experimental data at 838 nm (circles) 
and calculated values (lines) based on a 1:1 binding isotherm assuming that the six porphyrin 
units of 6-ring act identically and independently while the host concentration was also 
allowed to change upon fitting. 
 
Table 5.2. Apparent 1:1 association constants measured by UV-vis-NIR titrations in CHCl3 at 
298 K for the pyridine–zinc porphyrin interaction using 6-ring as the host. Errors are quoted 
as two times the standard deviation based on two repetitions. 
Guest log K / M
–1





log K / M
–1
 COOP / M 
3B3 4.7 ± 0.1 3P1 5.2 ± 0.3 3B3 + 3P1 7.2 ± 0.2 150 
3B3 4.7 ± 0.1 3P2 5.4 ± 0.2 3B3 + 3P2 6.6 ± 0.2 30 
3B3 4.7 ± 0.1 4P1 5.2 ± 0.1 3B3 + 4P1 7.5 ± 0.5 300 
3B3 4.7 ± 0.1 4P2 5.2 ± 0.5 3B3 + 4P2 6.5 ± 0.1 30 
4B3 5.2 ± 0.1 3P1 5.2 ± 0.3 4B3 + 3P1 6.6 ± 0.2 30 
4B3 5.2 ± 0.1 3P2 5.4 ± 0.2 4B3 + 3P2 7.1 ± 0.1 60 
4B3 5.2 ± 0.1 4P1 5.2 ± 0.1 4B3 + 4P1 6.7 ± 0.3 30 
4B3 5.2 ± 0.1 4P2 5.2 ± 0.5 4B3 + 4P2 6.8 ± 0.1 40 
  




These results allowed us to calculate 6-ring effective molarities for the rosette 
complexes from Equations 5.1 and 5.2, assuming 𝐾f = 𝐾
6, where 𝐾 is an apparent 1:1 
association constants for the pyridine–zinc porphyrin interaction for the formation of  rosette 





KPy,1 and KPy,2 from the reference methylpyridine UV-vis-NIR titrations (Table 5.1). The 
determination of statistical factors for the formation of the rosette complexes inside 6-ring is 
shown in Figure 5.11 and the determination of statistical factors for the reference pyridine 
complexes that has to be taken into account is shown in Figure 5.12. The determined 6-ring 





Figure 5.11. Statistical factor Kσ for the rosette assembly inside 6-ring (R is a solubilising 
group, Ar = 3,5-bis(t-butyl)phenyl, n is 1 or 2, Py is a pyridine unit). Using higher external 
symmetry for ligands based on 4-pyridyl would not change the overall statistical factors as the 
internal and external statistical factors of the ligands and complex would cancel each other out 




















Table 5.3. Geometric averages of effective molarity for a sequential binding of H-bonded 
rosette system to 6-ring in CHCl3 at 298 K. Errors are quoted as two times the standard 
deviation. 
Ligand system (1:1) 𝐄𝐌̅̅̅̅̅ [M] 𝐄𝐌̅̅̅̅̅𝐬 [M] 
3B3 + 3P1 6.3 ± 3.7 2.1 ± 1.2 
3B3 + 3P2 1.2 ± 0.6 0.40 ± 0.20 
3B3 + 4P1 11 ± 15 3.7 ± 4.8 
3B3 + 4P2 0.69 ± 0.14 0.23 ± 0.05 
4B3 + 3P1 0.91 ± 0.55 0.30 ± 0.18 
4B3 + 3P2 3.6 ± 0.5 1.2 ± 0.2 
4B3 + 4P1 0.91 ± 0.66 0.30 ± 0.22 
4B3 + 4P2 1.2 ± 0.2 0.40 ± 0.08 
 
The determined effective molarities cluster around the value of 1 M with systems    
3B3 + 3P1, 3B3 + 4P1 and 4B3 + 3P2 showing the highest values (> 1 M) and system       
3B3 + 4P2 being the lowest. All these values are significantly lower (at least two orders of 
magnitude) than the reference system based on hexadentate ligand T (126 M).
5
 On the other 
hand, the determined values of effective molarities can still be considered high compared to 
the other supramolecular systems.
3
 Moreover, the alkyl chains between the pyridine and 
barbiturate units in 3B3 and 4B3 are quite long and it is known that the introduction of each 
additional rotor decrease the value of effective molarity in supramolecular systems.
13
 
Therefore, the optimisation of the linker length could lead to a significantly more cooperative 






5.6. NMR experiments 
We conducted 
1
H NMR experiments to further characterise the complexes in solution.  
To do that, we chose systems with highest and lowest effective molarities (namely             
3B3 + 3P1, 3B3 + 4P1, 4B3 + 3P2 and 3B3 + 4P2). As an example, the system 3B3 + 3P1 is 
discussed here and the rest can be found in the Experimental section. A 1:3:3 mixture of        
6-ring, 3B3 and 3P1 resulted in highly complicated 
1
H NMR spectra with broad peaks as 
seen in Figure 5.13c, especially when compared to the 
1
H NMR spectra of separate 6-ring and 
a 1:1 mixture of 3B3 and 3P1 at the same concentrations (Figure 5.13a-b). This is probably 
due to an intermediate exchange of the free components and assemblies on the 
1
H NMR time-
scale. A very broad N-H rosette peak was observable, what points out to the rosette assembly. 
 
 
Figure 5.13. Partial 
1
H NMR (500 MHz, CDCl3, 298 K) spectra of (a) 6-ring (0.16 mM), (b) 
mixture of 3B3 (0.48 mM) and 3P1 (0.48 mM) and (c) mixture of 6-ring (0.16 mM), 3B3 
(0.48 mM) and 3P1 (0.48 mM). 
  




5.7. Conclusion and future work 
In this chapter, we designed and prepared H-bonded rosette systems using various 
barbiturate-pyridine and pyrimidine-pyridine ligands with different linker lengths and 
different position of nitrogen atom of pyridine. We used UV-vis-NIR titrations in chloroform 
to show that these systems assemble inside 6-ring in a cooperative fashion. The effective 
molarities of sequential binding of the rosette systems to 6-ring were determined to range 
from 0.23 to 3.7 M, which is significantly lower (two to three orders of magnitude) compared 
to the reference 6-ring•T complex, probably due to ligands being too floppy. On the other 
hand, the determined values of effective molarity are still high compared to other 
supramolecular systems from the literature.  
 
The results from this study could be used for the application of the H-bonded rosette 
system as an easily-removable supramolecular template for the synthesis of 6-ring. After the 
reaction, a simple change of the solvent could disrupt the H-bonded system and remove the 
rosette from 6-ring, which would overcome the issues connected with using the original 
covalent hexadentate template T. This could potentially show a new way for the construction 
of advanced molecular architectures where covalent templates are difficult or even impossible 










5.8. Experimental section 
5.8.1. General 
The syntheses of B, C and P were described in the Chapter III and the synthesis of    
6-ring was described in the Chapter IV. The chemicals were bought from commercial 
suppliers and used without further purifications unless stated otherwise. Solvents were either 





 and CombiFlash Rf
+ 
Lumen (with UV light detection at 254 nm and 
280 nm and evaporative light scattering detector for Lumen) with pre-packed puriFlash 
columns from Interchim (silica, 25 μm) with a loading of mixtures on Celite were used. The 
microwave used was Biotage Initiator
+
. The reactions were monitored either by glass TLC 
plates coated with silica gel 60 F254 (Merck) and the plates were inspected by UV light 
(254 nm) or by LSMS Waters Acquity H-class UPLC coupled with a single quadrupole 
Waters SQD2 with the conditions as follows: UPLC Column (see below), solvent A: Water + 
0.1% formic acid; solvent B: acetonitrile od THF (see below) + 0.1% formic acid; gradient 
and flow rate (see below); column temperature of 40 °C, the signal was monitored at 254 nm 
and 280 nm. 
 
Columns 
Col1: ACQUITY UPLC CSH C18 Column, 130Å, 1.7 μm, 2.1 mm X 50 mm 
Col3: ACQUITY UPLC HSS T3 Column, 100Å, 1.8 μm, 2.1 mm X 50 mm 
Methods 
  MeCN-FAST: Gradient: 0 – 2 minutes 5% – 100%B + 1 minute 100%B 
    Flow rate: 0.6 ml/min 
  MeCN-SLOW: Gradient: 0 – 4 minutes 5% – 100%B + 1 minute 100%B 
     Flow rate: 0.6 ml/min 
  THF-FAST: Gradient: 0 – 2 minutes 5% – 80%B + 1 minute 80%B 
           Flow rate: 0.4 ml/min 
  THF-SLOW: Gradient: 0 – 4 minutes 5% – 80%B + 1 minute 80%B 
            Flow rate: 0.4 ml/min 
THF_FAST_5%-35%: Gradient of 0-2 minutes 5% – 35%B + 1 minute 100%B 





C NMR spectra were recorded on Bruker 400 MHz Avance III HD SmartProbe 
Spectrometers at 400 MHz for 
1
H, 128 MHz for 
11
B, 101 MHz for 
13
C or on a Bruker 
500 MHz AVIII HD SmartProbe Spectrometer at 500 MHz for 
1
H and 126 MHz for 
13
C. All 
chemicals shift are quoted in ppm and were referenced to the residual peaks of used solvents: 
CDCl3 (
1
H: 7.26 ppm; 
13
C: 77.00 ppm), CD3OD (
1
H: 3.31 ppm; 
13





H: 2.50 ppm; 
13
C: 39.52 ppm). Coupling constants J are stated in Hz. FT-IR spectra were 
measured on a Bruker Alpha spectrometer. HR-MS spectra were obtained on a Waters Xevo
 
G2-S, Waters Vion IMS Qtof or Waters LCT Premier by electrospray-ionisation of samples. 
Melting points were recorder on a Mettler-Toledo MP90 system. Elemental analysis was 
performed by the Microanalysis facility at the Department of Chemistry at the University of 
Cambridge.  





Synthesis of a3 
 
 
To a solution of 3-(pyridin-3-yl)propan-1-ol (1 mL, 1.06 g, 7.7 mmol) and NEt3 (3 mL) in 
CH2Cl2 (50 mL) was added methanesulfonyl chloride (0.8 mL, 10.3 mmol, 1.4 eq) at 0 °C in 
small parts over the period of 90 minutes. The reaction mixture was stirred at 0 °C for 
additional 30 minutes and then diluted with CH2Cl2 (50 mL). The still-cool solution was 
washed with H2O (2×30 mL) and brine (30 mL), dried with MgSO4 and solvents were 
removed under reducer pressure (at no more than 30 °C). A combiflash of the residue on 
silica gel (PE/EtOAc, EtOAc: 0%→100%) provided the title compound as yellowish liquid 
(1.65 g; quant.) 
(This compound is quite unstable even when stored in fridge.) 
 
1
H NMR (CDCl3, 400 MHz, 298 K): δ 8.53 – 8.42 (m, 2H), 7.52 (dt, J = 8.0 Hz, 2.0 Hz, 1H), 
7.23 (dd, J = 8.0, 5.0 Hz, 1H), 4.24 (t, J = 6.0 Hz, 2H), 3.01 (s, 3H), 2.80 – 2.74 (t, J = 7.0 Hz, 
2H), 2.13 – 2.05 (m, 2H). 
13





























Synthesis of b3 
 
 
a3 (2.41 g, 11.1 mmol) was flushed with nitrogen. Then THF (20 mL) was added, which 
produced slurry solution. The reaction mixture was cooled to –78 °C. To this solution, 
BH3•SMe2 (6.0 mL, 2.0M solution in THF, 12 mmol) was added dropwise at –78 °C. After 
30 minutes of stirring, the cooling bath was removed. After stirring at RT for 1 hour, the 
conversion was checked by TLC (10:1 EtOAc/MeOH) and additional BH3•SMe2 (1.0 mL, 
2.0M solution in THF, 2 mmol; altogether 14 mmol) was added dropwise at –78 °C. The 
solution was stirred for 15 minutes and the cooling bath was removed. After additional 
30 minutes of stirring, the mixture was cooled again to –78 °C and methanol (9 mL) was 
added dropwise. After 15 minutes, the cooling bath was removed and the mixture was 
allowed to heat to room temperature and then solvents were removed under reduced pressure. 
A combiflash of the residue on silica (Celite loading, PE/EtOAc; EtOAc: 0%→100%) 
provided the title compound (2.25 g, 88% yield) as transparent oil, which crystalise upon 
standing in a freezer over a couple of days/weeks to form a white solid. 
 
1
H NMR (CDCl3, 400 MHz, 298 K): δ 8.45 – 8.43 (m, 2H), 7.78 (d, J = 8.0 Hz, 1H), 7.45 
(dd, J = 8.0, 6.0 Hz, 1H), 4.25 (td, J = 6.0, 1.0 Hz, 2H), 3.02 (d, J = 1.0 Hz, 3H), 2.84 (t, 
J = 8.0 Hz, 2H), 2.75 – 2.15 (br, 3H), 2.16 – 2.02 (m, 2H). 
1
H NMR (CDCl3, 400 MHz, 298 K, 
11
B decoupled): δ 8.45 – 8.43 (m, 2H), 7.78 (d, J = 
8.0 Hz, 1H), 7.45 (dd, J = 8.0, 6.0 Hz, 1H), 4.24 (t, J = 6.0 Hz, 2H), 3.02 (d, J = 1 Hz, 3H), 
2.83 (t, J = 8.0 Hz, 2H), 2.55 (s, 3H), 2.16 – 2.02 (m, 2H). 
13
C NMR (CDCl3, 101 MHz, 298 K): δ 147.2, 145.4, 139.2, 138.5, 125.2, 68.11, 37.4, 29.9, 
28.6. 
11
B NMR (CDCl3, 128 MHz, 298 K, normal glass): δ –12.4 (d, J = 88 Hz) 
 
HR-MS (ESI): Calculated for C9H15BNO3S [M–H]
+
 228.0866, found: 228.0865 
(Δ = 0.4 ppm) 
 
FT-IR (thin film): 2936, 2360, 2310, 2271, 1620, 1585, 1486, 1443, 1346, 1331, 1164.  
 
MP: 51 – 53 °C 
 






























Synthesis of c3-BH3 and c3 
 
 
NaH (60% in mineral oil, 255 mg, 6.38 mmol) was flushed with nitrogen. THF (10 mL) was 
added and the mixture was cooled to 0 °C. Then diethyl-2-butylmalonate (1.45 mL, 
6.52 mmol) was added dropwise (the solution became clear after the addition). b3 (718 mg, 
3.13 mmol) was added as a solid. After 1 hour of stirring, the cooling bath was removed. The 
mixture was heated at 60 °C for 4 hours and after cooling to RT, water (20 mL) was added 
and the mixture was extracted with dichloromethane (4 × 30 mL). The organic phase was 
dried over MgSO4 and the solvents were removed under reduced pressure. A combiflash of 
the residue on silica (Celite loading, PE/EtOAc, EtOAc: 0%→50%) provided after drying in 
vacuum oven overnight products c3-BH3 (655 mg, 60% yield) and c3 (219 mg, 21% yield) as 
transparent dense liquids (c3-BH3 crystalise upon storage in freezer over a couple of weeks). 
 




H NMR (CDCl3, 400 MHz, 298 K): δ 8.42 – 8.40 (m, 2H), 7.70 (d, J = 8.0 Hz, 1H), 7.40 
(dd, J = 8.0, 6.0 Hz, 1H), 4.21 – 4.06 (m, 4H), 3.00 – 2.11 (br, 3H), 2.66 (t, J = 8.0 Hz, 2H), 
1.91 – 1.78 (m, 4H), 1.59 – 1.46 (m, 2H), 1.32 – 1.23 (m, 2H), 1.20 (t, J = 7.0 Hz, 6H), 1.11 – 
1.03 (m, 3H), 0.85 (t, J = 7.0 Hz, 3H). 
1
H NMR (CDCl3, 400 MHz, 298 K, 
11
B decoupled): δ 8.42 – 8.40 (m, 2H), 7.70 (d, J = 
8.0 Hz, 1H), 7.40 (dd, J = 8.0, 6.0 Hz, 1H), 4.21 – 4.08 (m, 4H), 2.66 (t, J = 8.0 Hz, 2H), 2.55 
(s, 3H), 1.92 – 1.77 (m, 4H), 1.60 – 1.45 (m, 2H), 1.34 – 1.23 (m, 2H), 1.20 (t, J = 7.0 Hz, 
6H), 1.15 – 1.01 (m, 2H), 0.86 (t, J = 7.0 Hz, 3H). 
13
C NMR (CDCl3, 101 MHz, 298 K): δ 171.4, 147.1, 145.1, 139.6, 138.8, 124.9, 61.1, 57.2, 
32.8, 32.2, 31.7, 26.1, 25.1, 22.8, 14.00, 13.8. 
11
B NMR (CDCl3, 128 MHz, 298 K, normal glass): δ –12.4 (d, J = 79 Hz) 
 
HR-MS: Calculated for C21H34BN2O4 [M+CH3CN–H]
+
 389.2612, found: 389.2627 
(Δ = 3.9 ppm) 
 












H NMR (CDCl3, 400 MHz, 298 K): δ 8.38 – 8.36 (m, 2H), 7.41 (d, J = 8.0 Hz, 1H), 7.13 
(dd, J = 8.0, 5.0 Hz, 1H), 4.09 (q, J = 7.0 Hz, 4H), 2.56 (t, J = 7.5 Hz, 2H), 1.91 – 1.71 (m, 
4H), 1.55 – 1.37 (m, 2H), 1.28 – 1.17 (m, 2H), 1.14 (t, J = 7.0 Hz, 6H), 1.06 – 0.98 (m, 2H), 
0.81 (t, J = 7.5 Hz, 3H). 
13
C NMR (CDCl3, 101 MHz, 298 K): δ 171.5, 149.8, 147.3, 136.8, 135.6, 123.1, 60.9, 57.2, 
32.9, 31.9, 31.5, 25.9, 25.4, 22.7, 13.9, 13.7. 
 
HR-MS: Calculated for C19H30NO4 [M+H]
+
 336.2175, found: 336.2173  (Δ = 0.6 ppm) 
 








































C NMR   
 




Synthesis of 3B3-BH3 and 3B3 
 
 
NaH (60% in mineral oil, 300 mg, 7.5 mmol) was flushed with nitrogen and DMF (6 mL) was 
added. The mixture was cooled to 0 °C and urea (1.18 g, 19.6 mmol) was added. After 
2 hours of stirring, c3-BH3 (646 mg, 1.85 mmol) in DMF (7 mL) was added at 0 °C. The 
mixture was stirred overnight at RT and a saturated solution of NH4Cl (5 mL) was added with 
cooling to 0 °C. Water (10 mL) was added and the mixture was extracted with 
dichloromethane (3 × 40 mL). The collected organic phase was dried over MgSO4 and the 
solvents were removed under reduced pressure (60 °C, <14 mBar). A combliflash of residue 
on silica (Celite loading, PE/EtOAc, EtOAc: 0%→100%) provided after drying in vacuum 
oven overnight products 3B3-BH3 (350 mg, 60% yield) and 3B3 (117 mg, 21% yield) as 
white crystalline solids. 
 




H NMR (CD3OD, 400 MHz, 298 K): δ 8.42 (s, 2H), 7.88 (d, J = 8.0 Hz, 1H), 7.53 (dd, 
J = 8.0, 6.0 Hz, 1H), 2.95 – 2.09 (br, 3H), 2.69 (t, J = 7.5 Hz, 2H), 1.97 – 1.86 (m, 4H), 1.58 – 
1.50 (m, 2H), 1.32 – 1.22 (m, 2H), 1.22 – 1.13 (m, 2H), 0.87 (t, J = 7.0 Hz, 3H). 
1
H NMR (CD3OD, 400 MHz, 298 K, 
11
B decoupled): δ 8.42 (s, 2H), 7.88 (d, J = 8.0 Hz, 
1H), 7.53 (dd, J = 8.0, 6.0 Hz, 1H), 2.69 (t, J = 7.5 Hz, 2H), 2.54 (s, 3H), 1.97 – 1.86 (m, 4H), 
1.58 – 1.51 (m, 2H), 1.32 – 1.22 (m, 2H), 1.22 – 1.13 (m, 2H), 0.87 (t, J = 7.0 Hz, 3H). 
13
C NMR (CD3OD, 101 MHz, 298 K): δ 174.9, 151.2, 148.4, 146.4, 141.0, 140.6, 126.5, 
56.7, 40.1, 38.6, 33.1, 28.1, 27.1, 23.6, 14.0. 
11
B NMR (CD3OD, 128 MHz, 298 K, normal glass): δ –12.6 
 
HR-MS: Calculated for C16H23BN3O3 [M–H]
+
 316.1832, found: 316.1844 (Δ = 3.8 ppm) 
 
FT-IR (thin film): 3326, 3104, 2959, 2931, 2860, 2368, 1753, 1699, 1619, 1585, 1486, 1441, 




MP:  > 161°C (decompose and produce gas) 
 
Compound 3B3: 
































Synthesis of 3B3 
 
 
To a mixture of 3B3-BH3 (274 mg, 0.86 mmol) and methanol (15 mL) [note: not dissolved 
even at RT] at 0 °C, HCl (conc., 100 μL, 1.2 mmol) was added. After 15 minutes, the cooling 
bath was removed and the mixture was stirred at RT until full conversion was reached 
(2 hours), which was checked by LCMS. A saturated solution of NaHCO3 (4 mL) was added 
(pH > 8) and then a saturated solution of NH4Cl (30 mL) was added (pH < 7). The mixture 
was extracted with dichloromethane (4 × 50 mL), dried over MgSO4, the solvents were 
removed under reducer pressure. A combiflash of the residue on silica (Celite loading, 
PE/EtOAc, EtOAc: 0%→100%) provided after drying in vacuum oven overnight the title 
compound (170 mg, 65% yield) as a white crystalline solid. 
 
1
H NMR (CD3OD, 400 MHz, 298 K): δ 8.37 – 8.35 (m, 2H), 7.67 – 7.64 (m, 1H), 7.35 (ddd, 
J = 8.0, 5.0, 1.0 Hz, 1H), 2.64 (t, J = 7.5 Hz, 2H), 2.00 – 1.85 (m, 4H), 1.58 – 1.50 (m, 2H), 
1.33 – 1.22 (m, 2H), 1.21 – 1.10 (m, 2H), 0.86 (t, J = 7.0 Hz, 3H). 
13
C NMR (CD3OD, 101 MHz, 298 K): δ 175.0, 151.4, 150.0, 147.8, 139.0, 138.2, 125.2, 
56.9, 40.0, 39.0, 33.4, 28.1, 27.4, 23.7, 14.0.  
 
HR-MS (ESI): Calculated for C16H22N3O3 [M+H]
+
 304.1661, found: 304.1668 (Δ = 2.3 ppm) 
 





MP: 184 – 186 °C 
 
EA: Required for C16H21N3O3: C 63.35, H 6.98, N 13.85; found: C 62.92, H 7.09, N 13.66. 
 


















Synthesis of a4 
 
 
To a solution of 3-(pyridin-4-yl)propan-1-ol (1.29 g, 9.4 mmol) and NEt3 (4 mL) in CH2Cl2 
(50 mL) was added methanesulfonyl chloride (1.2 mL, 15.5 mmol, 1.6 eq) at 0 °C in small 
parts over the period of 90 minutes. The still-cool solution was washed with H2O (50 mL) and 
brine (25 mL), dried with MgSO4 and solvents were removed under reducer pressure (at no 
more than 30 °C). A combiflash of the residue on silica gel (PE/EtOAc, EtOAc: 0%→100%) 
provided the title compound as transparent oil (1.53 g, 77% yield). 
 
1
H NMR (CDCl3, 400 MHz, 298 K): δ 8.50 (dd, J = 4.5, 1.5 Hz, 2H), 7.11 (d, J = 6.0 Hz, 
2H), 4.22 (t, J = 6.0 Hz, 2H), 2.99 (s, 3H), 2.76 – 2.72 (m, 2H), 2.11 – 2.04 (m, 2H). 
13



































Synthesis of b4 
 
 
a4 (1.53 g, 7.11 mmol) was flushed with nitrogen. Then THF (10 mL) was added and the 
reaction mixture was cooled to –78 °C. To this solution, BH3•SMe2 (4.0 mL, 2.0M solution in 
THF, 8 mmol) was added dropwise at –78 °C. After 30 minutes of stirring, the cooling bath 
was removed. After stirring at RT for 2.5 hours, the mixture was cooled again to –78 °C and 
methanol (3 mL) was added dropwise. After 10 minutes, the cooling bath was removed and 
the mixture was allowed to heat to room temperature and then solvents were removed under 
reduced pressure. A combiflash of the residue on silica (Celite loading, PE/EtOAc; EtOAc: 
0%→100%) provided the title compound (1.44 g, 88% yield) as transparent oil, which 
crystalise upon standing in the freezer over a couple of days/weeks to form a white solid. 
 
1
H NMR (CDCl3, 400 MHz, 298 K): δ 8.47 (d, J = 6.5 Hz, 2H), 7.34 (d, J = 6.5 Hz, 2H), 
4.25 (t, J = 6.0 Hz, 2H), 3.02 (s, 3H), 2.90 – 2.86 (m, 2H), 2.63 (br, 3H), 2.14 – 2.07 (m, 2H). 
1
H NMR (CDCl3, 400 MHz, 298 K, 
11
B decoupled): δ 8.47 (d, J = 6.0 Hz, 2H), 7.34 (d, 
J = 6.0 Hz, 2H), 4.25 (t, J = 6.0 Hz, 2H), 3.03 (s, 3H), 2.90 – 2.86 (m, 2H), 2.54 (s, 3H), 2.14 
– 2.07 (m, 2H). 
13
C NMR (CDCl3, 101 MHz, 298 K): δ 153.7, 147.3, 125.3, 68.0, 37.5, 31.0, 29.2. 
11
B NMR (CDCl3, 128 MHz, 298 K, normal glass): δ –12.7 (d, J = 86 Hz). 
 
HR-MS (ESI): Calculated for C9H15BNO3S [M–H]
+
 228.0866, found: 228.0855 
(Δ = 4.7 ppm) 
 




MP: 58 °C (melts and decomposes) 
 

























B NMR (normal glass) 
 




Synthesis of c4-BH3 and c4 
 
 
NaH (60% in mineral oil, 334 mg, 8.35 mmol) was flushed with nitrogen. THF (10 mL) was 
added and the mixture was cooled to 0 °C. Then diethyl-2-butylmalonate (1.9 mL, 
8.54 mmol) was added dropwise. After 30 minutes of stirring b4 (631 mg, 2.76 mmol) was 
added as a solid. The mixture was heated at 60 °C for 5 hours and then after cooling to RT, 
water (20 mL) was added and the mixture was extracted with dichloromethane (3 × 50 mL). 
The organic phase was dried over MgSO4 and the solvents were removed under reduced 
pressure. A combiflash of the residue on silica (Celite loading, PE/EtOAc, EtOAc: 0%→50%) 
provided after drying in vacuum oven overnight products c4-BH3 (472 mg, 49% crude yield) 
as transparent oil and c4 (110 mg, 23% crude yield) as yellowish oil. (Both products 
contained an additional impurity and were used in the next reactions without further 
purification.) 
 




H NMR (CDCl3, 400 MHz, 298 K): δ 8.46 (d, J = 6.0 Hz, 2H), 7.29 (d, J = 6.5 Hz, 2H), 
4.22 – 4.10 (m, 4H), 2.73 (t, J = 7.5 Hz, 2H), 1.90 – 1.83 (m, 4H), 1.62 – 1.54 (m, 2H), 1.33 – 
1.25 (m, 2H), 1.22 (t, J = 7.0 Hz, 6H), 1.13 – 1.05 (m, 2H), 0.88 (t, J = 7.5 Hz, 3H). 
1
H NMR (CDCl3, 400 MHz, 298 K, 
11
B decoupled): δ 8.46 (d, J = 6.0 Hz, 2H), 7.29 (d, 
J = 6.0 Hz, 2H), 4.21 – 4.10 (m, 4H), 2.73 (t, J = 7.5 Hz, 2H), 2.56 (s, 3H), 1.90 – 1.83 (m, 
4H), 1.62 – 1.53 (m, 2H), 1.33 – 1.27 (m, 2H), 1.22 (t, J = 7.0 Hz, 6H), 1.12 – 1.05 (m, 2H), 
0.88 (t, J = 7.3 Hz, 3H). 
13
C NMR (CDCl3, 101 MHz, 298 K): δ 171.5, 155.0, 147.2, 146.8, 125.2, 121.7, 61.2, 57.2, 
35.2, 32.3, 31.8, 26.1, 24.3, 22.8, 14.1, 13.8. 
11






FT-IR (thin film): 2959, 2935, 2872, 2362, 2308, 2280, 1725, 1630, 1562, 1504, 1463, 1439, 










H NMR (CDCl3, 400 MHz, 298 K): δ 8.48 (d, J = 5.5 Hz, 2H), 7.09 (d, J = 6.0 Hz, 2H), 
4.19 – 4.12 (m, 4H), 2.61 (t, J = 7.5 Hz, 2H), 1.91 – 1.83 (m, 4H), 1.57 – 1.49 (m, 2H), 1.34 – 
1.24 (m, 2H), 1.21 (t, J = 7.0 Hz, 6H), 1.11 – 1.03 (m, 2H), 0.88 (t, J = 7.5 Hz, 3H). 
13
C NMR (CDCl3, 101 MHz, 298 K): δ 171.7, 150.7, 149.7, 123.8, 61.1, 57.3, 35.2, 32.0, 







































B (normal glass) 
 
















Synthesis of 4B3 
 
 
NaH (60% in mineral oil, 57 mg, 1.4 mmol) was flushed with nitrogen and DMF (2 mL) was 
added. The mixture was cooled to 0 °C and urea (197 mg, 3.28 mmol) was added. After 
90 minutes of stirring, c4 (102 mg, 0.30  mmol) in DMF (4 mL) was added at 0 °C. The 
mixture was stirred for 5 days at RT and a saturated solution of NH4Cl (5 mL) was added with 
cooling to 0 °C. Water (10 mL) was added and the mixture was extracted with 
dichloromethane (3 × 50 mL). The collected organic phase was dried over MgSO4 and the 
solvents were removed under reduced pressure (60 °C, <14 mBar). A combliflash of residue 
on silica (Celite loading, PE/EtOAc, EtOAc: 0%→100%) provided after drying in vacuum 
oven at 40 °C overnight the title product (350 mg, 50% yield) as a white crystalline solid. 
 
1
H NMR (CD3OD, 400 MHz, 298 K): δ 8.40 (dd, J = 4.5, 1.5 Hz, 2H), 7.25 (dd, J = 4.5, 
1.5 Hz, 2H), 2.65 (t, J = 7.5 Hz, 2H), 1.95 – 1.92 (m, 2H), 1.90 – 1.85 (m, 2H), 1.60 – 1.51 
(m, 2H), 1.33 – 1.23 (m, 2H), 1.20 – 1.12 (m, 2H), 0.87 (t, J = 7.0 Hz, 3H). 
13
C NMR (CD3OD, 101 MHz, 298 K): δ 175.0, 153.3, 149.9, 125.6, 56.9, 40.1, 39.0, 35.6, 
28.1, 26.5, 23.7, 14.0. 
 
HR-MS (ESI): Required for C16H22N3O3 [M+H]
+
 304.1656, found: 304.1644 (Δ = 3.91 ppm). 
 





MP: 174 – 176 °C 
 
EA: Required for C16H21N3O3: C 63.35, H 6.98, N 13.85; found: C 62.67, H 7.01, N 13.44. 
 


















Synthesis of 3P1-Cl 
 
A mixture of 4,6-dichloropyrimidin-2-amine (689 mg, 4.20 mmol), 3-picolylamine (1 mL, 
1 g, 9.8 mmol), K2CO3 (437 mg, 3.17 mmol) and tBuOH (15 mL) were heated at 50 °C for 
4 days. The mixture was evaporated and water (20 mL) was added. The mixture was then 
sonicated for 2 minutes. The obtained solid was collected by suction and dried overnight in 
vacuum oven at 40 °C to provide the title compound (831 mg, 84% yield) as a white solid. 
 
1
H NMR (CD3OD/CDCl3, 400 MHz, 298 K): δ 8.47 (d, J = 1.5 Hz, 1H), 8.39 (d, J = 3.5 Hz, 




-DMSO, 126 MHz, 298 K): δ 164.0, 163.0, 157.6, 149.0, 148.2, 135.4, 135.2, 
123.6, 92.8, 41.08. 
 
HR-MS (ESI): Calculated for C10H11N5Cl [M+H]
+
 236.0703, found: 236.0693 (Δ = 4.2 ppm) 
 




MP: 198 – 200 °C 
 


























Synthesis of 3P2-Cl 
 
A mixture of 4,6-dichloropyrimidin-2-amine (776 g, 4.64 mmol), 3-(2-aminoethyl)pyridine 
(1 mL, 1 g, 7.5 mmol), K2CO3 (490 mg, 3.55 mmol) and tBuOH (18 mL) were heated at 
50 °C for 2 days. The mixture was evaporated and water (20 mL) was added. The mixture 
was then sonicated for 30 minutes. The obtained solid was collected by suction and dried 
overnight in vacuum oven at 40 °C to provide the title compound (840 mg, 73% yield) as a 
pale yellow solid. 
 
1
H NMR (CD3OD, 400 MHz, 298 K): δ 8.41 (d, J = 2.0 Hz, 1H), 8.37 (dd, J = 5.0, 1.5 Hz, 
1H), 7.74 (dt, J = 8.0, 1.5 Hz, 1H), 7.36 (dd, J = 8.0, 5.0 Hz, 1H), 5.78 (s, 1H), 3.59 (s, 2H), 




-DMSO, 126 MHz, 298 K): δ 164.1, 163.1, 157.3, 150.0, 147.5, 136.5, 135.1, 
123.6, 92.8, 41.3, 32.0. 
 
HR-MS (ESI): Calculated for C11H13N5Cl [M+H]
+
 250.0859, found: 250.0850 (Δ = 3.6 ppm) 
 




MP: 152 – 157 °C 
 
























Synthesis of 4P1-Cl 
 
A mixture of 4,6-dichloropyrimidin-2-amine (800 mg, 4.88 mmol), 4-picolylamine (3 mL, 
3.18 g, 29 mmol), K2CO3 (676 mg, 4.89 mmol) and tBuOH (15 mL) were heated at 60 °C 
overnight. The mixture was evaporated and water (30 mL) was added. The mixture was then 
sonicated for 30 minutes and the mixture dissolved. After standing, the form solid was 
collected and dried in the vacuum oven overnight to provid the title compound (727 mg, 63% 
yield) as a pale yellow solid. 
 
1
H NMR (CD3OD, 400 MHz, 298 K): δ 8.44 (d, J = 6.0 Hz, 2H), 7.35 (d, J = 6.0 Hz, 2H), 




-DMSO, 126 MHz, 298 K): δ 164.2, 163.0, 157.8, 149.6, 148.9, 122.3, 92.8, 
42.3. 
 
HR-MS (ESI): Calculated for C10H11N5Cl [M+H]
+
 236.0697, found: 236.0694 (Δ = 1.5 ppm) 
 




MP: > 136 °C (carbonisation) 
 


























Synthesis of 4P2-Cl 
 
A mixture of 4,6-dichloropyrimidin-2-amine (1.06 g, 6.46 mmol), 4-(2-aminoethyl)pyridine 
(1.2 mL, 1.2 g, 10 mmol), K2CO3 (0.76 g, 5.5 mmol) and tBuOH (15 mL) were heated at 
50 °C for 3 days. The mixture was evaporated and water (30 mL) was added. The mixture 
was then sonicated for 20 minutes. The obtained solid was collected by suction and dried 




H NMR (CD3OD, 400 MHz, 298 K): δ 8.43 – 8.42 (m, 2H), 7.33 (d, J = 6.0 Hz, 2H), 5.79 
(s, 1H), 3.61 (s, 2H), 2.93 (t, J = 7.0 Hz, 2H). 
13
C NMR (CD3OD, 101 MHz, 298 K): δ 165.7, 164.4, 162.8, 151.7, 149.9, 126.1, 94.8, 41.9, 
35.8. 
 
HR-MS (ESI): Calculated for C11H13N5Cl [M+H]
+
 250.0854, found: 250.0850 (Δ = 1.4 ppm) 
 




MP: 157 °C (carbonisation) 
 

























Synthesis of 3P1 
 
 
3P1-Cl (337 mg, 1.43 mmol) was flushed with nitrogen in a MW vial. n-Pentylamine (1 mL, 
0.9 g, 10 mmol) was added and the mixture was heated in microwave at 160 °C for 2 hours. A 
saturated solution of NaHCO3 (15 mL) was added and the mixture was extracted with 
CH2Cl2/MeOH (20:1, 2 × 50mL) and CH2Cl2 (2 × 50 mL). The organic phase was dried over 
MgSO4, evaporated and loaded to Celite. A combiflash of the residue on silica 




H NMR (CD3OD, 400 MHz, 298 K): δ 8.50 (s, 1H), 8.38 (d, J = 4.0 Hz, 1H), 7.77 (d, 
J = 7.5 Hz, 1H), 7.34 (dd, J = 7.0, 5.0 Hz, 1H), 4.89 (s, 1H), 4.46 (s, 2H), 3.08 (t, J = 7.0 Hz, 
2H), 1.52 – 1.43 (m, 2H), 1.29 (d, J = 2.5 Hz, 4H), 0.88 (t, J = 6.0 Hz, 3H). 
13
C NMR (CD3OD, 101 MHz, 298 K): δ 165.2, 165.1, 164.0, 149.1, 148.4, 137.7, 137.1, 
125.1, 74.0, 43.2, 42.3, 30.3, 30.1, 23.5, 14.4. 
 
HR-MS (ESI): Calculated for C15H23N6 [M+H]
+
 287.1979, found: 287.1976 (Δ = 0.98  ppm) 
 




LCMS Method: Col3_MeCN_FAST_5%-35% 
 
  














Synthesis of 3P2 
 
 
3P2-Cl (123 mg, 0.493 mmol) was flushed with nitrogen in a MW vial. n-Pentylamine (1 mL, 
0.9 g, 10 mmol) was added and the mixture was heated in microwave at 150 °C for 7 hours. A 
saturated solution of NaHCO3 (10 mL) was added and the mixture was extracted with 
dichloromethane (4 × 30 mL). The organic phase was dried over MgSO4, evaporated and 
loaded to Celite. A combiflash of the residue on silica (CH2Cl2/MeOH: MeOH 0%→10%) 
provided the title compound (124 mg, 84% yield) as orange dense oil. 
 
1
H NMR (CD3OD, 400 MHz, 298 K): δ 8.41 (s, 1H), 8.36 (d, J = 4.0 Hz, 1H), 7.71 (d, 
J = 7.5 Hz, 1H), 7.33 (dd, J = 7.5, 5.0 Hz, 1H), 3.45 (t, J = 7.0 Hz, 2H), 3.12 (t, J = 7.0 Hz, 
2H), 2.88 (t, J = 7.0 Hz, 2H), 1.56 – 1.53 (m, 2H), 1.35 – 1.30 (m, 4H), 0.91 (t, J = 6.0 Hz, 
3H). 
13
C NMR (CD3OD, 101 MHz, 298 K): δ 165.1, 165.0, 163.9, 150.4, 147.9, 138.7, 137.4, 
125.1, 73.6, 43.2, 42.3, 33.8, 30.3, 30.2, 23.5, 14.4. 
 
HR-MS (ESI): Calculated for C16H25N6 [M+H]
+ 
301.2141, found: 301.2142  (Δ = 0.3 ppm) 
 




























Synthesis of 4P1 
 
 
4P1-Cl (105 mg, 0.45 mmol) was flushed with nitrogen in a MW vial. n-Pentylamine (1 mL, 
0.9 g, 10 mmol) was added and the mixture was heated in microwave at 160 °C for 3 hours. A 
saturated solution of NaHCO3 (15 mL) was added and the mixture was extracted with 
CH2Cl2/MeOH (20:1, 2 × 50 mL) and CH2Cl2 (2 × 50 mL). The organic phase was dried over 
MgSO4, evaporated and loaded to Celite. A combiflash of the residue on silica 
(CH2Cl2/MeOH: MeOH 0%→20%) provided the title compound (71 mg, 55% yield) as 
orange dense oil. 
 
1
H NMR (CD3OD, 400 MHz, 298 K): δ 8.42 (d, J = 5.5 Hz, 2H), 7.35 (d, J = 5.0 Hz, 2H), 
4.86 (s, 1H), 4.47 (s, 2H), 3.08 (t, J = 7.0 Hz, 2H), 1.52 – 1.43 (m, 2H), 1.29 (d, J = 3.0 Hz, 
4H), 0.88 (t, J = 6.5 Hz, 3H). 
13
C NMR (CD3OD, 101 MHz, 298 K): δ 165.2, 165.2, 163.9, 152.3, 149.9, 123.6, 74.0, 44.7, 
42.3, 30.3, 30.1, 23.5, 14.4. 
 
HR-MS (ESI): Calculated for C15H23N6 [M+H]
+
 287.1979, found: 287.1975 (Δ = 1.26 ppm) 
 























Synthesis of 4P2 
 
 
4P2-Cl (100 mg, 0.40 mmol) was flushed with nitrogen in a MW vial. n-Pentylamine (1 mL, 
0.9 g, 10 mmol) was added and the mixture was heated in microwave at 160 °C for 5 hours. A 
saturated solution of NaHCO3 (10 mL) and water (10 mL) were added and the mixture was 
extracted with CH2Cl2/MeOH (20:1, 50 mL) and CH2Cl2 (3 × 50 mL). The organic phase was 
dried over MgSO4, evaporated and loaded to Celite. A combiflash of the residue on silica 




H NMR (CDCl3, 400 MHz, 298 K): δ 8.53 (d, J = 6.0 Hz, 2H), 7.15 (d, J = 6.0 Hz, 2H), 
4.80 (s, 1H), 4.60 – 4.41 (m, 3H), 3.51 (dd, J = 13.0, 7.0 Hz, 2H), 3.13 (dd, J = 13.0, 7.0 Hz, 
2H), 2.89 (t, J = 7.0 Hz, 2H), 1.61 – 1.54 (m, 2H), 1.39 – 1.30 (m, 4H), 0.90 (t, J = 7.0 Hz, 
3H). 
13
C NMR (CDCl3, 101 MHz, 298 K): δ 164.1, 163.8, 162.2, 150.0, 148.0, 124.1, 72.5, 41.7, 
41.7, 35.1, 29.1, 29.0, 22.4, 14.0. 
 
HR-MS (ESI): Calculated for C16H25N6 [M+H]
+
 301.2135, found: 301.2131 (Δ = 1.30 ppm) 
 
























The conformational search was done by molecular mechanics in Schrödinger Suite 
2016-4 using MacroModel suite. A global minimum structure was found by conformational 
search using OPLS3 as a force field and without using any solvent model and with using no 
cut-off for non-covalent interactions. For semi-empirical calculations, PM6 as implemented in 




5.8.4. UV-vis-NIR titrations 
General 
The UV-vis-NIR titrations were recorded on a Cary 60 UV-Vis machine (Agilent 
Technologies) at 298 K. Freshly opened CHCl3 (HPLC quality, stabilised with amylene) was 
used as a solvent and was filtered over basic alumina plug before use. A host solution with 
known concentration was prepared and fraction of this solution was transferred into a glass 
cuvette. Then, a guest solution with known concentration was prepared. A change of UV-vis-
NIR absorption upon addition of aliquots of guest solution was followed. The observed 
changes of UV-vis-NIR absorbance were analysed using a purpose-written fitting macro in 
Microsoft Excel (written by Prof Hunter). A 1:1 binding isotherm was used to fit the 
experimental data assuming that all six porphyrin units of 6-ring coordinate a pyridine ligand 
and act identically and independently. The concentration of host was allowed to change upon 
fitting. The experiments were measured at least two times on at least two different days with 
freshly prepared solutions in order to eliminate possible systematic errors. The results are 
stated as average values and errors are quoted as two times the standard deviation. 
  







Figure 5.E1. UV-vis-NIR titration (CHCl3, 298 K) of 4Py to 6-ring. UV-vis-NIR spectra are 
shown on the left with the spectrum of unbound 6-ring in thick black line and the end 
spectrum in red thick line. On the right are shown the experimental data at 833 nm (circles) 
and calculated values (line) based on a 1:1 binding isotherm assuming that the six porphyrin 




Figure 5.E2. UV-vis-NIR titration (CHCl3, 298 K) of 3B3 to 6-ring. UV-vis-NIR spectra are 
shown on the left with the spectrum of unbound 6-ring in thick black line and the end 
spectrum in red thick line. On the right are shown the experimental data at 842 nm (circles) 
and calculated values (line) based on a 1:1 binding isotherm assuming that the six porphyrin 







Figure 5.E3. UV-vis-NIR titration (CHCl3, 298 K) of 4B3 to 6-ring. UV-vis-NIR spectra are 
shown on the left with the spectrum of unbound 6-ring in thick black line and the end 
spectrum in red thick line. On the right are shown the experimental data at 831 nm (circles) 
and calculated values (line) based on a 1:1 binding isotherm assuming that the six porphyrin 
units of 6-ring act identically and independently. 
 
 
Figure 5.E4. UV-vis-NIR titration (CHCl3, 298 K) of 3P1 to 6-ring. UV-vis-NIR spectra are 
shown on the left with the spectrum of unbound 6-ring in thick black line and the end 
spectrum in red thick line. On the right are shown the experimental data at 831 nm (circles) 
and calculated values (line) based on a 1:1 binding isotherm assuming that the six porphyrin 
units of 6-ring act identically and independently. 
 





Figure 5.E5. UV-vis-NIR titration (CHCl3, 298 K) of 3P2 to 6-ring. UV-vis-NIR spectra are 
shown on the left with the spectrum of unbound 6-ring in thick black line and the end 
spectrum in red thick line. On the right are shown the experimental data at 836 nm (circles) 
and calculated values (line) based on a 1:1 binding isotherm assuming that the six porphyrin 




Figure 5.E6. UV-vis-NIR titration (CHCl3, 298 K) of 4P1 to 6-ring. UV-vis-NIR spectra are 
shown on the left with the spectrum of unbound 6-ring in thick black line and the end 
spectrum in red thick line. On the right are shown the experimental data at 852 nm (circles) 
and calculated values (line) based on a 1:1 binding isotherm assuming that the six porphyrin 
units of 6-ring act identically and independently. A 1:1 binding isotherm struggles to describe 
the experimental data correctly, but the concentration of ligand for half bound is 7 μM and the 







Figure 5.E7. UV-vis-NIR titration (CHCl3, 298 K) of 4P2 to 6-ring. UV-vis-NIR spectra are 
shown on the left with the spectrum of unbound 6-ring in thick black line and the end 
spectrum in red thick line. On the right are shown the experimental data at 843 nm (circles) 
and calculated values (line) based on a 1:1 binding isotherm assuming that the six porphyrin 
units of 6-ring act identically and independently. 
 
 
Figure 5.E8. UV-vis-NIR titration (CHCl3, 298 K) of a 1:1 mixture of P and 3B3 to 6-ring. 
UV-vis-NIR spectra are shown on the left with the spectrum of unbound 6-ring in thick black 
line and the end spectrum in red thick line. On the right are shown the experimental data at 
831 nm (circles) and calculated values (line) based on a 1:1 binding isotherm assuming that 
the six porphyrin units of 6-ring act identically and independently. 
 





Figure 5.E9. UV-vis-NIR titration (CHCl3, 298 K) of a 1:1 mixture of P and 4B3 to 6-ring. 
UV-vis-NIR spectra are shown on the left with the spectrum of unbound 6-ring in thick black 
line and the end spectrum in red thick line. On the right are shown the experimental data at 
831 nm (circles) and calculated values (line) based on a 1:1 binding isotherm assuming that 
the six porphyrin units of 6-ring act identically and independently. 
 
 
Figure 5.E10. UV-vis-NIR titration (CHCl3, 298 K) of a 1:1 mixture of B and 3P1 to 6-ring. 
UV-vis-NIR spectra are shown on the left with the spectrum of unbound 6-ring in thick black 
line and the end spectrum in red thick line. On the right are shown the experimental data at 
831 nm (circles) and calculated values (line) based on a 1:1 binding isotherm assuming that 







Figure 5.E11. UV-vis-NIR titration (CHCl3, 298 K) of a 1:1 mixture of B and 3P2 to 6-ring. 
UV-vis-NIR spectra are shown on the left with the spectrum of unbound 6-ring in thick black 
line and the end spectrum in red thick line. On the right are shown the experimental data at 
836 nm (circles) and calculated values (line) based on a 1:1 binding isotherm assuming that 
the six porphyrin units of 6-ring act identically and independently. 
 
 
Figure 5.E12. UV-vis-NIR titration (CHCl3, 298 K) of a 1:1 mixture of B and 4P1 to 6-ring. 
UV-vis-NIR spectra are shown on the left with the spectrum of unbound 6-ring in thick black 
line and the end spectrum in red thick line. On the right are shown the experimental data 
at 852 nm (circles) and calculated values (line) based on a 1:1 binding isotherm assuming that 
the six porphyrin units of 6-ring act identically and independently. 
 





Figure 5.E13. UV-vis-NIR titration (CHCl3, 298 K) of a 1:1 mixture of B and 4P2 to 6-ring. 
UV-vis-NIR spectra are shown on the left with the spectrum of unbound 6-ring in thick black 
line and the end spectrum in red thick line. On the right are shown the experimental data at 
843 nm (circles) and calculated values (line) based on a 1:1 binding isotherm assuming that 
the six porphyrin units of 6-ring act identically and independently. 
 
 
Figure 5.E14. UV-vis-NIR titration (CHCl3, 298 K) of a 1:1 mixture of C and 3P1 to 6-ring. 
UV-vis-NIR spectra are shown on the left with the spectrum of unbound 6-ring in thick black 
line and the end spectrum in red thick line. On the right are shown the experimental data at 
831 nm (circles) and calculated values (line) based on a 1:1 binding isotherm assuming that 







Figure 5.E15. UV-vis-NIR titration (CHCl3, 298 K) of a 1:1 mixture of C and 3P2 to 6-ring. 
UV-vis-NIR spectra are shown on the left with the spectrum of unbound 6-ring in thick black 
line and the end spectrum in red thick line. On the right are shown the experimental data at 
836 nm (circles) and calculated values (line) based on a 1:1 binding isotherm assuming that 
the six porphyrin units of 6-ring act identically and independently. 
 
 
Figure 5.E16. UV-vis-NIR titration (CHCl3, 298 K) of a 1:1 mixture of C and 4P1 to 6-ring. 
UV-vis-NIR spectra are shown on the left with the spectrum of unbound 6-ring in thick black 
line and the end spectrum in red thick line. On the right are shown the experimental data at 
852 nm (circles) and calculated values (line) based on a 1:1 binding isotherm assuming that 
the six porphyrin units of 6-ring act identically and independently. 
 





Figure 5.E17. UV-vis-NIR titration (CHCl3, 298 K) of a 1:1 mixture of C and 4P2 to 6-ring. 
UV-vis-NIR spectra are shown on the left with the spectrum of unbound 6-ring in thick black 
line and the end spectrum in red thick line. On the right are shown the experimental data at 
843 nm (circles) and calculated values (line) based on a 1:1 binding isotherm assuming that 





Figure 5.E18. UV-vis-NIR titration (CHCl3, 298 K) of a 1:1 mixture of 3B3 and 3P1 to       
6-ring. UV-vis-NIR spectra are shown on the left with the spectrum of unbound 6-ring in 
thick black line and the end spectrum in red thick line. On the right are shown the 
experimental data at 835 nm (circles) and calculated values (line) based on a 1:1 binding 







Figure 5.E19. UV-vis-NIR titration (CHCl3, 298 K) of a 1:1 mixture of 3B3 and 3P2 to        
6-ring. UV-vis-NIR spectra are shown on the left with the spectrum of unbound 6-ring in 
thick black line and the end spectrum in red thick line. On the right are shown the 
experimental data at 838 nm (circles) and calculated values (line) based on a 1:1 binding 
isotherm assuming that the six porphyrin units of 6-ring act identically and independently. 
 
 
Figure 5.E20. UV-vis-NIR titration (CHCl3, 298 K) of a 1:1 mixture of 3B3 and 4P1 to       
6-ring. UV-vis-NIR spectra are shown on the left with the spectrum of unbound 6-ring in 
thick black line and the end spectrum in red thick line. On the right are shown the 
experimental data at 831 nm (circles) and calculated values (line) based on a 1:1 binding 
isotherm assuming that the six porphyrin units of 6-ring act identically and independently. 
 





Figure 5.E21. UV-vis-NIR titration (CHCl3, 298 K) of a 1:1 mixture of 3B3 and 4P2 to       
6-ring. UV-vis-NIR spectra are shown on the left with the spectrum of unbound 6-ring in 
thick black line and the end spectrum in red thick line. On the right are shown the 
experimental data at 842 nm (circles) and calculated values (line) based on a 1:1 binding 
isotherm assuming that the six porphyrin units of 6-ring act identically and independently. 
 
 
Figure 5.E22. UV-vis-NIR titration (CHCl3, 298 K) of a 1:1 mixture of 4B3 and 3P1 to       
6-ring. UV-vis-NIR spectra are shown on the left with the spectrum of unbound 6-ring in 
thick black line and the end spectrum in red thick line. On the right are shown the 
experimental data at 831 nm (circles) and calculated values (line) based on a 1:1 binding 







Figure 5.E23. UV-vis-NIR titration (CHCl3, 298 K) of a 1:1 mixture of 4B3 and 3P2 to       
6-ring. UV-vis-NIR spectra are shown on the left with the spectrum of unbound 6-ring in 
thick black line and the end spectrum in red thick line. On the right are shown the 
experimental data at 837 nm (circles) and calculated values (line) based on a 1:1 binding 
isotherm assuming that the six porphyrin units of 6-ring act identically and independently. 
 
 
Figure 5.E24. UV-vis-NIR titration (CHCl3, 298 K) of a 1:1 mixture of 4B3 and 4P1 to       
6-ring. UV-vis-NIR spectra are shown on the left with the spectrum of unbound 6-ring in 
thick black line and the end spectrum in red thick line. On the right are shown the 
experimental data at 834 nm (circles) and calculated values (line) based on a 1:1 binding 
isotherm assuming that the six porphyrin units of 6-ring act identically and independently. 
 





Figure 5.E25. UV-vis-NIR titration (CHCl3, 298 K) of a 1:1 mixture of 4B3 and 4P2 to       
6-ring. UV-vis-NIR spectra are shown on the left with the spectrum of unbound 6-ring in 
thick black line and the end spectrum in red thick line. On the right are shown the 
experimental data at 835 nm (circles) and calculated values (line) based on a 1:1 binding 
isotherm assuming that the six porphyrin units of 6-ring act identically and independently. 
5.8.5. NMR experiments 
 
Figure 5.S26. Partial 
1
H NMR (500 MHz, CDCl3, 298 K) spectra of (a) 6-ring (0.16 mM), 
(b) mixture of 3B3 (0.48 mM) and 4P1 (0.48 mM) and (c) mixture of 6-ring (0.16 mM), 3B3 






Figure 5.S27. Partial 
1
H NMR (500 MHz, CDCl3, 298 K) spectra of (a) 6-ring (0.16 mM), 
(b) mixture of 3B3 (0.48 mM) and 4P2 (0.48 mM) and (c) mixture of 6-ring (0.16 mM), 3B3 
(0.48 mM) and 4P2 (0.48 mM). 
 
 
Figure 5.S28. Partial 
1
H NMR (500 MHz, CDCl3, 298 K) spectra of (a) 6-ring (0.16 mM), 
(b) mixture of 4B3 (0.48 mM) and 3P2 (0.48 mM) and (c) mixture of 6-ring (0.16 mM), 4B3 
(0.48 mM) and 3P2 (0.48 mM). 
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Hybrid hydrogen-bonded/            
metal-coordinated cage 
  





Nature uses simple building blocks to assemble highly complex well-defined 
structures by multivalent non-covalent interactions.
1
 The scientific community has found a 
large number of artificial systems that resemble these structures found in nature.
2
 There are 
two main ways the synthetic systems are assembled: hydrogen-bonding and metal-
coordination. The former is used in capsules and the latter in metal-coordinated cages. Cages 




 and other suitable 
ligands.
7
 Capsules use the direction, polarity and self-complementarity of hydrogen bonds.
8
 
Both types have attracted substantial attention thanks to their host-guest and stimuli-
responsive behaviour,
9,10
 and sometimes just pure curiosity and sportsmanship.
11
 Conversely, 
there are not many examples in which these two methods of assembly are utilised together in 




One of the hydrogen-bonded motifs that have been used in the formation of capsules 
as well as hybrid 2D structures is the rosette motif (Figure 6.1). The groups of Whitesides, 
Reindhout and others studied extensively the rosette self-assembly, crystal packing and 
kinetic stability.
15,16
 The Reindhout group prepared a molecular container based on double 
rosettes using a calix[4]arene ditriaminotriazine.
17
 They were able to use this system for the 










Several hybrid systems based on the rosette motif have been prepared. The Whitesides 
group synthesised a tris(triazine) hub containing imidazole groups on the periphery.
18
 They 
were able to assemble them with zinc porphyrins to form hybrid systems as confirmed by 
1
H 
NMR spectroscopy, ESI-MS and GPC. The Reinhout group used the rosette motif to prepare 
rosette metallo-dendrimers with molecular weights up to 28 kDa.
19
 The group of Therrien 
used this motif to prepare supramolecular piano-stool complexes of Ru, Rh and Ir on the 
periphery of the rosette.
20





All of the aforementioned examples of hybrid complexes based on rosette motif have 
one important thing in common: since the metal-coordinated fragment is always on the 
periphery, it is not a crucial part of the architecture of the complex. In other words, if the 
metallic part is removed, the main 3D structure of the complex remains the same. There is 
only one example of 3D hybrid architecture based on the rosette motif, where removing the 
metal part changes the 3D topology significantly: The group of Li prepared a strapped 
porphyrin cyanuric acid and mixed it with a triazine and pyridine-substituted barbiturate to 
prepare a hybrid cage structure.
22
 The removal of metal-coordinated fragment from the double 
rosette complex would lead to the disassembly and produce a single rosette complex. 
Unfortunately, they characterised this cage only by simple 
1
H NMR spectroscopy and did not 
explore the host-guest and stimuli-responsive behaviour. There are only a limited number of 
systems using different motifs that can be considered genuine hybrid hydrogen-bonded/metal-
coordinated cages in the literature. 
 
We hypothetised that the rosette motif could be employed for the preparation of a new 
discrete 3D hybrid hydrogen-bonded/metal-coordinated system. The design and assembly of 
such system is described in this chapter. 
  





We decided to use the barbiturate-pyridine type of molecules explored in Chapter V to 
form the target hybrid cage by a coordination of a metal to pyridine units (Figure 6.2). The 
first choice was to employ palladium(II) salts because their pyridine complexes are well-
defined, well-studied and easily prepared (usually by a simple mixing of compounds).
23
 






Figure 6.2. Hybrid hydrogen-bonded/metal-coordinated cage (R is a solubilising group). 
 
The ultimate aim of this project was to fully characterise the target complex in solution 
and if possible also in solid state. For that, a detailed study by 2D NMR spectroscopy was 
conducted and different additional techniques tried. Moreover, the host-guest behaviour of the 
cage was explored. Since the target cage has hybrid character, it was shown that each of its 
parts was able to respond selectively to a different stimulus. 
 
We tried to find the alkyl linkers between the barbiturate and the pyridine units that 
would provide the optimal geometry for the target cage complex: the barbiturate and pyridine 
units in perpendicular planes. The coordination of palladium(II) to the pyridine unit in trans 
fashion should then produce a complex with two parallel rosettes. A structure search of 
CCDC suggested two lead candidates (Figure 6.3); the first one without any alkyl linker 








Figure 6.3. Barbiturate-pyridines (a) 4B0 and (b) 4B1 (R is a solubilising group) and X-ray 
structures of (c) CCDC 1549455 and (d) CCDC 217698 structures showing the right 
geometry for the target cage (other atoms of the molecules were removed for clarity). 
Colouring of atoms: C (grey), N (blue), O (red) and H (white). 
 
As the second rosette component, different pyrimidines and triazines with substituents that 
should increase the probability of successful crystallisation were utilised (Figure 6.4).  
 
 
Figure 6.4. Pyrimidines and triazines used to form cages in this study. 
 
6.3. Modelling 
Firstly, we modelled the target hybrid cages based on both 4B0 and 4B1 
computationally using semi-empirical method PM6. As the starting points, ideal cage 
structures similar to the one showed in Figure 6.2 were used. tBP was chosen as the second 
rosette component. Their optimisation provided possible structures of the target cages as 
depicted in Figure 6.5 (alkyl groups were replaced by hydrogen atoms to decrease the 
computational costs). The structure predicted for 4B1 is much more packed in comparison 
with 4B0. In addition, the rosette of complex with 4B0 is much flatter that should correlate 












Figure 6.5. PM6 optimised possible structures of hybrid cages based on (a) 4B0 and (b) 4B1 
using tBP as the second partner (alkyl groups were replaced by hydrogen atoms in the 
calculations). Hydrogen atoms that do not contribute to hydrogen-bonding were omitted for 
clarity. Colouring: barbiturate-pyridine in red, pyrimidine in blue, palladium atoms in black, 
chlorine atoms in yellow, green dashed line is the hydrogen-bond. 
  




6.4. Synthesis of cage components 
4B1 was synthesised using slightly altered literature procedure utilising DMF instead 
of ethanol for the second step that resulted in an increased yield (Scheme 6.1). 
 
 
Scheme 6.1. Synthesis of barbiturate-pyridine 4B1. 
 
Pyrimidines containing isobutyl (iBP), isopropyl (iPP) and tert-butylphenyl (tBP) 
were synthesised in one step syntheses in excellent yields (Scheme 6.2). Triazines iBT and 





Scheme 6.2. Synthesis of pyrimidines iPP, iBP and iBP and triazines iBT and tBT. 
  




Next, the palladium complex Pd(4B1)2Cl2 was isolated as a solid by reacting 4B1 with 
Pd(ACN)2Cl2 (Scheme 6.3). The 
1
H NMR and 
13
C NMR spectra showed the expected 
downfield of the pyridine C-H as shown in Figure 6.6. HR-MS and elemental analysis 
additionally confirmed the stoichiometry (see the Experimental section).  
 
Scheme 6.3. Preparation of Pd(4B1)2Cl2 and trans-Pt(4B1)2Cl2. 





Figure 6.6. (a) (b) Partial 
1
H NMR (400 MHz, CDCl3/CD3OD (1:1), 298 K) spectrum of (a) 
4B1 and (b) Pd(4B1)2Cl2. (c) (d) Partial 
13
C NMR (101 MHz, CDCl3/CD3OD (1:1), 298 K) 
spectrum of (c) 4B1 and (d) Pd(4B1)2Cl2. The selected peaks are assigned using the labelling 
scheme shown and coloured in red. 




Then, the corresponding platinum complex was prepared. It is usually possible to 
isolate both cis and trans platinum complexes due to their different stabilities.
24
 Conversely, 
palladium complexes have intermediate lability which prevents this. The trans platinum 
complexes are normally prepared at elevated temperatures, at which cis complexes isomerise 
into trans complexes.
24
 For the target cage, trans configuration is desirable. We therefore 
prepared trans-Pt(4B1)2Cl2 from cis-bis(acetonitrile)-dichloroplatinum in DMF at 80 °C 
(Scheme 6.3). The prepared complex was stable enough for purification by column 
chromatography. We were able to obtain an X-ray structure of this complex (Figure 6.7). The 
measurement and analysis was done by Dan-George Dumitrescu at Elettra-Sincrotrone 
Trieste. The structure showed the desired perpendicular architecture of two barbiturates. They 
were directed towards opposite sides, but it is expected that the -CH2- linker would allow 
them to rotate. 
 
 
Figure 6.7. X-ray structure of trans-Pt(4B1)2Cl2. Only one molecule from the crystal lattice 
is shown. Water and hydrogens were removed for clarity. Colouring of atoms: C (grey), N 
(blue), O (red), Pt (black) and Cl (yellow). 
 
6.5. Preparation of hybrid complexes 
To prepare the rosette hybrid cage, Pd(4B1)2Cl2 and pyrimidine iPP were added as 
solids to a Y-NMR tube, followed by the addition of CDCl3. Pd(4B1)2Cl2 is not soluble in 
CDCl3, but it dissolved in the presence of iPP. This provided the first indication that the 
desired complex was forming as the solubility of rosette building blocks increases 
significantly when the rosette complex is formed.
15
 In addition, 
1
H NMR spectrum showed 
the formation of the well-defined characteristic rosette peaks of bound NH of barbiturate in 
the region of δ 14 – 15 ppm as well as bound NH and NH2 from pyrimidine in the region of    




δ 7 – 9 ppm (Figure 6.8a). Comparing this to premixed rosette 4B1•iPP of the same 
concentration in CDCl3 (Figure 6.8b), Pd(4B1)2Cl2•iPP2 showed the formation of much more 
stable rosette. When the palladium salt was added to the premixed rosette 4B1•iPP, the 
formation of the same rosette complex was observed by 
1
H NMR spectroscopy (Figure 6.8c). 
In addition, when all the compounds were mixed together in a one-pot fashion, the same 
1
H NMR spectrum was obtained (Figure 6.8d).  
 
 
Figure 6.8. Partial 
1
H NMR (500 MHz, CDCl3, 298 K, [iPP] ~ 20 mM) spectra of (a) 1:2 
mixture of Pd(4B1)2Cl2 and iPP (b) 1:1 mixture of  4B1 and iPP (asterisk represents a broad 
peak), (c) adding a half equivalent of  Pd(ACN)2Cl2 to the 1:1 mixture of 4B1 and iPP and (d) 
2:2:1 mixture of  4B1, iPP and Pd(ACN)2Cl2.Colouring of peaks: barbiturate N-H in red, 
pyrimidine NH/NH2 in blue. 
 
Similar results were obtained when iBP was used. Unfortunately, these complexes 
decomposed over time. Pd(4B1)2Cl2•iBP fully decomposed in three days, which was assessed 
by 
1
H NMR spectra looking at the disappearance of characteristic rosette peaks and the 
change of the pyridine peaks and C-H of pyrimidine (Figure 6.9a). Moreover, the 
decomposition showed the same rate even when the cage was diluted 10-fold (Figure 6.9b). 





C NMR spectroscopy did not provide useful information as most of the peaks were broad 
(see the Experimental section). We did not explore this further as a more suitable system was 
found (see below), but can be probably attributed to insertion of palladium into aromatic C-H 
of pyrimidines.  
 
 
Figure 6.9. Partial 
1
H NMR (400 MHz, CDCl3, 298 K) spectra of the decomposition of 
complex Pd(4B1)2Cl2•iBP2 over time at the concentration of a) 12 mM and b) 1.2 mM. 
 
When iBT was used, a solid precipitated from the mixture and using tBP led to the 
formation of a gel. Finally, using tBT, we were able to prepare a rosette complex that was 




stable over a period of weeks as shown in Figure 6.10. Surprisingly, no coordination of 
palladium to triazine was observed. The bulkiness of tBT probably positively influences the 




Figure 6.10. Partial 
1
H NMR (400 MHz, CDCl3, 298 K, 10 mM) spectra of complex 
Pd(4B1)2Cl2•tBT2 (a) immediately after mixing and (b) after 6 weeks. The peaks are assigned 
using the labelling scheme shown. 
 
Next, we explored complexes based on platinum. As all of them produced gels or 
precipitated out of the solutions within a couple of hours/days, they will not be discussed here. 
This also prevented us from exploring if the complexes based on platinum are more stable 
than the ones based on palladium, as was hypothesised.   




6.6. Characterisation of complexes 
To characterise the 3D structure of Pd(4B1)2Cl2•tBT2 in solution, we applied NOESY 
NMR spectroscopy (Figure 6.11a). This experiment allowed us to see cross-peaks due to NOE 
between the N-H in both barbiturate and triazine (Figure 6.11b). The triazine NH2 is close in 
space only to N-H in barbiturate and N-H in triazine. In comparison, triazine N-H has all the 
expected connections for the rosette structure. The same applies for the N-H of barbiturate. 
 
Next, we applied DOSY NMR experiments to obtain the diffusion coefficients (D) of 
complex Pd(4B1)2Cl2•tBT2 and rosette 4B1•tBT to compare them using mesitylene as an 
internal reference (Figure 6.12). The diffusion coefficient is related to a hydrodynamic radius 







        (6.1) 
where kB is the Boltzmann’s constant, T is a temperature and η0 is a viscosity of a solvent. 
 
It is possible to estimate the hydrodynamic radius of the studied complex either 
directly, or by using an internal reference with known hydrodynamic radius. Mesitylene is 
often employed as such reference (with Rmesitylene = 3.0 Å).
28






       (6.2) 
 
This allowed us to determine the experimental hydrodynamic radii for 4B1•tBT and 
Pd(4B1)2Cl2•tBT2 as 12 Å and 17 Å, respectively (Table 6.1). 






Figure 6.11. (a) Partial NOESY (700 MHz, CDCl3, 298 K, 10 mM) spectrum of complex 










Figure 6.12. DOSY NMR (
1
H, 400 MHz, CDCl3, 298 K, [tBT] = 16 mM) spectra of (a) 
4B1•tBT (red line) and (b) Pd(4B1)2Cl2•tBT2 (red line) using mesitylene as an internal 
reference (green line). 
 





] Rexp [Å] 
a
 Rtheo [Å] 
b
 Rtheo [Å] 
c
 
mesitylene 1.65 × 10
–9
 - 3 3 
4B1•tBT 4.2 × 10
–10
 12 15 12 
Pd(4B1)2Cl2•tBT2 2.9 × 10
–10






From DOSY NMR experiments (CDCl3, 298 K, [tBT] = 16 mM) using mesitylene 
(Rmesitylene = 3.0 Å) as an internal reference. 
b
From PM6 optimised structures based on a radius (see Figure 6.13). 
c
From PM6 optimised structures using method of Timmerman et al. (see Figure 6.13). 
d
For two different optimised structures (see Figure 6.13). 
 
To gain more insight into these values, we optimised all the structures by the semi-
empirical method PM6 (Figure 6.13). Two different structures of Pd(4B1)2Cl2•tBT2 were 
found. The one being more open is about 10 kJ·mol
–1
 less stable as shown in Figure 6.13c-d. 
The hydrodynamic radius can be predicted by a radius of the studied molecule if the molecule 
is spherical. The results are depicted in Table 6.1. This provided a good agreement for 
mesitylene and Pd(4B1)2Cl2•tBT2. The less stable structure of Pd(4B1)2Cl2•tBT2 as judged 
by PM6 energies provided an excellent agreement with the experimental value of 
hydrodynamic radii. PM6 is a semi-empirical method that does not take any solvent effects 
into account, therefore calculations using higher theory and including solvent models could 
predict this structure to be more stable. On the other hand, 4B1•tBT was not described well 




by the radius. This is not surprising, since this complex is not spherical as seen from the 
modelling in Figure 6.13b. Alternatively, Timmerman et al. showed a different way for the 
prediction of a hydrodynamic radius for non-spherical molecules by averaging the XYZ 
dimensions of the gas-phase optimised structures.
20
 Such approach was successfully 
employed in various rosette assemblies. Following this method, we observed an excellent 
agreement of the predicted hydrodynamic radii for mesitylene and 4B1•tBT with the 
experimental values (Table 6.1). However, this method did not provide a good description of 
the experimental data for either structure of Pd(4B1)2Cl2•tBT2. In addition, the authors of the 
method stated that this procedure sometimes struggles to predict the hydrodynamic radius 
correctly and they were not able to explain for which systems this happens. Therefore we 
cannot exclude that one of such systems is Pd(4B1)2Cl2•tBT2. 
 





Figure 6.13. PM6 optimised structures of (a) mesitylene, (b) 4B1•tBT and (c), (d) 
Pd(4B1)2Cl2•tBT2 (showing two different isomers with different relative energies). 
Colouring: mesitylene in green, 4B1 in red, tBT in blue, palladium atoms in black, chlorine 
atoms in yellow. The determination of radius is shown on left (dashed pink lines connect 
centroids of the molecules with the most distant atoms in orange), the determination of XYZ 
dimensions is shown on the right. All the distances are in Å. 




Next, we conducted a dilution experiment of Pd(4B1)2Cl2•tBT2 in CDCl3 at 298 K 
(Figure 6.14). It was possible to observe the characteristic rosette peaks at concentrations as 





H NMR (500 MHz, CDCl3, 298 K) dilution experiment of Pd(4B1)2Cl2•tBT2. 
Colouring of peaks: barbiturate N-H in red, triazine NH/NH2 in blue.  
 
Unfortunately, we were not able to use the DMSO denaturation experiments employed 
by the Whitesides group and others to establish the hydrogen-bond stability of the cage,
28,29
 
because Pd(4B1)2Cl2 was not stable in DMSO solutions as showed in Figure 6.15. This was 
confirmed by the appearance of multiple peaks in 
1
H NMR spectra directly after DMSO 
addition and their change over time, and was probably due to the formation of Pd–DMSO 
complexes. 
 
To conclude the characterisation section, combining all the inferences from different 
methods, there is a high probability that the structure of Pd(4B1)2Cl2•tBT2 in solution 
(CDCl3, 298 K) is as suggested – the hybrid cage shown in Figure 6.16. 
 





Figure 6.15. Partial 
1
H NMR (400 MHz, d
6
-DMSO, 298 K) spectra of Pd(4B1)2Cl2 (a) 
directly after the addition of solvent and (b) after 1 day. 
 
 
Figure 6.16. Postulated structure of Pd(4B1)2Cl2•tBT2 in CDCl3 at 298 K (Ar = p-tert-
butylphenyl).  
 
To further characterise the complex, ESI-MS was used. Unfortunately, this method did 
not provide any additional information. It can be noted that it was difficult to obtain even the 
mass spectrum of Pd(4B1)2Cl2. Because of that, the Ag
+
–labelling technique for MALDI MS 
will be explored.
30
 Since Pd(4B1)2Cl2•tBT2 contains chlorine atoms, the successful 
characterisation of the complex by this method might be hampered by AgCl precipitation.      
A large number of different conditions for the crystallisation were explored and several 
crystals were submitted for an X-ray analysis. 
  




6.7. Host-guest and stimuli-responsive behaviour of hybrid cage 
The cavity of the cage is quite large as was shown in Figure 6.13. This led us to 
explore the cage ability to encapsulate fullerenes. Adding fullerenes C60 and C70 as solids to 
CDCl3 or CDCl3/d
8
-toluene mixtures of the cage did not result in their dissolving, which 
would show the formation of the host-guest complex. In addition, no change was observed in 
the 
1
H NMR spectra. 
 
The mixed architecture of the prepared complexes should provide different platforms 
for various stimuli as shown in Figure 6.17. A stronger ligand (such as phosphine) should 
remove the metal from the pyridine unit, and by that also change the double rosette complex 
to a single rosette. A cyanurate (such as cya) should replace the barbiturate in the rosette since 





Figure 6.17. Responsive behaviour of hybrid cage Pd(4B1)2Cl2•tBT2 to different stimuli: (a) 
phosphine and (b) a cyanurate cya (Ar = p-tert-butylphenyl). 




To test our hypotheses, we added PPh3 to the Pd(4B1)2Cl2•tBT2 solution, which 
resulted in the removal of palladium from pyridine units as judged by the upfield movement 
of C-H of the pyridine unit of 4B1 as well as significant broadening of characteristic rosette 
peaks in 
1
H NMR spectra (see Figure 6.18a-b), that is comparable to single rosettes. 
Additionally, 
31
P NMR spectra showed a formation of Pd(PPh3)2Cl2.
31
 When we tried to 
recover the cage by the addition of Pd(ACN)2Cl2, we observed the formation of mixed 
pyridine–phosphine–palladium species by 
1
H NMR and 
31
P NMR spectroscopy 
(Figure 6.18c). This was corroborated by mixing 4B1, PPh3 and Pd(ACN)2Cl2 separately that 
resulted in the corresponding 
1
H NMR and 
31
P NMR spectra as seen in Figure 6.18d.  
 
When a more bulky phosphine bis(diphenylphosphino)ferrocene (dppf) was used, the 
displacement of palladium worked in the same fashion as for PPh3 (Figure 6.19a-b). Then it 
was possible to recover the hybrid cage by the addition of Pd(ACN)2Cl2 that produced the 
same 
1
H NMR spectrum as for the starting complex with additional Pd(dppf)Cl2 peaks as 
depicted in Figure 6.19c. Moreover, no change in 
31
P NMR spectra was observed in this case, 
which provided an additional proof. 
 
Finally, we explored the possibility of exchanging the barbiturate in the rosette with a 
cyanuarate. Adding cya to the solution of Pd(4B1)2Cl2•tBT2 led to the precipitation of the 
solid inside the NMR tube. This was probably Pd(4B1)2Cl2 that is not soluble in CDCl3. It 
was possible to observe the formation of cya•tBT rosette and the disappearance of the 
aromatic signals of the 4B1-unit in the remaining solution by 
1
H NMR spectra as shown in 

















Figure 6.18. Partial 
1
H NMR (400 MHz, CDCl3, 298 K) spectra (left) and partial 
31
P NMR 
(162 MHz, CDCl3, 298 K) spectra (right) of (a) complex Pd(4B1)2Cl2•tBT2 (10 mM), (b) 
after addition of PPh3 (asterisk represents a broad peak), (c) followed by addition of 
Pd(ACN)2Cl2; (d) separate mixture of Pd(ACN)2Cl2, PPh3 and 4B1. Colouring of peaks: 4B1 
in red, tBT in blue and PPh3 in green. 
 
 
Figure 6.19. Partial 
1
H NMR (400 MHz, CDCl3, 298 K) spectra (left) and partial 
31
P NMR 
(162 MHz, CDCl3, 298 K) spectra (right) of (a) complex Pd(4B1)2Cl2•tBT2 (8 mM), (b) after 
addition of dppf (asterisk represents a broad peak), (c) followed by addition of Pd(ACN)2Cl2. 
Colouring of peaks: 4B1 in red, tBT in blue and dppf in green. 
 
 





Figure 6.20. Partial 
1
H NMR (400 MHz, CDCl3, 298 K) spectra of (a) Pd(4B1)2Cl2•tBT2 
(1.2 mM; selected peaks of the 4B1-part are highlighted in red), (b) after addition of cya. 
 
6.8. Conclusion and future work 
In this chapter, we designed and prepared hybrid hydrogen-bonded/metal-coordinated 
cages using barbiturate-pyridines, pyrimidines or triazines and palladium or platinum salts. 
These complexes are a rare example of architectures where both hydrogen-bonding and 
metal-coordination form the crucial part of the topology of the complex, since if either is 
removed, the architecture changes drastically. Most of the prepared cages decomposed, 
produced gels or precipitated out of the CDCl3 solutions over time. The most stable system 




C NMR and 2D 
NMR spectroscopy experiments (including NOESY and DOSY) to establish their structure in 
solution. Due to their mixed character, they show unusual dynamic behaviour as both of their 
parts response selectively to different stimuli such as phosphine and cyanurate. This research 
could be extended to prepare well-defined discrete heterometal assemblies by preparing metal 
complexes from pyridine derivatives of pyrimidines or triazines in corresponding fashion. An 
example of such platinum-palladium system is shown in Figure 6.21. 
 
 






Figure 6.21. Possible future direction to prepare heterometalic hybrid cages using pyridine-
substituted pyrimidine as the second partner (R is a solubilising group). The structure was 
optimised by PM6 (alkyl groups were replaced by hydrogen in the calculations). Hydrogen 
atoms that do not contribute to hydrogen-bonding were omitted for clarity. Colouring: 
barbiturate-pyridine in red, pyrimidine-pyridine in blue, palladium atoms in black, platinum 
atoms in green, chlorine atoms in yellow, green dashed line is the hydrogen-bond. 
  




6.9.  Experimental section 
6.9.1. General 
The synthesis of cya was described in Chapter III. The chemicals were bought from 
commercial suppliers and used without further purifications unless stated otherwise. Solvents 





 and CombiFlash Rf
+ 
Lumen (with UV light detection 
at 254 nm and 280 nm and evaporative light scattering detector for Lumen) with pre-packed 
puriFlash columns from Interchim (silica, 25 μm) with a loading of mixtures on Celite were 
used. The microwave used was Biotage Initiator
+
. The reactions were monitored by LSMS 
Waters Acquity H-class UPLC coupled with a single quadrupole Waters SQD2 with the 
conditions as follows: UPLC Column (see below), solvent A: Water + 0.1% formic acid; 
solvent B: acetonitrile od THF (see below) + 0.1% formic acid; gradient and flow rate (see 
below); column temperature of 40 °C, the signal was monitored at 254 nm and 280 nm. 
 
Columns 
Col1: ACQUITY UPLC CSH C18 Column, 130Å, 1.7 μm, 2.1 mm X 50 mm 
Col3: ACQUITY UPLC HSS T3 Column, 100Å, 1.8 μm, 2.1 mm X 50 mm 
Methods 
  MeCN-FAST: Gradient: 0 – 2 minutes 5% – 100%B + 1 minute 100%B 
    Flow rate: 0.6 ml/min 
  MeCN-SLOW: Gradient: 0 – 4 minutes 5% – 100%B + 1 minute 100%B 
     Flow rate: 0.6 ml/min 
  THF-FAST: Gradient: 0 – 2 minutes 5% – 80%B + 1 minute 80%B 
           Flow rate: 0.4 ml/min 
  THF-SLOW: Gradient: 0 – 4 minutes 5% – 80%B + 1 minute 80%B 
            Flow rate: 0.4 ml/min 
THF_FAST_5%-35%: Gradient of 0-2 minutes 5% – 35%B + 1 minute 100%B 





C NMR spectra were recorded on Bruker 400 MHz Avance III HD SmartProbe 
Spectrometers at 400 MHz for 
1
H and 101 MHz for 
13
C or on a Bruker 500 MHz Avance TCI 
CryoProbe Spectrometer and Bruker 500 MHz AVIII HD SmartProbe Spectrometer at 
500 MHz for 
1
H and 126 MHz for 
13
C, or on a Bruker 700 MHz Avance II+ TXO Cryoprobe 
Spectrometer at 700 MHz for 
1








All chemicals shift are quoted in ppm and were referenced to the residual peaks of used 
solvents: CDCl3 (
1
H: 7.26 ppm; 
13
C: 77.00 ppm), CD3OD (
1
H: 3.31 ppm; 
13





H: 2.50 ppm; 
13
C: 39.52 ppm). Coupling constants J are stated in Hz. NOESY 
spectra were recorded on Bruker 700 MHz Avance II+ TXO Cryoprobe Spectrometer. DOSY 
NMR experiments were conducted on a Bruker 400 MHz Avance III HD SmartProbe 
Spectrometer. FT-IR spectra were measured on a Bruker Alpha spectrometer. HR-MS spectra 
were obtained on a Waters Xevo
 
G2-S, Waters Vion IMS Qtof or Waters LCT Premier by 
electrospray-ionisation of samples. Melting points were recorder on a Mettler-Toledo MP90 
system. Elemental analysis was performed by the Microanalysis facility at the Department of 
Chemistry at the University of Cambridge. The X-ray measurement and analysis of          
trans-Pt(4B1)2Cl2 was done by Dan-George Dumitrescu at Elettra-Sincrotrone Trieste.   
 
6.9.2. Modelling 
For semi-empirical calculations, PM6 as implemented in Gaussian 09 was used.32 
  





Synthesis of 4B1-D 
 
 
NaH (60% in mineral oil, 1.13 g, 28.3 mmol) was flushed with N2 and THF (60 mL) was 
added. Diethyl 2-butylmalonate (4.5 mL, 4.4 g, 20 mmol) was then added at 0 °C. After 
stirring at RT for 30 minutes, 4-(chloromethyl)pyridine (97%, 1.65 g, 12.5 mmol) was then 
added. The mixture was refluxed overnight. A saturated solution of NaCl (20 mL) and water 
(10 mL) were added the mixture was extracted with dichloromethane (4 × 50 mL). The 
collected organic phase was dried over MgSO4 and the solvents were removed under reduced 
pressure. A combliflash of residue on silica (Celite loading, PE/EtOAc, EtOAc: 0%→100%) 
provided the title product (2.75 g, 72% yield) as yellowish liquid. 
 
1
H NMR (CDCl3, 400 MHz, 298 K): δ 8.50 (dd, J = 4.5, 1.5 Hz, 2H), 7.05 (dd, J = 4.5, 
1.5 Hz, 2H), 4.26 – 4.11 (m, 4H), 3.23 (s, 2H), 1.88 – 1.72 (m, 2H), 1.39 – 1.29 (m, 4H), 1.25 
(t, J = 7.0 Hz, 6H), 0.93 (t, J = 7.0 Hz, 3H). 
 








Synthesis of 4B1 
 
 
NaH (60% in mineral oil, 1.4 g, 35 mmol) was flushed with N2 and DMF (40 mL) was added. 
Urea (5.0 g, 83 mmol) was then added at 0 °C. After 30 minutes, the ice bath was removed. 
After additional stirring for 1 hour, 4B1-D (2.4 g, 7.8 mmol) was added at 0 °C. The mixture 
was then stirred at 40 °C for 2 days. A saturated solution of NH4Cl (100 mL) and ethyl acetate 
(150 mL) were added. The organic phase was separated, washed with water (3 × 50 mL) and 
dried over MgSO4 and the solvents were removed under reduced pressure. A combliflash of 
residue on silica (Celite loading, PE/EtOAc, EtOAc: 0%→100%) provided the title product 
(0.92 g, 43% yield) as a white crystalline solid. 
 
1
H NMR (CDCl3, 400 MHz, 298 K): δ 8.50 (dd, J = 4.5, 1.5 Hz, 2H), 7.83 (s, 2H), 7.04 (dd, 
J = 4.5, 1.4 Hz, 2H), 3.27 (s, 2H), 2.19 – 2.09 (m, 2H), 1.38 – 1.29 (m, 2H), 1.28 – 1.18 (m, 
2H), 0.89 (t, J = 7.0 Hz, 3H). 
13
C NMR (CDCl3, 101 MHz, 298 K): δ 171.0, 150.2, 147.0, 143.7, 124.6, 58.0, 42.8, 39.9, 
27.0, 22.5, 13.6. 
 
MP:  252 – 254 °C 
 
EA: Required for C14H17N3O3: C 61.08, H 6.22, N 15.26; found: C 61.21, H 6.26, N 15.13. 
 








Synthesis of iPP 
 
 
4,6-Dichloropyrimidin-2-amine (317 mg, 1.89 mmol) was flushed with nitrogen in a MW 
vial. Isopropylamine (2.3 mL, 1.6 g, 27 mmol) was added and the mixture was heated in 
microwave at 140 °C for 25 hours. A saturated solution of NaHCO3 (20 mL) was added and 
the mixture was extracted with CH2Cl2/MeOH (10:1; 3 × 50 mL) and CH2Cl2 (50 mL). The 
organic phase was dried over MgSO4, evaporated and loaded to Celite. A combiflash of the 
residue on silica (CH2Cl2/MeOH: MeOH 0%→10%) provided the title compound (334 mg, 
84% yield) as a pale-orange solid. 
 
1
H NMR (CD3OD, 400 MHz, 298 K): δ 4.90 (s, 1H), 3.83 – 3.73 (m, 2H), 1.17 (d, J = 6.5 
Hz, 12H). 
13
C NMR (CDCl3, 101 MHz, 298 K): δ 163.3, 162.5, 72.6, 42.7, 22.9. 
 
HR-MS (ESI): Required for C10H20N5 [M+H]
+
 210.1719, found: 210.1713  (Δ = 2.9  ppm). 
 




MP:  128 – 131 °C 
 

















Synthesis of iBP 
 
 
4,6-Dichloropyrimidin-2-amine (307 mg, 1.87 mmol) was flushed with nitrogen in a MW 
vial. Isopropylamine (2 mL, 18.8 mmol) was added and the mixture was heated in microwave 
at 130 °C for 18 hours. The remaining amine was removed under reduced pressure and the 
residue was loaded on Celite. A combiflash of the residue on silica (EtOAc/MeOH: MeOH 
0%→5%→10%) provided the title compound (392 mg, 88% yield) as a yellowish solid. 
 
1
H NMR (CDCl3, 400 MHz, 298 K): δ 4.79 (s, 1H), 4.57 (s, 2H), 4.46 (s, 2H), 3.00 – 2.93 
(m, 4H), 1.90 – 1.78 (m, 2H), 0.95 (d, J = 6.5 Hz, 12H). 
13
C NMR (CDCl3, 101 MHz, 298 K): δ 164.4, 162.4, 71.9, 49.4, 28.3, 20.3. 
 
HR-MS (ESI): Calculated for C12H24N5 [M+H]
+ 
238.2032, found: 238.2035 (Δ = 1.3 ppm) 
 




MP: 151 – 153 °C 
 

















Synthesis of tBP 
 
 
4,6-Dichloropyrimidin-2-amine (178 mg, 1.06 mmol) was flushed with nitrogen in a MW 
vial. N,N-diisopropylethylamine (0.5 mL, 2.48 mmol), isopropyl alcohol (1.0 mL) and 4-
tertbutylaniline (0.6 mL, 562 mg, 3.77 mmol) were added and the mixture was heated in 
microwave at 150 °C for 1 hours. Then, additional 4-tert-butylaniline (0.5 μL, 467 mg, 
3.14 mmol) was added under nitrogen atmosphere and the mixture was heated in microwave 
at 170 °C for 10 hours. A saturated solution of NaHCO3 (20 mL) and water (20 mL) were 
added and the mixture was extracted with CH2Cl2/MeOH (10:1; 2 × 50 mL) and CH2Cl2 
(2 × 50 mL). The organic phase was dried over MgSO4, evaporated and loaded to Celite. A 
combiflash of the residue on silica (CH2Cl2/MeOH: MeOH 0%→10%) provided the title 





-DMSO, 400 MHz, 298 K): δ 8.52 (s, 2H), 7.44 (d, J = 8.5 Hz, 4H), 7.25 (d, 
J = 8.5 Hz, 4H), 5.80 (s, 2H), 5.50 (s, 1H), 1.26 (s, 18H). 
 
MP:  281 – 284 °C 
 
LCMS Method: Col3-MeCN-SLOW 
 








Synthesis of iBT 
Synthesis according to the published procedure using isobutylamine.
26
 Pale yellowish solid, 
463 mg (30% yield). 
 
1
H NMR (CDCl3/CD3OD, 400 MHz, 298 K): δ 5.22 – 4.62 (m, 4H), 2.07 – 1.82 (m, 2H), 
1.07 (d, J = 6.5 Hz, 12H). (referenced to CD3OD) 
 
MP: 129 – 131 °C 
 












Synthesis of tBT 
Synthesis according to the published procedure.
26
 White solid, 1.4 g (55 % yield). 
 
1
H NMR (CDCl3/CD3OD, 400 MHz, 298 K): δ 7.41 (d, J = 8.5 Hz, 4H), 7.29 (d, J = 8.5 Hz, 
4H), 1.28 (s, 18H). (referenced to CD3OD) 
 
MP: 287 – 289 °C 
 









Synthesis of Pd(4B1)2Cl2 
 
 
4B1 (78.30 mg, 284 μmol) and Pd(ACN)2Cl2 (36.85 mg, 142 μmol) in DCM (10 mL) and 
MeOH (10 mL) were sonicated for 5 minutes and the solvents were removed under reduced 
pressure. This provided the title product (101 mg, 98% yield) as a pale yellow solid. 
 
1
H NMR (CDCl3/CD3OD, 400 MHz, 298 K): δ 8.58 (d, J = 6.5 Hz, 4H, A), 7.13 (d, 
J = 6.5 Hz, 4H, B), 3.26 (s, 4H, D), 2.04 – 2.00 (m, 4H, H), 1.32 – 1.18 (m, 8H, J + I), 0.86 (t, 
J = 7.0 Hz, 6H, K). (referenced to CD3OD) 
13
C NMR (CDCl3/CD3OD, 126 MHz, 298 K): δ 172.9 (F), 153.6 (A), 150.0 (G), 149.5 (C), 
127.1 (B), 57.8 (E), 41.7 (D), 41.2 (H), 27.4 (I), 23.1 (J), 13.9 (K). (referenced to CD3OD) 
 






 749.0844, found: 749.0833 
(Δ = 1.5 ppm). 
 




MP: 324 °C (transition/carbonisation) 
 

















Synthesis of trans-Pt(4B1)2Cl2 
 
 
4B1 (58.81 mg, 214 μmol) and cis-bis(acetonitrile)dichloroplatinum (37.3 mg, 107 μmol) in 
DMF (4 mL) were stirred at 80 °C under N2 for 4 days. The solvent was then evaporated and 
a combliflash of residue on silica (Celite loading, DCM/MeOH, MeOH: 0%→10%) provided 
the title product (19 mg, 22% yield) as a yellowish solid. 
 
1
H NMR (CDCl3/CD3OD, 400 MHz, 298 K): δ 8.66 (d, J = 6.5 Hz, 4H, A), 7.11 (d, 
J = 6.5 Hz, 4H, B), 3.28 (s, 4H, D), 2.08 – 1.98 (m, 4H, H), 1.36 – 1.17 (m, 8H, J + I), 0.87 (t, 
J = 7.0 Hz, 6H, K). (referenced to CD3OD) 
13
C NMR (CDCl3/CD3OD, 126 MHz, 298 K): δ 172.7 (F), 153.8 (A), 149.8 (G), 149.0 (C), 
127.2 (B), 57.6 (E), 41.4 (D), 41.1 (H), 27.2 (I), 23.0 (J), 13.8 (K). (referenced to CD3OD) 
 






 816.1642, found: 816.1638 
(Δ = 0.5 ppm). 
 




EA: Required for C28H34Cl2N6O6Pt: C 41.18, H 4.20, N 10.29; found: C 40.25, H 4.02, 
N 9.73. 
 


















Preparation of Pd(4B1)2Cl2•iPP2 
 
Step-wise 
4B1 (5.64 mg, 20.5 μmol) and Pd(ACN)2Cl2 (2.68 mg, 10.3 μmol), were added to a Y-NMR 
tube as solids. CDCl3 (0.6 mL) was added and the mixture was sonicated and shaken for 
5 minutes, which resulted in precipitation. Then, iPP (4.16 mg, 20.0 μmol) as a solid and 
additional CDCl3 (0.4 mL) were added and the mixture was shaken until everything dissolved. 
 
From 4B1•iPP 
4B1 (5.70 mg, 20.7 μmol) and iPP (4.38 mg, 20.9 μmol) were added to a Y-NMR tube as 
solids and CDCl3 (0.6 mL) was added. Afterwards, Pd(ACN)2Cl2 (2.72 mg, 10.5 μmol) as a 




Pd(ACN)2Cl2 (2.80 mg, 10.8 μmol),  4B1 (5.98 mg, 21.7 μmol ) iPP (4.57 mg, 21.9 μmol) 
were added to a Y-NMR tube as solids. CDCl3 (1 mL) was added and the mixture was 






Preparation of Pd(4B1)2Cl2•iBP2 
Pd(ACN)2Cl2 (2.99 mg, 11.5 μmol), 4B1 (5.98 mg, 23.1 μmol) iBP (5.45 mg, 23.0 μmol) 
were added to a Y-NMR tube as solids. CDCl3 (1 mL) was added and the mixture was 
sonicated and shaken for 10 minutes until everything dissolved. 
 
The 10-fold diluted sample was prepared as follow: 
0.1 mL of the above final solution was transferred to a NMR tube and additional CDCl3 
(0.9 mL) was added and the mixture was well mixed. 
 
  




























Preparation of Pd(4B1)2Cl2•tBT2 
 
 
To a Y-NMR tube, Pd(4B1)2Cl2 (6.04 mg, 8.31 μmol) and tBT (6.53 mg, 16.7 μmol) were 
added as solids. CDCl3 (0.8 mL) was added and the mixture was sonicated and shaken for 
5 minutes until everything dissolved. 
 
1
H NMR (CDCl3, 400 MHz, 298 K): δ 14.33 (s, 12H, L), 9.41 (s, 24H, 4), 8.65 (d, 
J = 6.5 Hz, 12H, A), 7.62 (d, J = 8.5 Hz, 24H, 6), 7.37 (d, J = 8.5 Hz, 24H, 7), 7.18 (d, 
J = 6.5 Hz, 12H, B), 6.96 (s, 24H, 1), 3.41 (s, 12H, D), 2.19 – 2.08 (m, 12H, H), 1.38 (s, 
108H, 10), 1.3 (m, 24H, J + I, covered by tert-butyl), 0.89 (t, J = 7.0 Hz, 18H, K). 
13
C NMR (CDCl3, 126 MHz, 298 K): δ 174.7 (F), 165.7 (2), 163.4 (3), 153.3 (A), 153.0 (G), 
148.0 (C), 146.3 (8), 136.3 (5), 126.7 (B), 125.3 (7), 121.8 (6), 57.2 (E), 42.7 (H), 38.5 (D), 

















6.9.4. Stimuli-responsive behaviour 
Response to PPh3 
•Addition of PPh3 
To a Y-NMR tube, Pd(4B1)2Cl2 (7.37 mg, 10.1 μmol) and tBT (6.53 mg, 20.1 μmol) were 
added as solids. CDCl3 (0.7 mL) was added and the mixture was sonicated and shaken for 
5 minutes until everything dissolved. PPh3 (5.32 mg, 20.3 μmol) as a solid and additional 
CDCl3 (0.1 mL) were added and the mixture was shaken for 2 minutes.  
•Recovery of the cage after addition of PPh3 
To the solution above, Pd(ACN)2Cl2 (2.66 mg, 10.3 μmol) as a solid and additional CDCl3 
(0.2 mL) were added and the mixture was shaken for 5 minutes. 
•Separate experiment to prove the formation of mixed pyridine–phosphine–palladium species  
To a Y-NMR tube, Pd(ACN)2Cl2 (5.68 mg, 21.6 μmol), 4B1 (6.06 mg, 22.0 μmol) and PPh3 
(5.74 mg, 21.9 μmol) were added as solids. CDCl3 (0.8 mL) was added and the mixture was 
sonicated and shaken for 2 minutes until everything dissolved. 
 
Response to dppf 
•Addition of dppf 
To a Y-NMR tube, Pd(4B1)2Cl2 (6.05 mg, 8.3 μmol) and tBT (6.67 mg, 17.1 μmol) were 
added as solids. CDCl3 (0.7 mL) was added and the mixture was sonicated and shaken for 
5 minutes until everything dissolved. dppf (4.60 mg, 8.3 μmol) as a solid and additional 
CDCl3 (0.1 mL) were added and the mixture was shaken for 2 minutes.  
•Recovery of the cage after addition of dppf 
To the solution above, Pd(ACN)2Cl2 (2.16 mg, 8.3 μmol) as a solid and additional CDCl3 
(0.1 mL) were added and the mixture was shaken for 5 minutes. 
 
Response to cya 
Pd(4B1)2Cl2 (10.55 mg, 14.5 μmol), tBT (11.46 mg, 29.3 μmol) and CDCl3 (2 mL) were 
sonicated for 10 minutes. 0.1 mL of this solution was then transferred to a Y-NMR tube and 
additional CDCl3 (0.5 mL) was added.  To this solution, cya (0.30 mg, 1.5 μmol) was added 
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